Alexander J. Lazar

Peer-Reviewed Articles

1. Patel RR, Feit J, Werling G, White NM, Bishop AJ, Lin PP, Valenzuela Perez RF, Lazar AJ, Benjamin RS, Patel SR, Ludwig J, Ravi V, Livingston JA, Zarzour MA, Conley A, Somaiah N, Araujo DM. Primary Synovial Sarcoma of the Abdomen and Pelvis. Am J Clin Oncol, 2025. e-Pub 2025. PMID: 41342607.
2. Ruiz-Cordero R, Wang Q, Kumar G, Akgul M, Creighton CJ, Rao P, Tamboli P, Zheng L, Zhao J, Murugan P, Shen S, Brimo F, Ezhilarasan R, Sulman E, Wani K, Lazar AJ, Kim T, Chen K, Bhat KPL, Kannan K, Wang J, Karam JA, Sircar K. Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples. Eur Urol Oncol 8(6):1629-1638, 2025. e-Pub 2025. PMID: 41193273.
3. Msaouel P, Tannir NM, Meric-Bernstam F, King JM, Voss MH, Cheng JP, Thomas SS, Lim ZD, Karki M, He R, Genovese G, Sheth RA, Ingram DR, Shamsutdinova D, Wani KM, Wang WL, Lazar AJ, Knipper-Davis D, Berlinski A, Soares T, Stupichev D, Kryukov K, Davitavyan S, Novokreshchenova A, Lebedev D, Kurpe S, Kravets A, Belousov D, Hensley M, Bagaev A, Paradiso F, Kushnarev V. Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling. Cell Rep Med 6(11):102423, 2025. e-Pub 2025. PMID: 41172996.
4. Morad G, Damania AV, Melendez B, Singh BB, Veguilla FJ, Soto RA, Hoballah YM, Sahasrabhojane PV, Wong MC, Ahmed MM, Rico RN, Lewis KN, Wani K, Shamsutdinova DD, Lazcano Segura RN, Ingram DR, Goethe EA, Day A, Flores II, McDaniel LK, Chelvanambi M, Johnson SB, Dimitriou F, Gupta P, Oberai S, Zal MA, Doss P, Jamal MA, Hayase E, Wathoo C, Norberg LM, Jenkins SL, Nass S, Gumin J, Long L, Yang J, Bradley GR, Bekal MP, Dono AG, Pichardo-Rojas PS, Andrewes SW, Ballester LY, Losh JS, Liang J, Huo L, Nielsen DC, Parker Kerrigan BC, Brastianos PK, Fowlkes NW, Chang CC, Jenq RR, Gomez-Manzano C, Huse JT, Davies MA, Lazar AJ, Bhat KP, Tandon N, Esquenazi Y, Peterson CB, Puduvalli VK, Lang FF, Johnston CD, Bullman S, Ajami NJ, Ferguson SD, Wargo JA. Microbial signals in primary and metastatic brain tumors. Nat Med 31(11):3675-3688, 2025. e-Pub 2025. PMID: 41238915.
5. Knisely, A, Dai, Y, Barlow, GL, Lee, S, Lawson, BC, Clark, HD, Fellman, B, Yuan, Y, Lu, W, Lubo Julio, IC, Lazcano, RN, Chelvanambi, M, Melendez, B, Singh, BB, Singh, B, Wani, K, Chen, J, Yeh, CC, Gao, J, Barnes, S, Shi, O, Khan, KB, Serrano, A, Gomez Bolanos, L, Scalise, CB, Cheung, SK, Dutta, P, Velichko, S, ElNaggar, AC, Liu, MC, Wilke, RN, How, JA, Ramondetta, LM, Boruta II, DM, Richardson, G, Shafer, A, Westin, SN, Sims, TT, Sood, AK, Ramirez, PT, Lazar, A, Soliman, PT, Lu, KH, Haymaker, CL, Solis Soto, LM, Wargo, J, Grisham, RN, Wucherpfennig, K, Wang, L, Jazaeri, AA. Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy. Clinical Cancer Research 31(19):4122-4135, 2025. e-Pub 2025. PMID: 40748258.
6. Burton, EM, Milton, D, Tetzlaff, M, Wani, K, Ross, MI, Postow, MA, Segura Lazcano, R, Glitza, IC, Wong, MK, Patel, SP, Diab, A, Gershenwald, JE, McQuade, JL, Warner, AB, Prieto, V, Lee, JE, Goepfert, RP, Fisher, SB, Song, A, Malke, J, Simon, JM, Ariyan, C, Torres Cabala, CA, Davies, MA, Lazar, AJ, Wargo, J, Tawbi, H, Amaria, RN. Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma. Journal of Clinical Oncology 43(26):2856-2862, 2025. e-Pub 2025. PMID: 40638872.
7. Satpathy, S, Clark, NM, Chen, YJ, Hosseini, N, Chang, YH, Hsiao, Y, Lei, JT, Petralia, F, Chen, JS, Geffen, Y, Heiman, DI, Paul, I, Cho, H, Hollenberg, M, Marino, GB, Lin, KT, Mannan, R, White, CJ, Allen, J, Avanessian, SC, Kane, MH, Wolfe, A, Kinarivala, M, Liu, W, Anand, S, Lin, MW, Haines, M, Bergstrom, EJ, Hussey, G, Li, GX, Mani, DC, Fang, H, Jaehnig, EJ, Keshishian, H, Miller, B, Su, KY, Hsiao, YJ, Hsu, HH, Hsieh, MS, Hsu, KH, Monovoukas, A, Gohsman, S, Thorup, JR, Deng, Y, Akiyama, Y, Deng, EZ, Sheng-Wen Chen, E, Krek, A, Espinoza, R, Ma, W, Charytonowicz, D, Sebra, R, Lin, JH, Chen, YS, Hsu, YC, Lin, ZS, Chen, KC, Yeh, CW, Wang, YT, Lazar, AJ, Mesri, M, An, E, Zhang, X, Clauser, KR, Fenyö, D, Chinnaiyan, AM, Zhang, B, Ding, L, Ruggles, K, Newton, CJ, Zhang, H, Wang, P, Hostetter, G, Omenn, GS, Kumar-Sinha, C, Thiagarajan, M, Govindan, R, Paik, PK, Parolia, A, Li, QK, Ma'ayan, A, Getz, G, Dhanasekaran, SM, Robles, AI, Chang, GC, Yang, PC, Yu, SL, Chen, HY, Nesvizhskii, AI, Carr, SA, Mani, DR, Cieślik, M, Chen, YJ, Gillette, MA, Lu, CW, Chu, CH, Shen, CY, Han, CL, Lin, CC, Lin, CY, Chen, CW, Lin, CH, Hsu, HE, Tsai, HJ, Wu, JJ, Lin, JW, Waniwan, J, Liao, KH, Chen, PH, Huang, PR, Huang, SM, Lin, TC, Lai, WC, Chiu, WT, Chiang, XH, Chang, YL, Chen, YM, Chen, YL, Wang, YW, Lin, YW, Chang, YC, Huang, YT, Lien, Y, Zheng, ZR, Hashimi, AS, Mohan, A, Pandey, A, Pilozzi, A, Webster, A, Paulovich, A, Dagar, A, Godwin, AK, Pruetz, B, Williams, BO, Druker, BJ, Rohrer, DC, Chan, DW, Petrov, D, Chesla, DW, Davaar, D, Duffy, E, Wilson, GD, Zhao, G, Kołodziejczak, I, Lubinski, J, Huang, J, Hafron, J, Tyner, JW, Koomen, JM, Zaalishvili, K, Ketchum, KA, Wiznerowicz, M, Domagalski, MJ, Anurag, M, Borucki, M, Edwards, N, Vatanian, N, Grady, P, Piehowski, PD, Bogdan, P, Li, Q, Fonseca, R, Madan, R, Thangudu, RR, Crispen, R, Matteotti, R, Bremner, RM, Cerda, S, Cottingham, SL, Tsang, S, Cai, S, Liu, T, Bauer, T, Maggio, WW, Jing, X, Zhang, Y, Shutack, Y, Andric, ZG. Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures. Cancer cell 43(9):1731-1757.e17, 2025. e-Pub 2025. PMID: 40749670.
8. Bhinder, B, Friedl, V, Sethuraman, S, Risso, D, Chiotti, K, Mashl, RJ, Ellrott, K, Lee, JA, Wong, C, Gyan, K, Deshpande, A, Imielinski, MB, Bareja, R, Stuart, JM, Peto, M, Hoadley, KA, Lazar, AJ, Cherniack, AD, Zhu, J, Cao, S, Rubin, MA, Wang, W, Bathe, OF, Robine, N, Ding, L, Laird, PW, Zhou, W, Shen, H, Thorsson, V, Yeh, JJ, Bailey, M, Zhou, DC, Peng, X, Goldman, M, Li, Y, Korkut, A, Sahni, N, Hayes, DN, Mensah, MK, Felau, I, Kemal, A, Caesar-Johnson, SJ, Demchok, JA, Yang, L, Ferguson, ML, Tarnuzzer, R, Wang, Z, Zenklusen, JC, Cancer Genome Atlas Network, Spellman, P, Elemento, O. Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profiles. Scientific reports 15(1), 2025. e-Pub 2025. PMID: 40615649.
9. Huang J, Yuan C, Jiang J, Chen J, Badve SS, Gokmen=Polar Y, Segur RL, Yan X, Lazar AJ, Gao J, Yao B, Epstein M, Wang L, Hu J. Bridging cell morphological behaviors and molecular dynamics in multi-modal spatial omics with MorphLink. Nat Commun 16(1):5878, 2025. e-Pub 2025. PMID: 40595621.
10. Traweek, R, Zoghbi, M, Segura Lazcano, R, Cope, B, Bishop, AJ, Farooqi, AS, Mitra, D, Yoder, A, Guadagnolo, BA, Ingram, D, Wani, K, Shamsutdinova, D, Lazar, AJ, Wang, WL, Scally, CP, Keung, EZ, Torres, KE, Hunt, KK, Ratan, R, Livingston, JA, Nakazawa, MS, Araujo, DM, Patel, S, Ravi, V, Conley, AP, Zarzour, MA, Somaiah, N, Roland, CL, Nassif, EF. Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. ESMO Open 10(7), 2025. e-Pub 2025. PMID: 40561658.
11. Ayabe, RI, Seo, YD, Melendez, B, Fields, BC, Diggs, LP, Segura Lazcano, R, Singh, BB, Wani, K, Ingram, D, Johnson, S, Chelvanambi, M, Hudgens, CW, Hernandez, S, Ajami, NJ, Wargo, J, Lazar, AJ, Knafl, M, Woodman, SE, Halperin, DM, Estrella, JS, Maxwell, JE. Cancer Testis Antigen Expression Correlates with Immune Activation and Survival in Small Bowel Neuroendocrine Tumors. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 40638874.
12. Tercan, B, Apolonio, VH, Chagas, VS, Wong, CK, Lee, JA, Yau, C, Benz, CC, Stuart, JM, Karlberg, BJ, Ellrott, K, Grewal, JK, Jones, SJ, Knijnenberg, TA, Castro, MA, Chagas, VS, Apolonio, VH, Friedl, V, Stuart, JM, Uzunangelov, V, Wong, C, Beroukhim, R, Cherniack, AD, Gao, GF, Getz, G, Hoyt, SH, Loinaz, X, Roh, W, Stewart, C, Westlake, L, Benz, C, Grewal, JK, Jones, SJ, Robertson, AG, Caesar-Johnson, SJ, Demchok, JA, Felau, I, Kemal, A, Tarnuzzer, R, Wang, PI, Wang, Z, Yang, L, Zenklusen, JC, Akbani, R, Broom, BM, Ju, Z, Schultz, A, Ojesina, AI, Hoadley, KA, Lal, A, Lazar, AJ. Protocol for assessing distances in pathway space for classifier feature sets from machine learning methods. STAR Protocols 6(2), 2025. e-Pub 2025. PMID: 40106435.
13. Grewal, JK, Robertson, AG, Ellrott, K, Wong, CK, Lee, JA, Yau, C, Tercan, B, Castro, MA, Benz, C, Knijnenburg, T, Castro, MA, Chagas, VS, Apolonio, VH, Friedl, V, Stuart, JM, Uzunangelov, V, Wong, C, Andersen, JB, Cherniack, AD, Gao, GF, Getz, G, Hoyt, SH, Roh, W, Westlake, L, Benz, CC, Grewal, JK, Jones, SJ, Robertson, AG, Caesar-Johnson, SJ, Demchok, JA, Felau, I, Kemal, A, Tarnuzzer, R, Wang, Z, Yang, L, Zenklusen, JC, Akbani, R, Broom, BM, Ju, Z, Schultz, A, Ojesina, AI, Hoadley, KA, Lal, A, Ramazzotti, D, Wang, C, Lazar, AJ, Roberts, LR, Kim, TK, Shmulevich, I, Tercan, B. Protocol for obtaining cancer type and subtype predictions using subSCOPE. STAR Protocols 6(2), 2025. e-Pub 2025. PMID: 40202838.
14. Zhu, Y, Solis Soto, LM, Pant, S, Vega, EA, Vinuela, E, Bozorgui, B, Vauthey, JN, Aguayo, G, Wang, Z, Lu, W, Chen, X, Mino, B, Kakarala, L, Dai, J, Liu, S, Wani, K, Lazar, AJ, Carapeto, F, Lee, S, Wistuba, II, Korkut, A, Javle, M, Kwong, L. Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance. Modern Pathology 38(11), 2025. e-Pub 2025. PMID: 40541865.
15. Kołodziejczak-Guglas I, Simões RLS, de Souza Santos E, Demicco EG, Lazcano Segura RN, Ma W, Wang P, Geffen Y, Storrs E, Petralia F, Colaprico A, da Veiga Leprevost F, Pugliese P, Ceccarelli M, Noushmehr H, Nesvizhskii AI, Kamińska B, Priebe W, Lubiński J, Zhang B, Lazar AJ, Kurzawa P, Mesri M, Robles AI, Clinical Proteomic Tumor Analysis Consortium, Ding L, Malta TM, Wiznerowicz M. Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets. Cell Genomics, 2025. e-Pub 2025. PMID: 40250426.
16. Martins Rodrigues F, Terekhanova NV, Imbach KJ, Clauser KR, Esai Selvan M, Mendizabal I, Geffen Y, Akiyama Y, Maynard M, Yaron TM, Li Y, Cao S, Storrs EP, Gonda OS, Gaite-Reguero A, Govindan A, Kawaler EA, Wyczalkowski MA, Klein RJ, Turhan B, Krug K, Mani DR, Leprevost FDV, Nesvizhskii AI, Carr SA, Fenyö D, Gillette MA, Colaprico A, Iavarone A, Robles AI, Huang KL, Kumar-Sinha C, Aguet F, Lazar AJ, Cantley LC, Marigorta UM, Gümüş ZH, Bailey MH, Getz G, Porta-Pardo E, Ding L, Analysis Consortium CPT. Precision proteogenomics reveals pan-cancer impact of germline variants. Cell 188(9):2312-2335, 2025. e-Pub 2025. PMID: 40233739.
17. Ginn, MP, Denu, RA, Ingram, D, Wani, K, Lazar, AJ, Harrison, DJ, Nakazawa, MS, Conley, AP, Patel, S, Livingston, JA. TFCP2 Fusion-Positive Rhabdomyosarcomas. Cancers 17(9), 2025. e-Pub 2025. PMID: 40361368.
18. Kumar, S, Pelster, MS, Hasanov, M, Guerrieri, R, Hudgens, CW, Ledesma, D, Wang, F, Fischer, G, Simon, JM, Haydu, LE, Katlowitz, KV, Yennu Nanda, VG, McQuade, JL, Kwong, L, Huse, J, Lazar, AJ, Tetzlaff, M, Gershenwald, JE, Joon, A, Chen, K, Li, Z, Ram, P, Ferguson, SD, Davies, MA. Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis. Acta Neuropathologica Communications 13(1), 2025. e-Pub 2025. PMID: 40229864.
19. Grimm SL, Karki M, Blum KA, Bertocchio JP, He R, Tripathi DN, Zacharias NM, Lebenthal JM, Sheth RA, Rao P, Genovese G, Lu Z, Bast Jr RC, Ingram DR, Lazcano R, Wani KM, Wei-Lien Wang WL, Lazar AJ, Tannir NM, Walker CL, Coarfa C, Msaouel P. CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation. Clin Cancer Res 31(6):1057-1068, 2025. e-Pub 2025. PMID: 39836407.
20. Patel, R, Bishop, AJ, Lazar, AJ, Lin, PP, Benjamin, RS, Patel, S, Ludwig, JA, Ravi, V, Vaporciyan, AA, Araujo, DM. Primary Intrathoracic Synovial Sarcoma. Cancers 17(5), 2025. e-Pub 2025. PMID: 40075593.
21. Coleman K, Schroeder A, Loth M, Zhang D, Park JH, Sung JY, Blank N, Cowan AJ, Qian X, Chen J, Jiang J, Yan H, Samarah LZ, Clemenceau JR, Jang I, Kim M, Barnfather I, Rabinowitz JD, Deng Y, Lee EB, Lazar AJ, Gao J, Furth EE, Hwang TH, Wang L, Thaiss CA, Hu J, Li M. Resolving tissue complexity by multimodal spatial omics modeling with MISO. Nat Methods, 2025. e-Pub 2025. PMID: 39815104.
22. Sibai, M, Cervilla, S, Grases, D, Musulen, E, Segura Lazcano, R, Mo, CK, Davalos, V, Fortian, A, Bernat, A, Romeo, M, Tokheim, C, Barretina, J, Lazar, AJ, Ding, L, Grande, E, Alonso-Gordoa, T, Álvarez-Maestro, M, Andrada, E, Azueta, A, Javier Burgos, RB, Castellano, D, Climent, MA, Domínguez, M, Albert Font, ID, Galante, I, Galvan, P, García, JF, García del Muro, X, Guerrero-Ramos, F, Malats, N, Marqués, M, Maroto, P, Martínez de Villarreal, J, Moreno-Oya, A, Paramio, JM, Pinto, A, Prat, A, Puente, J, Reig, O, Real, FX, Real, FX, Esteller, M, Bailey, M, Porta-Pardo, E. The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity. Cell Reports 44(2), 2025. e-Pub 2025. PMID: 39864059.
23. Andrew Livingston, J, Blay, JY, Trent, JC, Valverde Morales, C, Agulnik, M, Gounder, M, Le Cesne, A, McKean, M, Wagner, MJ, Stacchiotti, S, Agresta, S, Quintás-Cardama, A, Reilly, SA, Healy, K, Hickman, D, Zhao, T, Ballesteros-Perez, A, Khalil, A, Collins, M, Piel, J, Horrigan, K, Lefkovith, A, Innis, S, Lazar, AJ, Cote, GM, Wagner, AJ. A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors. Clinical Cancer Research 31(4):628-638, 2025. e-Pub 2025. PMID: 39660994.
24. Ellrott K, Wong CK, Yau C, Castro MAA, Lee JA, Karlberg BJ, Grewal JK, Lagani V, Tercan B, Friedl V, Hinoue T, Uzunangelov V, Westlake L, Loinaz X, Felau I, Wang PI, Kemal A, Caesar-Johnson SJ, Shmulevich I, Lazar AJ, Tsamardinos I, Hoadley KA, Analysis Network CGA, Robertson AG, Knijnenburg TA, Benz CC, Stuart JM, Zenklusen JC, Cherniack AD, Laird PW. Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets. Cancer Cell, 2025. e-Pub 2025. PMID: 39753139.
25. Guerrieri RA, Fischer GM, Kircher DA, Joon AY, Cortez JR, Grossman AH, Hudgens CW, Ledesma DA, Lazcano R, Onana CY, Knighton BG, Kumar S, Hu Q, Gopal YNV, McQuade JL, Deng W, Haydu LE, Gershenwald JE, Lazar AJ, Tetzlaff MT, Holmen SL, Davies MA. Oxidative Phosphorylation (OXPHOS) Promotes the Formation and Growth of Melanoma Lung and Brain Metastases. bioRxiv, 2025. e-Pub 2025. PMID: 39896644.
26. Tomczak, K, Patel, MS, Bhalla, A, Peterson, CB, Landers, S, Callahan, SC, Zhang, D, Wong, J, Landry, JP, Lazar, AJ, Livingston, JA, Guadagnolo, BA, Lyu, H, Lillemoe, HA, Roland, CL, Keung, EZ, Scally, CP, Hunt, KK, McCutcheon, IE, Slopis, JM, Gu, J, Scheet, PA, Wang, L, Rai, K, Torres, KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Molecular Carcinogenesis 64(1):44-56, 2025. e-Pub 2025. PMID: 39600120.
27. Torres, MB, Leung, CH, Zoghbi, M, Segura Lazcano, R, Ingram, D, Wani, K, Keung, EZ, Zarzour, MA, Scally, CP, Hunt, KK, Conley, AP, Bishop, AJ, Guadagnolo, BA, Farooqi, AS, Mitra, D, Yoder, A, Nakazawa, MS, Araujo, DM, Livingston, A, Ratan, R, Patel, S, Ravi, V, Lazar, AJ, Roland, CL, Somaiah, N, Nassif, EF. Dedifferentiated liposarcomas treated with immune checkpoint blockade. Frontiers in immunology 16, 2025. e-Pub 2025. PMID: 40370451.
28. Giani C, Salawu A, Ljevar S, Denu RA, Napolitano A, Palmerini E, Connolly EA, Ogura K, Wong DD, Scanferla R, Rosenbaum E, Bajpai J, Li ZC, Bae S, D'Ambrosio L, Bialick S, Wagner AJ, Lee ATJ, Kosela-Paterczyk H, Baldi GG, Brunello A, Lee YC, Loong HH, Boikos S, Campos F, Cicala CM, Maki RG, Hindi N, Figura C, Almohsen SS, Patel S, Jones RL, Ibrahim T, Karim R, Kawai A, Carey-Smith R, Boyle R, Taverna SM, Lazar AJ, Demicco EG, JVMG B, Dei Tos AP, Fletcher C, Baumhoer D, Sbaraglia M, Schaefer IM, Miceli R, Gronchi A, Stacchiotti S. International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease. Am J Surg Pathol 49(1):27-34, 2025. e-Pub 2025. PMID: 39466087.
29. Patel RR, Delclos GL, DeSantis SM, Cannell MB, Lupo PJ, Bishop AJ, Lazar AJ, Lin PP, Benjamin RS, Patel SR, Ludwig J, Ravi V, Livingston JA, Somaiah N, Zarzour MA, Conley AP, Araujo DM. Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?. Am J Clin Oncol 48(1):21-27, 2025. e-Pub 2025. PMID: 39224003.
30. Denu, RA, Quintana-Perez, CD, Wangsiricharoen, S, Ingram, D, Wani, K, Lazar, AJ, Ratan, R, Roland, CL, You, YN. DNA mismatch repair deficiency as a biomarker in sarcoma. Surgical Oncology Insight 1(4), 2024. e-Pub 2024. PMID: 40190387.
31. Serrano, A, Rocha, P, Freitas Lima, C, Stewart, A, Zhang, B, Diao, L, Fujimoto, J, Cardnell, R, Lu, W, Khan, KB, Sable, B, Ellison, AR, Wistuba, II, Concannon, KF, Halperin, DM, Czerniak, BA, Sircar, K, Zhang, M, Cargill, KR, Wang, Q, Aparicio, A, Lazar, AJ, Hernandez, S, Estrella, JS, Ramalingam, P, El-Naggar, AK, Kalhor, N, Gay, CM, Byers, LA, Solis Soto, LM. Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms. npj Precision Oncology 8(1), 2024. e-Pub 2024. PMID: 39558076.
32. Patel RR, Gopalakrishnan V, Amini B, Lazar AJ, Lin PP, Benjamin RS, Bishop AJ, Goepfert RP, Araujo DM. Oncologic Outcomes in Patients with Localized, Primary Head and Neck Synovial Sarcoma. Cancers (Basel) 16(23):4119, 2024. e-Pub 2024. PMID: 39682304.
33. Lyu HG, Witt RG, Rajkot N, Keung EZ, Torres KE, Hunt KK, Somaiah N, Lazar AJ, Roland CL, Scally CP. Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center. Ann Surg Oncol 31(13):9258-9264, 2024. e-Pub 2024. PMID: 39230849.
34. Beird HC, Cloutier JM, Gokgoz N, Eeles C, Griffin AM, Ingram DR, Wani KM, Segura RL, Cohen L, Ho C, Wunder JS, Andrulis IL, Futreal PA, Haibe-Kains B, Lazar AJ, Wang WL, Przybyl J, Demicco EG. Epigenomic and transcriptomic profiling of solitary fibrous tumors identifies site-specific patterns and candidate genes regulated by DNA methylation. Lab Invest 104(11):102146, 2024. e-Pub 2024. PMID: 39357799.
35. Patil MD, Wangsiricharoen S, AJ <, Moon B, Madewell JE, Collins MT, Guise TA. Approach to determining etiology of hypophosphatemia in a patient with coexisting phosphaturic mesenchymal tumor and fibrous dysplasia. JBMR Plus 9(1):ziae145, 2024. e-Pub 2024. PMID: 39664934.
36. Bowen MB, Melendez B, Zhang Q, Yang RK, Fellman BM, Lawson BC, Adjei NN, Celestino J, Wani KM, Singh B, Urbauer DL, Lazar AJ, Lu KH, Wargo JA, Westin SN, Yates MS. Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion. Clin Cancer Res 30(22):5073-5082, 2024. e-Pub 2024. PMID: 38922360.
37. Gingrich A, Wangsiricharoen S, Torres MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE. Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas): Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol 31(12):7950-7956, 2024. e-Pub 2024. PMID: 39150618.
38. Folkert IW, Molina Arocho WA, To TKJ, Devalaraja S, Molina IS, Shoush J, Mohei H, Zhai L, Akhtar MN, Kochat V, Arslan E, Lazar AJ, Wani K, Israel WP, Zhang Z, Chaluvadi VS, Norgard RJ, Liu Y, Fuller AM, Dang MT, Roses RE, Karakousis GC, Miura JT, Fraker DL, Eisinger-Mathason TSK, Simon MC, Weber K, Tan K, Fan Y, Rai K, Haldar M. An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axis. J Exp Med 221(10), 2024. e-Pub 2024. PMID: 39347789.
39. Giani, C, Denu, RA, Ljevar, S, Gronchi, A, Napolitano, A, Rosenbaum, E, Salawu, A, Bajpai, J, Connolly, E, Lee, A, Trent, J, Kosela, H, Chia-Chen Li, Z, Ogura, K, Palmerini, E, Baldi, GG, Brunello, A, Campos, F, Cicala, CM, Maki, RG, Wagner, AJ, Andelkovic, V, Loong, HH, Wong, DD, Jones, RL, Tap, WD, Taverna, SM, Lazar, AJ, Demicco, EG, Hong, A, Bovée, JV, Dei Tos, AP, Fletcher, CD, Baumhoer, D, Sbaraglia, M, Schaefer, IM, Miceli, R, Stacchiotti, S. Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease. ESMO Open 9(9), 2024. e-Pub 2024. PMID: 39265219.
40. Sundaram L, Kumar A, Zatzman M, Salcedo A, Ravindra N, Shams S, Louie BH, Bagdatli ST, Myers MA, Sarmashghi S, Choi HY, Choi WY, Yost KE, Zhao Y, Granja JM, Hinoue T, Hayes DN, Cherniack A, Felau I, Choudhry H, Zenklusen JC, Farh KK, McPherson A, Curtis C, Laird PW, Analysis Network‡ CGA, Demchok JA, Yang L, Tarnuzzer R, Caesar-Johnson SJ, Wang Z, Doane AS, Khurana E, Castro MAA, Lazar AJ, Broom BM, Weinstein JN, Akbani R, Kumar SV, Raphael BJ, Wong CK, Stuart JM, Safavi R, Benz CC, Johnson BK, Kyi C, Shen H, Corces MR, Chang HY, Greenleaf WJ. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers. Science 385(6713):eadk9217, 2024. e-Pub 2024. PMID: 39236169.
41. Lazcano R, Ingram DR, Panse G, Lazar AJ, Wang WL, Cloutier JM. TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3. Hum Pathol 151:105632, 2024. e-Pub 2024. PMID: 39084565.
42. Kasper B, Baldini E, Bonvalot S, Callegaro D, Cardona K, Colombo C, Corradini N, Crago A, Dei Tos AP, Dileo P, Elnekave E, Erinjeri JP, Fariba N, Farma J, Ferrari A, Fiore M, Gladdy R, Gounder M, Haas R, Husson O, Kurtz JE, Lazar AJ, Orbach D, Penel N, Ratan R, Raut CP, Roland CL, Schut AR, Sparber-Sauer M, Strauss DC, Van der Graaf W, Vitellaro M, Weiss A, Gronchi A, Working Group TDT. Current Management of Desmoid Tumors: An Update from the Desmoid Tumor Working Group. JAMA Oncol 10(8):1121-1128, 2024. e-Pub 2024. PMID: 38900421.
43. Huang J, Yuan C, Jiang J, Chen J, Badve SS, Gokmen-Polar Y, Segura RL, Yan X, Lazar A, Gao J, Epstein M, Wang L, Hu J. MorphLink: Bridging Cell Morphological Behaviors and Molecular Dynamics in Multi-modal Spatial Omics. bioRxiv, 2024. e-Pub 2024. PMID: 39253421.
44. Jiang J, Liu Y, Qin J, Chen J, Wu J, Pizzi MP, Lazcano R, Yamashita K, Xu Z, Pei G, Cho KS, Chu Y, Sinjab A, Peng F, Yan X, Han G, Wang R, Dai E, Dai Y, Czerniak BA, Futreal A, Maitra A, Lazar AJ, Kadara H, Jazaeri AA, Cheng X, Ajani J, Gao J, Hu J, Wang L. METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nat Commun 15(1):7312, 2024. e-Pub 2024. PMID: 39181865.
45. Nakazawa MS, Livingston JA, Zarzour MA, Bishop AJ, Ratan R, Ludwig JA, Araujo DM, Somaiah N, Ravi V, Nassif EF, Roland CL, Lazar AJ, Guadagnolo BA, Harrison DJ, Benjamin RS, Patel SR, Conley AP. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort. Rare Tumors 16:20363613241271669, 2024. e-Pub 2024. PMID: 39105190.
46. Nakazawa MS, Ian M Silverman IM, Rimkunas V, Veloso A, Glodzik D, Johnson A, Ohsumi TK, Patel S, Conley AP, Roland CL, Soliman PT, Beird H, Wu CC, Ingram DR, Lazcano R, Song D, Wani K, Lazar AJ, Yap TA, Wang WL, Livingston JA. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Mol Cancer Ther, 2024. e-Pub 2024. PMID: 38561019.
47. Chen A, Sharma N, Patel P, Olivares S, Bahrami A, Barnhill RL, Blokx WAM, Bosenberg M, Busam KJ, de La Fouchardière A, Duncan LM, Elder DE, Ko JS, Landman G, Lazar AJ, Lezcano C, Lowe L, Maher N, Massi D, Messina J, Mihic-Probst D, Parker DC, Redpath M, Scolyer RA, Shea CR, Spatz A, Tron V, Xu X, Yeh I, Jung Yun S, Zembowicz A, Gerami P. The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic Neoplasms. Am J Surg Pathol 48(6):708-718, 2024. e-Pub 2024. PMID: 38590014.
48. Raso MG, Barrientos Toro E, Evans K, Rizvi Y, Lazcano R, Akcakanat A, Sini P, Trapani F, Madlener EJ, Waldmeier L, Lazar A, Meric-Bernstam F. Heterogeneous Profile of ROR1 Protein Expression across Tumor Types. Cancers (Basel) 16(10), 2024. e-Pub 2024. PMID: 38791952.
49. Pilié PG, Giuliani V, Wang WL, McGrail DJ, Bristow CA, Ngoi NYL, Kyewalabye K, Wani KM, Le H, Campbell E, Sanchez NS, Yang D, Gheeya JS, Goswamy RV, Holla V, Shaw KR, Meric-Bernstam F, Liu CY, Ma X, Feng N, Machado AA, Bardenhagen JP, Vellano CP, Marszalek JR, Rajendra E, Piscitello D, Johnson TI, Likhatcheva M, Elinati E, Majithiya J, Neves J, Grinkevich V, Ranzani M, Luzarraga MR, Boursier M, Armstrong L, Geo L, Lillo G, Tse WY, Lazar AJ, Kopetz SE, Geck Do MK, Lively S, Johnson MG, Robinson HMR, Smith GCM, Carroll CL, Di Francesco ME, Jones P, Heffernan TP, Yap TA. Ataxia-Telangiectasia Mutated (ATM) loss of function displays variant and tissue-specific differences across tumor types. Clin Cancer Res 30(10):2121-2139, 2024. e-Pub 2024. PMID: 38416404.
50. Gerami P, Chen A, Sharma N, Patel P, Hagstrom M, Kancherla P, Geraminejad T, Olivares S, Biswas A, Bosenberg M, Busam KJ, de La Fouchardière A, Duncan LM, Elder DE, Ko J, Landman G, Lazar AJ, Lowe L, Massi D, Mihic-Probst D, Parker DC, Scolyer RA, Shea CR, Zembowicz A, Yun SJ, Blokx WAM, Barnhill RL. BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms. Am J Surg Path, 2024. e-Pub 2024. PMID: 38525831.
51. Nasr LF, Zoghbi M, Lazcano R, Nakazawa M, Bishop AJ, Farooqi A, Mitra D, Guadagnolo BA, Benjamin R, Patel S, Ravi V, Araujo DM, Livingston A, Zarzour MA, Conley AP, Ratan R, Somaiah N, Lazar AJ, Roland C, Keung EZ, Nassif Haddad EF. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers (Basel) 16(9):1763, 2024. e-Pub 2024. PMID: 38730715.
52. Li GX, Chen L, Hsiao Y, Mannan R, Zhang Y, Luo J, Petralia F, Cho H, Hosseini N, da Veiga Leprevost F, Calinawan A, Li Y, Anand S, Dagar A, Geffen Y, Kumar-Sinha C, Chugh S, Le A, Ponce S, Guo S, Zhang C, Schnaubelt M, Naser Al Deen N, Chen F, Caravan W, Houston A, Hopkins A, Newton CJ, Wang X, Polasky DA, Haynes S, Yu F, Jing X, Chen S, Robles AI, Mesri M, Thiagarajan M, An E, Getz GA, W Linehan WM, Hostetter G, Jewell SD, Chan DW, Wang P, Omenn GS, Mehra R, Ricketts CJ, Ding L, Chinnaiyan AM, Cieslik MP, Dhanasekaran SM, Zhang H, Nesvizhskii AI, Analysis Consortium CPT. Comprehensive Proteogenomic Characterization of Rare Kidney Tumors. Cell Rep Medicine 5(5):101547, 2024. e-Pub 2024. PMID: 38703764.
53. Roland CL, Nassif EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, M Zarzour A, Conley AP, Livingston JA, Tawbi HA, Mujtaba B, Nguyen S, Ingram DR, Shaw K, Wistuba II, Futreal PA, Wargo JA, Somaiah N, the trial IO. Phase II study of neoadjuvant immune checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. e-Pub 2024. PMID: 38351182.
54. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. e-Pub 2024. PMID: 38351182.
55. Denu RA, Joseph CP, Urquiola ES, Byrd PS, Yang RK, Ratan R, Zarzour MA, Conley AP, Araujo DM, Ravi V, Nassif Haddad EF, Nakazawa MS, Patel S, Wang WL, Lazar AJ, Somaiah N. Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors. Cancers (Basel) 16(9):1707, 2024. e-Pub 2024. PMID: 38730662.
56. Wangsiricharoen S, Ingram DR, Morey RR, Wani K, Lazar AJ, Wang WL. GPNMB Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor (PEComa). Mod Pathol 37(3):100426, 2024. e-Pub 2024. PMID: 38219952.
57. Petralia F, Ma W, Yaron TM, Caruso FP, Tignor N, Wang JN, Charytonowicz D, Johnson JL, Huntsman EM, Marino GB, Calinawan A, Evangelista JE, Selvan ME, Chowdhury S, Rykunov D, Krek A, Song X, Turhan B, Christianson KE, Lewis DA, Deng EZ, Clarke DJB, Whiteaker JR, Kennedy JJ, Zhao L, Lazcano R, Batra H, Raso G, Parra ER, Soundararajan R, Tang X, Li Y, Yi X, Satpathy S, Wang Y, Wiznerowicz M, González-Robles TJ, Iavarone A, Gosline SJC, Reva B, Robles AI, Nesvizhskii AI, Mani DR, Gillette M, Klein RJ, Cieslik M, Zhang B, Paulovich AG, Sebra R, Gümüş ZH, Hostetter G, Fenyö D, Omenn GS, Cantley LC, Ma'ayan A, Lazar AJ, Ceccarelli M, Wang P, Analysis Consortium ACPT. Pan-cancer proteogenomics characterization of tumor immunity. Cell 4(9):101173, 2024. e-Pub 2024. PMID: 38359819.
58. Kerr DA, Cloutier JM, Margolis M, Mata DA, Rodrigues Simoes NJ, Faquin WC, Dias-Santagata D, Chopra S, Charville G, Lazar AJ, Wang WL, Rosenberg AE, Tse JY. Mesenchymal Neoplasms with ACTB::GLI1 or PTCH1::GLI1 Fusion: An Emerging GLI1-altered Neoplasm with Metastatic and Recurrence Potential. Mod Pathol 37(2):100386, 2024. e-Pub 2024. PMID: 37992966.
59. Pozner A, Li L, Verma SP, Wang S, Barrott JJ, Nelson ML, Yu JSE, Negri GL, Colborne S, Hughes CS, Zhu JF, Lambert SL, Carroll LS, Smith-Fry K, Stewart MG, Kannan S, Jensen B, Mortenson KL, John C, Sikdar S, Liu H, Dang NH, Bourdage J, Li J, Vahrenkamp JM, Mortensen KL, Groundland JS, Wustrack R, Senger DL, Zemp FJ, Mahoney DJ, Gertz J, Zhang X, Lazar AJ, Hirst M, Morin GB, Nielsen TO, Shen PS, Jones KB. ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97. Nat Commun 15(1):1165, 2024. e-Pub 2024. PMID: 38326311.
60. Hu J, Lazar AJ, Ingram D, Wang WL, Zhang W, Jia Z, Ragoonanan D, Wang J, Xia X, Mahadeo K, Gorlick R, Li S. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. J Immunother Cancer 21(1):e006991, 2024. e-Pub 2024. PMID: 38199607.
61. Ozenberger BB, Li L, Wilson ER, Lazar AJ, Barrott JJ, Jones KB. EWSR1::ATF1 orchestrates the clear cell sarcoma transcriptome in human tumors and a mouse genetic model. Cancers 15(24):5750, 2023. e-Pub 2023. PMID: 38136296.
62. Denu RA, Yang RK, Lazar AJ, Conley AP. Clinico-genomic profiling of conventional and dedifferentiated chondrosarcomas reveals TP53 mutation to be associated with worse outcomes. Clin Cancer Res 29(23):4844-4852, 2023. e-Pub 2023. PMID: 37873234.
63. Deng N, Fahrmann JF, Reyes-Uribe L, Thoman WS, Munsell MF, Dennison JB, Murage E, Wu R, Hawk ET, Thirumurthi S, Lynch PM, Lazar AJ, Jindal S, Chu K, Chelvanambi M, Basen-Engquist K, Li Y, Wargo JA, McAllister F, Allison JP, Sharma P, Sinha KM, Hanash S, Gilchrist SC, and Vilar E. Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-associated Immunity in Lynch Syndrome Patients. Clin Cancer Res 29(21):4361-4372, 2023. e-Pub 2023. PMID: 37724990.
64. Denu RA, MoyersJT, Gouda MA, Conley AP, Lazar AJ, Subbiah V. The landscape of alterations from 1407 ultra-rare sarcomas from the AACR GENIE database: Clinical implications. Clin Cancer Res 29(22):4669-4678, 2023. e-Pub 2023. PMID: 37643131.
65. Cho, WC, Li, W, Gu, J, Wang, W, Ning, J, Sfamenos, S, Gill, P, Nagarajan, P, Curry, JL, Lazar, AJ, Prieto, V, Torres Cabala, CA, Aung, PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. Journal of cutaneous pathology 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
66. Liang WW, Lu RJ, Jayasinghe RG, Foltz SM, Porta-Pardo E, Geffen Y, Wendl MC, Lazcano R, Kolodziejczak I, Song Y, Govindan A, Demicco EG, Li X, Li Y, Sethuraman S, Payne SH, Fenyö D, Henry Rodriguez H, Wiznerowicz M, Shen H, Mani DR, Rodland KD, Lazar AJ, Robles AI, Ding L, Analysis Consortium CPT. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell 41(9):1567-1585, 2023. e-Pub 2023. PMID: 37582362.
67. Dou Y, Katsnelson L, Gritsenko M, Hu Y, Reva B, Hong R, Wang YT, Kolodziejczak I, Lu RJH, Tsai CF, Bu W, Liu W, Guo X, An E, Arend R, Bavarva J, Chen L, Chu RK, Czekański A, Davoli T, Demicco EG, DeLair D, Devereaux K, Dhanasekaran SM, Dottino P, Dover B, Fillmore TL, Foxall M, Hermann C, Hiltke T, Hostetter G, Jędryka M, Jewell S, Johnson I, Kahn A, Kumar-Sinha C, Kurzawa P, Lazar AJ, Lazcano R, Lei JT, Li Y, Liao Y, Lih TSM, Lin TT, Martignetti J, Masand R, Matkowski R, McKerrow W, Mesri M, Monroe ME, Moon J, Moore RJ, Nestor MD, Newton C, Omelchenko T, Omenn G, Payne SH, Petyuk VA, Robles AI, Rodriguez H, Ruggles KV, Rykunov D, Savage S, Schepmoes AA, Tujin Shi T, Zhiao Shi Z, Jimin Tan J, Mason Taylor M, Mathangi Thiagarajan M, Joshua Wang J, Karl K Weitz KK, Bo Wen B, C M Williams DM, Yige Wu Y, Matthew A Wyczalkowski MA, Xinpei Yi X, Xu Zhang X, Rui Zhao R, David Mutch D, Arul M Chinnaiyan AM, Smith RD, Nesvizhskii AI, Wang P, Wiznerowicz M, Ding L, Mani DR, Zhang H, Anderson ML, Rodland KD, Zhang B, Liu T, Fenyo D, Analysis Consortium TCPT. Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer Cell 41(9):1586-1605, 2023. e-Pub 2023. PMID: 37567170.
68. Wang JM, Hong R, Demicco EG, Tan J, Lazcano R, Moreira AL, Li Y, Calinawan A, Razavian N, Schraink T, Gillette MA, Omenn GS, An E, Rodriguez H, Tsirigos A, Ruggles KV, Ding L, Robles AI, Mani DR, Rodland KD, Lazar AJ, Liu W, Fenyö D, Analysis Consortium CPT. Deep-Learning Integrates Histopathology and Proteogenomics at a Pan-cancer Level. Cell Rep Med 4(9):101173, 2023. e-Pub 2023. PMID: 37582371.
69. Chagani S, De Macedo MP, Carapeto F, Wang F, Marzese DM, Wani K, Haydu LE, Peng W, Ong GT, Warren SE, Beechem JM, Hoon DSB, Mills GB, Tetzlaff MT, Lazar AJ, Kwong LN, Davies MA. Multiplatform analysis of intratumoral PTEN heterogeneity in melanoma. J Invest Dermatol 143(9):1779-1787, 2023. e-Pub 2023. PMID: 36871660.
70. Cass SH, Tobin JWD, Seo YD, Gener-Ricos G, Keung EZ, Burton EM, Davies MA, McQuade JL, Lazar AJ, Mason R, Millward M, Sandhu S, Khoo C, Warburton L, Guerra V, Haydon A, Dearden H, Menzies AM, Carlino M, Smith JL, Mollee P, Burgess M, Mapp S, Keane C, Atkinson V, Parikh SA, Markovic SN, Ding W, Call TG, Hampel PJ, Long GV, Wargo JA, Ferrajoli A. Efficacy of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma in Patients with Concomitant Chronic Lymphocytic Leukemia. Ann Oncol 34(9):796-805, 2023. e-Pub 2023. PMID: 37414216.
71. Geffen Y, Anand S, Akiyama Y, Yaron TM, Song Y, Johnson JL, Govindan A, Babur O, Li Y, Huntsman E, Wang LB, Birger C, Heiman DI, Zhang Q, Miller M, Maruvka JE, Haradhvala NJ, Calinawan A, Belkin S, Kerelsky A, Clauser KR, Krug K, Satpathy S, Payne SH, Mani DR, Gillette MA, Dhanasekaran SM, Thiagarajan M, Mesri M, Rodriquez H, Robles AI, Carr SA, Lazar AJ, Aguet F, Cantley LC, Ding L, Getz G, Analysis Consortium CPT. Pan-Cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186(18):3845-3967, 2023. e-Pub 2023. PMID: 37582358.
72. Li Y, Dou Y, Da Veiga Leprevost F, Geffen Y, Calinawan AP, Aguet F, Akiyama Y, Anand S, Birger C, Cao S, Chaudhary R, Chilappagari P, Cieslik M, Colaprico A, Zhou DC, Day C, Domagalski MJ, Esai Selvan M, Fenyö D, Foltz SM, Francis A, Gonzalez-Robles T, Gümüş ZH, Heiman D, Holck M, Hong R, Hu Y, Jaehnig EJ, Ji J, Jiang W, Katsnelson L, Ketchum KA, Klein RJ, Lei JT, Liang WW, Liao Y, Lindgren CM, Ma W, Ma L, MacCoss MJ, Martins Rodrigues F, McKerrow W, Nguyen N, Oldroyd R, Pilozzi A, Pugliese P, Reva B, Rudnick P, Ruggles KV, Rykunov D, Savage SR, Schnaubelt M, Schraink T, Shi Z, Singhal D, Song X, Storrs E, Terekhanova NV, Thangudu RR, Thiagarajan M, Wang LB, Wang JM, Wang Y, Wen B, Wu Y, Wyczalkowski MA, Xin Y, Yao L, Yi X, Zhang H, Zhang Q, Zuhl M, Getz G, Ding L, Nesvizhskii AI, Wang P, Robles AI, Zhang B, Payne SH, Analysis Consortium CPT. Proteogenomic data and resources for pan-cancer analysis. Cancer Cell 41(8):1397-1406, 2023. e-Pub 2023. PMID: 37582339.
73. Goyal Y, Busch GT, Pillai M, Li J, Boe RH, Grody EI, Chelvanambi M, Dardani IP, Emert B, Bodkin N, Braun J, Fingerman D, Kaur A, Jain N, Ravindran PT, Mellis IA, Kiani K, Alicea GM, Fane ME, Ahmed SS, Li H, Chen Y, Chai C, Kaster J, Witt RG, Lazcano R, Ingram DR, Johnson SB, Wani K, Dunagin MC, Lazar AJ, Weeraratna AT, Wargo JA, Herlyn M, Raj A. Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature 620(7974):651-659, 2023. e-Pub 2023. PMID: 37468627.
74. Li Y, Porta-Pardo E, Tokheim C, Bailey MH, Yaron TM, Stathias V, Geffen Y, Imbach KJ, Cao S, Anand S, Yo A, Liu W, Wyczalkowski MA, Song Y, Storrs EP, Wendl MC, Zhang W, Sibai M, Ruiz-Serra V, Liang WW, Terekhanova NV, Rodrigues FM, Clauser KR, Heiman DI, Zhang Q, Aguet F, Dhanasekaran SM, Birger C, Satpathy S, Zhou DC, Wang LB, Baral J, Johnson JL, Huntsman EM, Pugliese P, Colaprico A, Iavarone A, Chheda M, Ricketts CJ, Fenyö D, Payne SH, Rodriguez H, Robles AI, Gillette MA, Kumar-Sinha C, Lazar AJ, Cantley LC, Getz G, Ding L, Analysis Consortium CPT. Pan-Cancer proteogenomics connects oncogenic drivers to functional states. Cell 186(18):3921-3944, 2023. e-Pub 2023. PMID: 37582357.
75. Beird HC, Wu CC, Nakazawa M, Ingram D, Daniele JR, Lazcano R, Little L, Davies C, Daw NC, Wani K, Wang WL, Song X, Gumbs C, Zhang J, Rubin B, Conley A, Flanagan AM, Lazar AJ, Futreal PA. Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. HGG Adv 4(4):100224, 2023. e-Pub 2023. PMID: 37593416.
76. Chu Y, Dai E, Li Y, Han G, Pei G, Ingram DR, Thakkar K, Qin JJ, Dang M, Le X, Hu C, Deng Q, Sinjab A, Gupta P, Wang R, Hao D, Peng F, Yan X, Liu Y, Song S, Zhang S, Heymach JV, Reuben A, Elamin YY, Pizzi MP, Lu Y, Lazcano R, Hu J, Li M, Curran M, Futreal A, Maitra A, Jazaeri AA, Ajani JA, Swanton C, Cheng XD, Abbas HA, Gillison M, Bhat K, Lazar AJ, Green M, Litchfield K, Kadara H, Yee C, Wang L. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat Med 29(6):1550-1562, 2023. e-Pub 2023. PMID: 37248301.
77. Birkness-Gartman JE, Wangsiricharoen S, Lazar AJ, Gross JM. Esophageal Glomus Tumors: Rare Neoplasms with Aggressive Clinical Behavior. Histopathol 82(7):1048-1055, 2023. e-Pub 2023. PMID: 36788021.
78. Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early Phase Clinical Trials (SAMBA 101). Clin Cancer Res 29(9):1708-1718, 2023. e-Pub 2023. PMID: 37058010.
79. Romano G, Paradiso F, Li P, Shukla P, Barger LN, El Naggar O, Miller JP, Liang RJ, Helms TL, Lazar AJ, Wargo JA, Taraballi F, Costello JC, Kwong LN. Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma. Cancer Immunol Res 11(5):558-569, 2023. e-Pub 2023. PMID: 36820825.
80. Truong DD, Lamhamedi-Cherradi SE, Porter RW, Krishnan S, Swaminathan J, Gibson A, Lazar AJ, Livingston JA, Gopalakrishnan V, Gordon N, Daw NC, Navin NE, RGorlick R, Ludwig JA. Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing. BMC Cancer 23(1):488, 2023. e-Pub 2023. PMID: 37254069.
81. DuRoss AN, Phan J, Lazar AJ, Walker JM, Guimaraes AR, Baas C, Krishnan S, Jr TC, Sun C, Bagley AF. Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 15(3):e1867, 2023. e-Pub 2023. PMID: 36308008.
82. Nguyen TD, Wang Y, Bui T, Lazcano R, Ingram DR, Yi M, Vakulabharanam V, Luo L, Pina MA, Karakas C, Li M, Kettner NM, Somaiah N, Houghton PJ, Mawlawi O, Lazar AJ, Hunt KK, Keyomarsi K. Sequential targeting of retinoblastoma and DNA synthesis pathways is a therapeutic strategy for sarcomas that can be monitored in real-time. Cancer Res 83(6):939-955, 2023. e-Pub 2023. PMID: 36603130.
83. Nassif E, Joseph CP, Lazcano RN, Joseph JT, Thirasastr P, Lazar AJ, Somaiah N. Responses to the Combination of Gemcitabine with Sirolimus in Two Patients with TSC-mutated Sarcomas. Frontiers Oncol 19:1046442, 2023. e-Pub 2023. PMID: 36845725.
84. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis VO, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL. Sentinel Lymph Node Biopsy for Extremity and Truncal Sarcomas: A Systematic Review of the Literature. Ann Surg Oncol 30(2):958-967, 2023. e-Pub 2023. PMID: 36307665.
85. Ronen S, Ko JS, Rubin BP, Kilpatrick SE, Wang WL, Lazar AJ, Goldblum JR, Billings SD. Superficial Low-grade Fibromyxoid Sarcoma. J Cutan Pathol 50(2):147-154, 2023. e-Pub 2023. PMID: 36074249.
86. Denu, RA, Yang, RK, Lazar, AJ, Patel, SS, Lewis, VO, Roszik, J, Livingston, JA, Wang, W, Shaw, KR, Ratan, R, Zarzour, MA, Bird, JE, Raza, SM, Akdemir, KC, Ahnert, JR, Subbiah, V, Patel, S, Conley, AP. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes. Clinical Cancer Research 29(23):4844-4852, 2023. e-Pub 2023. PMID: 37747813.
87. Hahn AW, Menk AV, Rivadeneira DB, Augustin RC, Xu M, Jun Li J, Wu X, Mishra AK, Gide TN, Quek C, Zang Y, Spencer CN, Menzies AM, Daniel CR, Hudgens CW, Nowicki T, Haydu LE, Khan MAW, Gopalakrishnan V, Burton EM, Malke J, Simon JM, Bernatchez C, Putluri N, Woodman SE, Gopal V, Guerrieri R, Fischer GM, Wang J, Wani KM, Thompson JF, Lee JE, Hwu P, Ajami N, Gershenwald JE, Long GV, Scolyer RA, Tetzlaff MT, Lazar AJ, Schadendorf D, Wargo JA, Kirkwood JM, DeBarardinis RJ, Liang H, Futreal PA, Zhang J, Wilmott JS, Peng W, Davies MA, Delgoffe GM, Najjar YG, McQuade JL. Obesity is associated with altered tumor metabolism in metastatic melanoma. Clin Cancer Res 29(1):154-164, 2023. e-Pub 2023. PMID: 36166093.
88. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):480-489, 2023. e-Pub 2023. PMID: 36085392.
89. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):492, 2023. e-Pub 2023. PMID: 36245056.
90. Barnhill RL, Elder DE, Piepkorn MW, Knezevich SR, Reisch LM, Eguchi MM, Bastian BC, Blokx W, Bosenberg M, Busam KJ, Carr R, Cochran A, Cook MG, Duncan LM, Elenitsas R, de la Fouchardière A, Gerami P, Johansson I, Ko J, Landman G, Lazar AJ, Lowe L, Massi D, Messina J, Mihic-Probst D, Parker DC, Schmidt B, Shea CR, Scolyer RA, Tetzlaff M, Xu X, Yeh I, Zembowicz A, Elmore JG. Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement. JAMA Netw Open 6(1):e2250613, 2023. e-Pub 2023. PMID: 36630138.
91. Li Y, Lih TSM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, Wu Y, Lu RJH, Clark DJ, Kolodziejczak I, Hong R, Chen S, Zhao Y, Chugh S, Caravan W, Al Deen NN, Hosseini N, Newton CJ, Krug K, Xu Y, Cho KC, Hu Y, Zhang Y, Kumar-Sinha C, Ma W, Calinawan A, Wyczalkowski MA, Wendl MC, Wang Y, Guo S, Zhang C, Le A, Dagar A, Hopkins A, Cho H, da Veiga Leprevost F Jing H, Teo CG, Liu W, Reimers MA, Pachynski R, Lazar AJ, Chinnaiyan AM, Van Tine BA, Zhang B, Rodland KD, Getz G, Mani DR, Wang P, Chen F, Hostetter G, Thiagarajan M, Linehan WM, Fenyo D, Jewll SD, Omenn GS, Mehra R, Wiznerowicz M, Robles AI, Mesri M, Hiltke T, An E, Rodriguez H, Chan DW, Ricketts CJ, Nesvizhskii AI, Zhang H, Ding L, Analysis Consortium CPT. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell 41(1):139-163, 2023. e-Pub 2023. PMID: 36563681.
92. Cloutier JM, Lazar AJ, Wang WL. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity. Hum Pathol 130:88-94, 2022. e-Pub 2022. PMID: 36162599.
93. Barnhill R, van Laere S, Vermeulen P, Roman-Roman S, Gardrat S, Alsafadi S, Tarin M, Champenois G, Nicolas A, Matet A, Cassoux N, Servois V, Rodrigues M, Scolyer R, Lazar A, Romano E, Piperno-Neumann S, Mariani P, Lugassy C. L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases. Lab Invest 102(11):1214-1224, 2022. e-Pub 2022. PMID: 35672380.
94. Lazure P, Parikh AR, Ready NE, Davies MJ, Péloquin S, Caterino JM, Lewandowski R, Lazar AJ, Murray S. Challenges associated with the integration of immuno-oncology agents in clinical practice. BMC Med Educ 22(1):781, 2022. e-Pub 2022. PMID: 36371179.
95. Simpson RC, Shanahan ER, Batten M, Reijers ILM, Read M, Silva IP, Versluis JM, Ribeiro R, Angelatos AS, Tan J, Adhikari C, Menzies AM, Saw RPM, Gonzalez M, Shannon KF, Spillane AJ, Velickovic R, Lazar AJ, Damania AV, Mishra AK, Chelvanambi M, Banerjee A, Ajami NJ, Wargo JA, Macia L, Holmes AJ, Wilmott JS, Blank CU, Scolyer RA, Long GV. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and gut microbiome. Nat Med 28(11):2344-2352, 2022. e-Pub 2022. PMID: 36138151.
96. Bonvalot S, Rutkowski PL, Thariat J, Carrère S, Ducassou A, Sunyach MP, Agoston P, Hong AM, Mervoyer A, Rastrelli M, Moreno V, Li RK, Tiangco BJ, Herráez AC, Gronchi A, Sy-Ortin T, Hohenberger P, de Baère T, Le Cesne A, Helfre S, Saada-Bouzid E, Anghel RM, Kantor G, Montero A, Loong HH, Vergés R, Kacso G, Austen L, Servois VF, Wardelmann E, Dimitriu M, Said P, Lazar AJ, JVMG B, Le Péchoux C, Pápai Z. Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 114(3):422-432, 2022. e-Pub 2022. PMID: 35850363.
97. Nathenson MJ, Hu J, Ratan R, Somaiah N, Hsu R, DeMaria PJ, Catoe HW, Pang A, Subhawong TK, Amini B, Sweet K, Feister K, Malik K, Jagannathan J, Braschi-Amirfarzan M, Sheren J, Caldas Y, Moreno Tellez C, Rosenberg AE, Lazar AJ, Maki RG, Benedetto P, Cohen J, Trent J, Ravi V, Patel S, Wilky BA. Systemic chemotherapies retain anti-tumor activity in desmoid tumors independent of specific mutations in CTNNB1 or APC: A multi-institutional retrospective study. Clin Cancer Res 28(18):4092-4104, 2022. e-Pub 2022. PMID: 35180772.
98. Roh W, Geffen Y, Cha H, Miller M, Anand S, Kim J, Heiman DI, Gainor JF, Laird PW, Cherniack AD, Ock CY, Lee SH, Working Group GGNCICFCGTMPA. High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities. Cancer Res 82(21):3917-3931, 2022. e-Pub 2022. PMID: 36040373.
99. Bishop AJ, Amini B, Lin H, Raza SM, Patel S, Grosshans DR, Ghia A, Farooqi A, Guadagnolo BA, Mitra D, Akdemir KC, Lazar AJ, Wang WL, Alvarez-Breckenridge C, Bird J, Rhines LD, Somaiah N, Conley AP. Immune Checkpoint Inhibitors have Clinical Activity in Patients with Recurrent Chordoma. J Immunother 45(8):374-378, 2022. e-Pub 2022. PMID: 35943386.
100. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
101. Cloutier JM, Maloney NS, Wang WL, Lazar AJ. Pigmented PRRX1::NCOA1-rearranged Fibroblastic Tumor: A Rare Morphologic Variant of an Emerging Mesenchymal Tumor. J Cutan Pathol 49(9):802-807, 2022. e-Pub 2022. PMID: 35583270.
102. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis L, Salazar R, Barreto C, Chen HL, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin RS, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw N, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal PA, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
103. Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, Bishop AJ, Sturgis EM, Goepfert RP, Yalamanchili S, Botello G, Stephen BA, Patel A, Lazar AJ, Conley AP, Benjamin RS, Patel S, Futreal PA, Somaiah N, Naing A. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer 128(18):3383-3391, 2022. e-Pub 2022. PMID: 35792683.
104. Rubino F, Alvarez-Breckenridge C, Akdemir K, Conley AP, Bishop AJ, Wang WL, Lazar AJ, Rhines LD, DeMonte F, Raza SM. Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels. Front Oncol 12:997506, 2022. e-Pub 2022. PMID: 36248987.
105. Warmke LM, Maloney N, Leung CH, Lin H, Lazar AJ, Wang WL. SATB2 Expression in Undifferentiated Pleomorphic Sarcomas of Bone. Am J Clin Pathol 158(2):235-241, 2022. e-Pub 2022. PMID: 35311957.
106. Andrews MC, Oba J, Wu CJ, Zhu H, Karpinets T, Creasy CA, Forget MA, Yu X, Song X, Mao X, Robertson AG, Romano G, Li P, Burton EM, Lu Y, Sloane RS, Wani KM, Rai K, Lazar AJ, Haydu LE, Bustos MA, Shen J, Chen Y, Morgan MB, Wargo JA, Kwong LN, Haymaker CL, Grimm EA, Hwu P, Hoon DSB, Zhang J, Gershenwald JE, Davies MA, Futreal PA, Bernatchez C, Woodman SE. Multi-modal molecular programs regulate melanoma cell state. Nat Commun 13(1):4000, 2022. e-Pub 2022. PMID: 35810190.
107. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave S, De Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi L, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint Jr A, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Andreas Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W. The 5th Edition of the World Health Organization Classification of Lymphoid Tumours. Leukemia 36(7):1720-1748, 2022. e-Pub 2022. PMID: 35732829.
108. Chambwe N, Sayaman RW, Hu D, Huntsman S, Analysis Network CGA, Kemal A, Caesar-Johnson S, Zenklusen JC, Ziv E, Beroukhim R, Cherniack AD. Analysis of germline-driven ancestry-associated gene expression in cancers. STAR Protoc 3(3):101586, 2022. e-Pub 2022. PMID: 35942349.
109. Wang Y, Tian X, Zhang W, Zhang Z, Lazcano R, Hingorani P, Roth ME, Gill JD, Harrison DJ, Xu Z, Jusu S, Kannan S, Wang J, Lazar AJ, Earley EJ, Erickson SW, Gelb T, Huxley P, Lahdenranta J, Mudd G, Kurmasheva RT, Houghton PJ, Smith MA, Kolb EA, Gorlick R. Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma. Mol Cancer Ther 21(6):903-913, 2022. e-Pub 2022. PMID: 35312779.
110. Vellano CP, White MG, Andrews MC, Chelvanambi M, Witt MG, Daniele JR, Titus M, McQuade J, Conforti F, Burton EM, Lastrapes MJ, Ologun G, Cogdill AP, Morad G, Prieto P, Lazar AJ, Chu Y, Han G, Khan MAW, Helmink B, Davies MA, Amaria RN, Kovacs JJ, Woodman SE, Patel S, Hwu P, Peoples M, Lee JE, Cooper ZA, Zhu H, Gao G, Banerjee H, Lau M, Gershenwald JE, Lucci A, Keung EZ, Ross MI, Pala L, Pagan E, Lazcano RS, Liu Q, Borthwick M, Lau E, Yates MS, Westin SN, Wani K, Tetzlaff MT, Haydu L, Mahendra M, Ma XY, Logothetis C, Kulstad Z, Johnson S, Hudgens CW, Feng N, Federico L, Long G, P Futreal PA, Arur S, Tawbi HA, Moran AE, Wang L, Heffernan T, Marszalek J, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 616(7915):797-803, 2022. e-Pub 2022. PMID: 35705814.
111. Gounder MM, Agaram NP, Trabucco SE, Robinson V, Ferraro RA, Krishnan A, Lee J, Bolan P, Attia S, Abida W, Drilon A, Chi P, D’Angelo SP, Dickson MA, Keohan ML, Kelly CM, Meyer CF, Chawla S, Choy E, Chugh R, Moore JL, Okimoto R, Pollock RE, Ravi V, Singh AS, Somaiah N, Wagner AJ, Healey JH, Frampton GM, Venstrom JM, Ross JS, Ladanyi M, Singer S, Brennan MF, Schwartz GK, Lazar AJ, Thomas DM, Maki RG, Tap WD, Ali S, Jin DX. Clinical Genomic Profiling in the Management of Patients with Soft Tissue and Bone Sarcoma. Nat Commun 13(1):3406, 2022. e-Pub 2022. PMID: 35705558.
112. Bhalla AD, Landers SM, Singh AK, Landry JP, Yeagley MG, Meyerson GSB, Delgado-Baez CB, Dunnand S, Nguyen T, Ma X, Bolshakov S, Menegaz BA, Lamhamedi-Cherradi SE, Mao X, Song X, Lazar AJ, McCutcheon IE, Slopis JM, Ludwig JA, Lev DC, Rai K, Torres KE. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor. Lab Invest 102(6):658-666, 2022. e-Pub 2022. PMID: 35228656.
113. Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Real-World Use of Palbociclib Monotherapy in Retroperitoneal Liposarcomas at a Large Volume Sarcoma Center. Int J Cancer 150(12):2012-2024, 2022. e-Pub 2022. PMID: 35128664.
114. Lamhamedi-Cherradi SE, Maitituoheti M, Menegaz BA, Krishnan S, Vetter AM, Camacho P, Wu CC, Beird HC, Porter RW, Ingram DR, Ramamoorthy V, Mohiuddin S, McCall D, Truong DD, Cuglievan B, Futreal PA, Velasco AR, Anvar NE, Utama B, Titus M, Lazar AJ, Wang WL, Rodriguez-Aguayo C, Ratan R, Livingston JA, Rai K, MacLeod AR, Daw NC, Hayes-Jordan A, Ludwig JA. The Androgen Receptor is a Therapeutic Target in Desmoplastic Small Round Cell Sarcoma. Nat Commun 13(1):3057, 2022. e-Pub 2022. PMID: 35650195.
115. Zullow HJ, Sankar A, Ingram DR, D’Avino AR, Same Guerra DD, D'Avino AR, Collings CK, Lazcano R, Liang Y, Qi J, Lazar AJ, Kadoch C. The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Molec Cell 82(9):1737-1750, 2022. e-Pub 2022. PMID: 35390276.
116. Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell 40(5):509-523.e6, 2022. e-Pub 2022. PMID: 35537412.
117. Wu CC, Beird HC, Lamhamedi-Cherradi SE, Soeung M, Ingram D, Truong DD, Porter RW, Krishnan S, Little L, Gumbs C, Zhang J, Titus M, Genovese G, Ludwig JA, Lazar AJ, Hayes-Jordan A, Futreal PA. Multi-Site Desmoplastic Small Round Cell Tumors Are Genetically Related and Immune-Cold. NPJ Precis Oncol 6(1):21, 2022. e-Pub 2022. PMID: 35379887.
118. Members AUC, Fung MA, Vidal CI, Armbrecht EA, Andea AA, Cassarino DS, Comfere NI, Emanuel PO, Ferringer T, Hristov AC, Kim J, Lauer SR, Linos K, Missall TA, Motaparthi K, Novoa RA, Patel R, Shalin SC, Sundram U, Panel R, Calame A, Bennett DD, Duncan LM, Elston DM, Hosler GA, Hurley YM, Lazar AJ, Lowe L, Messina J, Myles J, Plaza JA, Prieto VG, Reddy V, Schaffer A, Subtil A. Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee. J Cutan Pathol 49(3):231-245, 2022. e-Pub 2022. PMID: 34536035.
119. Nosé V, Lazar AJ. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Familial Tumor Syndromes. Head Neck Pathol 16(1):143-157, 2022. e-Pub 2022. PMID: 35312981.
120. Wang J, Wang WL, Parkinson B, Sun H, Huo L, Wu Y, Hui Chen H, Gan Q, Shen T, Maloney N, Lazar AJ, Meis J, Yoon EC, Albarracin C, Krishnamurthy S, Middleton L, Resetkova E, Yu W, Lu W, Solis Soto LM, Wang S, Wistuba II, Chen W, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
121. Molina ER, Chim LK, Lamhamedi-Cherradi SE, Mohiuddin S, McCall D, Cuglievan B, Krishnan S, Porter RW, Ingram DR, Wang WL, Lazar AJ, Scott DW, Truong D, Daw NC, Ludwig JA, Mikos AG. Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients. Oncotarget 13:521-533, 2022. e-Pub 2022. PMID: 35284040.
122. Reyes-Múgica M, Chan JK, Hasle H, Lazar AJ, Rossi S, Ferrari A, Jarzembowski JA, Pritchard-Jones K, Hill DA, Jacques TS, Wesseling P, Lopez-Terrada DH, von Deimling A, Kratz CP, Cree IA, Alaggio R. A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. Cancer Discov 12(1):331-355, 2022. e-Pub 2022. PMID: 34921008.
123. Indave BI, Armon S, Watanabe R, Uttley L, White VA, Lazar AJ, Cree IA. Clonality, mutation and Kaposi sarcoma: a systematic review. Cancers 14(5):1201, 2022. e-Pub 2022. PMID: 35267506.
124. Nozzoli F, Lazar AJ, Castiglione F, Campanacci DA, Beltrami G, De Logu F, Caporalini C, Massi D, Roviello G. NTRK fusions detection in paediatric sarcomas to expand the morphological spectrum and clinical relevance of selected entities. Pathol Oncol Res 28:1610237, 2022. e-Pub 2022. PMID: 35295613.
125. Bill KLJ, Garnett J, Meaux I, Ma X, Creighton CJ, Bolshakov S, Barriere C, Debussche L, Lazar AJ, Prudner BC, Casadei L, Braggio D, Lopez G, Zewdu A, Bid H, Dina L, Pollock RE. Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma. Clin Cancer Res 28(2):431, 2022. e-Pub 2022. PMID: 35045964.
126. Benton S, Zhao J, Zhang B, Bahrami A, Barnhill RL, Busam K, Cerroni L, Cook MG, de la Fouchardière A, Elder DE, Johansson I, Landman G, Lazar AJ, LeBoit P, Lowe L, Massi D, Duncan LM, Messina J, Mihic-Probst D, Jr MM, Piepkorn MW, Schmidt B, Scolyer RA, Shea CR, Tetzlaff MT, Tron VA, Xu X, Yeh I, Yun SJ, Zembowicz A, Gerami P. Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms. Am J Surg Pathol 45(12):1597-1605, 2021. e-Pub 2021. PMID: 34757982.
127. Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374(6575):1632-1640, 2021. e-Pub 2021. PMID: 34941392.
128. cite El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Yang W, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S, Working Group IIB. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer 7(1):150, 2021. e-Pub 2021. PMID: 34853355.
129. Vega DM, Yee LM, McShane LM, Williams PM, Chen L, Vilimas T, Fabrizio D, Funari V, Newberg J, Bruce LK, Chen SJ, Baden J, Barrett JC, Beer P, Butler M, Cheng JH, Conroy J, Cyanam D, Eyring K, Garcia E, Green G, Gregersen VR, Hellmann MD, Keefer LA, Lasiter L, Lazar AJ, Li MC, Macconaill LE, Meier K, Mellert H, Pabla S, Pallavajjalla A, Pestano G, Salgado R, Samara R, Sokol ES, Stafford P, Budczies J, Stenzinger A, Tom W, Valkenburg KC, Wang X, Weigman V, Xie M, Xie Q, Zehir A, Zhao C, Zhao Y, Stewart MD, Allen J. TMB Consortium. Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms: Phase 2 of the Friends of Cancer Research TMB Harmonization Project. Ann Oncol 32(12):1626-1636, 2021. e-Pub 2021. PMID: 34606929.
130. Ramani NS, Patel KP, Routbort MJ, Alvarez H, Broaddus R, Chen H, Rashid A, Lazar AJ, Lucas FAS, Yao H, Manekia J, Dang H, Barkoh BA, Medeiros LJ, Luthra R, Roy-Chowdhuri S. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing. Arch Pathol Lab Med 145(11):1405-1412, 2021. e-Pub 2021. PMID: 33493304.
131. Sloane RAS, White MG, Witt RG, Banerjee A, Davies MA, Han G, Burton E, Ajami N, Simon JM, Bernatchez C, Haydu LE, Tawbi HA, Gershenwald JE, Keung E, Ross M, McQuade J, Amaria RN, Wani K, Lazar AJ, Woodman SE, Wang L, Andrews MC, Wargo JA. Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes. Cancers (Basel) 13(21):5301, 2021. e-Pub 2021. PMID: 34771465.
132. Kochat V, Raman AT, Landers S, Tang M, Bhalla AD, Schulz J, Terranova C, Landry JP, Beird H, Wu CC, Mao X, Ingram D, Zhang J, Keung EZ, Scally C, Roland CL, Hunt KK, Feig BW, Futreal A, Wang WL, Lazar AJ, Slopis J, McCutcheon I, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol 142(3):565-590, 2021. e-Pub 2021. PMID: 34283254.
133. Carrot-Zhang J, Han S, Zhou W, Damrauer JS, Kemal A, Analysis Network CGA, Cherniack AD, Beroukhim R. Analytical protocol to identify local ancestry-associated molecular features in cancer. STAR Protoc 2(4):100766, 2021. e-Pub 2021. PMID: 34585150.
134. Andrews MC, Duong CPM, Gopalakrishnan V, Iebba V, Chen WS, Derosa L, Khan AW, Cogdill AP, White MG, Wong MC, Ferrere G, Fluckiger A, Roberti MP, Opolon P, Tidjani Alou M, Yonekura S, Roh W, Spencer CN, Fernandez Curbelo I, Vence L, Reuben A, Johnson S, Arora R, Morad G, Lastrapes M, Baruch EN, Little L, Gumbs C, Cooper ZA, Prieto PA, Wani K, Lazar AJ, Tetzlaff MT, Hudgens CW, Callahan MK, Adamow M, Postow MA, Ariyan CE, Gaudreau PO, Nezi L, Raoult D, Mihalcioiu C, Elkrief A, Rossanna C Pezo RC, Haydu LE, Simon JM, Tawbi HA, McQuade J, Hwu P, Hwu WJ, Amaria RN, Burton EM, Woodman SE, Watowich S, Diab A, Patel SP, Glitza IC, Wong MK, Zhao L, Zhang J, Ajami NJ, Petrosino J, Jenq RR, Davies MA, Gershenwald JE, Futreal PA, Sharma P Allison JP, Routy B, Zitvogel L, Wargo JA. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nat Med 27(8):1432-1441, 2021. e-Pub 2021. PMID: 34239137.
135. Schaefer IM, Lundberg MZ, Demicco EG, Przybyl J, Matusiak M, Chibon F, Ingram DR, Hornick JL, Wang WL, Bauer S, Baker LH, Lazar AJ, van de Rijn M, Mariño-Enríquez A, Fletcher JA. Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. Cancer 127(15):2666-2673, 2021. e-Pub 2021. PMID: 33788262.
136. Panza E, Ozenberger BB, Straessler KM, Barrott JJ, Li L, Wang Y, Xie M, Boulet A, Titen SW, Mason CC, Lazar AJ, Ding L, Capecchi MR, Jones KB. The clear cell sarcoma functional genomic landscape. J Clin Invest 131(15), 2021. e-Pub 2021. PMID: 34156976.
137. Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med 145(7):842-850, 2021. e-Pub 2021. PMID: 33053175.
138. Leske H, Dalgleish R, Lazar AJ, Reifenberger G, Cree IA. A common classification framework for histone sequence alterations in tumours: an expert consensus proposal. J Pathol 254(2):109-120, 2021. e-Pub 2021. PMID: 33779999.
139. Tolwani A, Matusiak M, Bui N, Forgó E, Varma S, Baratto L, Iagaru A, Lazar AJ, van de Rijn M, Przybyl J. Prognostic relevance of the hexosamine biosynthesis pathway activation in leiomyosarcoma. NPJ Genom Med 6(1):30, 2021. e-Pub 2021. PMID: 33941787.
140. Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, Tang Z, Bassett R, Manekia J, Barkoh BA, Dang H, Roy-Chowdhuri S. Utilization of Cytology Smears Improves Success Rates of RNA-based Next-Generation Sequencing Gene Fusion Assays for Clinically Relevant Predictive Biomarkers. Cancer Cytopathology 129(5):374-382, 2021. e-Pub 2021. PMID: 33119213.
141. Dentro SC, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar AG, Yu K, Rubanova Y, Macintyre G, Demeulemeester J, Vázquez-García I, Kleinheinz K, Livitz DG, Malikic S, Donmez N, Sengupta S, Anur P, Jolly C, Cmero M, Rosebrock D, Schumacher SE, Fan Y, Fittall M, Drews RM, Yao X, Watkins TBK, Lee J, Schlesner M, Zhu H, Adams DJ, McGranahan N, Swanton C, Getz G, Boutros PC, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Martincorena I, Markowetz F, Mustonen V, Yuan K, Gerstung M, Spellman PT, Wang W, Morris QD, Wedge DC, Van Loo P, Evolution P, Group HW, Consortium TP. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell 184(8):2239-2254.e39, 2021. e-Pub 2021. PMID: 33831375.
142. Patel RR, Lupo PJ, Bishop AJ, Lin PP, Delclos GL, Lazar AJ, Benjamin RS, Araujo DM. Synovial Sarcoma of the Hand and Foot: An Institutional Review. Am J Clin Oncol 44(7):361-368, 2021. e-Pub 2021. PMID: 33927134.
143. Wagner MJ, Lyons YA, Siedel JH, Dood R, Nagaraja AS, Haemmerle M, Mangala LS, Chanana P, Lazar AJ, Wang WL, Ravi V, Holland EC, Sood AK. Combined VEGFR and MAPK pathway inhibition in angiosarcoma. Sci Rep 11(1):9362, 2021. e-Pub 2021. PMID: 33931674.
144. Warmke LM, Tinkham EG, Ingram DR, Lazar AJ, Panse G, Wang WL. INSM1 Expression in Angiosarcoma. Am J Clin Pathol 155(4):575-580, 2021. e-Pub 2021. PMID: 33210141.
145. Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist 26(3):250-260, 2021. e-Pub 2021. PMID: 33289298.
146. Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE. Comparison of Cancer Prevalence in Patients with Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020. JAMA Netw Open 4(3):e210945, 2021. e-Pub 2021. PMID: 33734413.
147. Cree IA, Indave I, Zavadil J, McKay J, Olivier M, Kozlakidis Z, Lazar AJ, Hyde C, Holdenrieder S, Hastings R, Rajpoot N, de la Fouchardiere A, Rous B, Zenklusen JC, Normanno N, Schilsky RL, participants ICR. The International Collaboration for Cancer Classification and Research (IC3R). Int J Cancer 148(3):560-571, 2021. e-Pub 2021. PMID: 32818326.
148. Ding Z, Ogata D, Roszik J, Qin Y, Kim SH, Tetzlaff MT, Lazar AJ, Davies MA, Ekmekcioglu S, Grimm EA. iNOS Associates with Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation. Front Oncol 11:631766, 2021. e-Pub 2021. PMID: 33643925.
149. Rathore R, Caldwell KE, Schutt C, Brashears CB, Prudner BC, Ehrhardt WR, Leung CH, Lin H, Daw NC, Beird HC, Giles A, Wang WL, Lazar AJ, Chrisinger JSA, Livingston JA, Van Tine BA. Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma. Cell Rep 34(4):108678, 2021. e-Pub 2021. PMID: 33503424.
150. Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Fouad Abdelhakeem AA, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal PA, Song S, Ajani JA, Wang L. Single-Cell Dissection of Intratumoral Heterogeneity and Lineage Diversity in Metastatic Gastric Adenocarcinoma. Nat Med 27(1):141-151, 2021. e-Pub 2021. PMID: 33398161.
151. Panse G, Mito JK, Ingram DR, Wani K, Khan S, Lazar AJ, Doyle LA, Wang WL. Radiation-Associated Sarcomas other than Malignant Peripheral Nerve Sheath Tumors Demonstrate Loss of Histone H3K27 Trimethylation. Histopathology 78(2):321-326, 2021. e-Pub 2021. PMID: 32735735.
152. Fischer GM, Guerrieri RA, Hu Q, Joon AY, Kumar S, Haydu LE, McQuade JL, Vashisht Gopal YN, Knighton B, Deng W, Hudgens CW, Lazar AJ, Tetzlaff MT, Davies MA. Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases. Neurooncol Adv 3(1):vdaa177, 2021. e-Pub 2021. PMID: 33575655.
153. White MG, Szczepaniak Sloane R, Witt RG, Reuben A, Gaudreau PO, Andrews MC, Feng N, Johnson S, Class CA, Bristow C, Wani K, Hudgens C, Nezi L, Manzo T, De Macedo MP, Hu J, Davis R, Jiang H, Prieto P, Burton E, Hwu P, Tawbi H, Gershenwald J, Lazar AJ, Tetzlaff MT, Overwijk W, Woodman SE, Cooper ZA, Marszalek JR, Davies MA, Heffernan TP, Wargo JA. Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma. Oncoimmunology 10(1):1992880, 2021. e-Pub 2021. PMID: 34777916.
154. Demetri GD, Antonescu CR, Bjerkehagen B, JVMG B, Boye K, Chacón M, Tos APD, Desai J, Fletcher JA, Gelderblom H, George S, Gronchi A, Haas RL, Hindi N, Hohenberger P, Joensuu H, Jones RL, Judson I, Kang YK, Kawai A, Lazar AJ, Le Cesne A, Maestro R, Maki RG, Martín J, Patel S, Penault-Llorca F, Raut CP, Rutkowski P, Safwat A, Sbaragllia M, Schaefer IM, Shen L, Serrano C, Schöffski P, Stacchiotti S, Hall KS, Tap WD, Thomas DM, Trent J, Valverde C, van der Graaf WTA, von Mehren M, Wagner A, Wardelmann E, Naito Y, Zalcberg J, Blay JY. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network. Ann Oncol 31(11):1506-1517, 2020. e-Pub 2020. PMID: 32891793.
155. Qin Y, Bollin K, de Macedo MP, Carapeto F, Kim KB, Roszik J, Wani KM, Reuben A, Reddy ST, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Lazar AJ, Hwu P, Patel SP. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer 8(2):e000960, 2020. e-Pub 2020. PMID: 33203661.
156. Fischer GM, Carapeto FCL, Joon AY, Haydu LA, Chen H, Wang F, Van Arnam JS, McQuade JL, Wani K, Kirkwood J, Tetzlaff MT, Lazar AJ, Tawbi HA, Gershenwald JE, Scoyler R, Long GV, Davies MA. Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker. Cancer Med 9(22):9650-8661, 2020. e-Pub 2020. PMID: 33016647.
157. Maitituoheti M, Keung EZ, Tang M, Yan L, Alam H, Han G, Singh AK, Raman AT, Terranova C, Sarkar S, Orouji E, Amin SB, Sharma S, Williams M, Samant NS, Dhamdhere M, Zheng N, Shah T, Shah A, Axelrad JB, Anvar NE, Lin YH, Jiang S, Chang EQ, Ingram DR, Wang WL, Lazar AJ, Lee MG, Muller F, Wang L, Ying H, Rai K. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant Melanoma. Cell Rep 33(3):108293, 2020. e-Pub 2020. PMID: 34289358.
158. Landers SM, Bhalla AD, Ma X, Lusby K, Ingram D, Al Sannaa G, Wang WL, Lazar AJ, Torres KE. AXL Inhibition Enhances MEK Inhibitor Sensitivity in Malignant Peripheral Nerve Sheath Tumors. J Cancer Sci Clin Ther 4(4):511-525, 2020. e-Pub 2020. PMID: 33283192.
159. Huang J, Sachdeva M, Xu E, Robinson TJ, Luo L, Ma Y, Williams NT, Lopez O, Cervia LD, Yuan F, Qin X, Zhang D, Owzar K, Gokgoz N, Seto A, Okada T, Singer S, Andrulis IL, Wunder JS, Lazar AJ, Rubin BP, Pipho K, Mello SS, Giudice J, Kirsch DG. The Long Noncoding RNA NEAT1 Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways. Mol Cancer Res 18(10):1534-1544, 2020. e-Pub 2020. PMID: 32561656.
160. Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Kelso S, Group MC, working group PNSMCM, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L, Consortium P. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun 11(1):4748, 2020. e-Pub 2020. PMID: 32958763.
161. Li CH, Prokopec SD, Sun RX, Yousif F, Schmitz N, Subtypes T, Translation C, Boutros PC, Consortium P. Sex differences in oncogenic mutational processes. Nat Commun 11(1):4330, 2020. e-Pub 2020. PMID: 32859912.
162. Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, to Proteomic LJITTFESAMOFITM, Biomarkers RP. IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. Cancers 12(7):1768, 2020. e-Pub 2020. PMID: 32630797.
163. Barnhill R, van Dam PJ, Vermeulen P, Champenois G, Nicolas A, Rawson RV, Wilmott JS, Thompson JF, Long GV, Cassoux N, Roman-Roman S, Busam KJ, Scolyer RA, Lazar AJ, Lugassy C. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value. J Pathol Clin Res 6(3):195-206, 2020. e-Pub 2020. PMID: 32304183.
164. Hudeček J, Voorwerk L, van Seijen M, Nederlof I, de Maaker M, van den Berg J, van de Vijver KK, Sikorska K, Adams S, Demaria S, Viale G, Nielsen TO, Badve SS, Michiels S, Symmans WF, Sotiriou C, Rimm DL, Hewitt SM, Denkert C, Loibl S, Loi S, Bartlett JMS, Pruneri G, Dillon DA, Cheang MCU, Tutt A, Hall JA, Kos Z, Salgado R, Kok M, Horlings HM, Working Group IIB. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. NPJ Breast Cancer 6(15), 2020. e-Pub 2020. PMID: 32436923.
165. Carrot-Zhang J, Chambwe N, Damrauer JS, Knijnenburg TA, Robertson AG, Yau C, Zhou W, Berger AC, Huang KL, Newberg J, Mashl RJ, Romanel A, Sayaman RW, Demichelis F, Felau I, Frampton G, Han S, Hoadley KA, Kemal A, Laird PW, Lazar AJ, Le X, Oak N, Shen H, Wong CK, Zenklusen JC, Ziv E, Analysis Network CGA, Cherniack AD, Beroukhim R. Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer. Cancer Cell 37(5):639-654, 2020. e-Pub 2020. PMID: 32396860.
166. Groisberg R, Roszik J, Conley AP, Lazar AJ, Portal DE, Hong DS, Naing A, Herzog CE, Somaiah N, Zarzour MA, Patel S, Brown RE, Subbiah V. Genomics, morphoproteomics, and treatment patterns of alveolar soft part sarcoma patients and response to multiple experimental therapies. Mol Cancer Ther 19(5):1165-1172, 2020. e-Pub 2020. PMID: 32127467.
167. Cortés-Ciriano I, Lee JJ, Xi R, Jain D, Jung YL, Yang L, Gordenin D, Klimczak LJ, Zhang CZ, Pellman DS, Working Group PSV, Park PJ, Consortium P. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet 52(3):331-341, 2020. e-Pub 2020. PMID: 32025003.
168. Kos Z, Roblin E, Kim RS, Michiels S, Gallas BD, Chen W, van de Vijver KK, Goel S, Adams S, Demaria S, Viale G, Nielsen TO, Badve SS, Symmans WF, Sotiriou C, Rimm DL, Hewitt S, Denkert C, Loibl S, Luen SJ, Bartlett JMS, Savas P, Pruneri G, Dillon DA, Cheang MCU, Tutt A, Hall JA, Kok M, Horlings HM, Madabhushi A, van der Laak J, Ciompi F, Laenkholm AV, Bellolio E, Gruosso T, Fox SB, Araya JC, Floris G, Hudecek J, Voorwerk L, Beck AH, Kerner J, Larsimont D, Declercq S, Van den Eynden G, Pusztai L, Ehinger A, Yang W, AbdulJabbar K, Yuan Y, Singh R, Hiley C, Bakir MA, Lazar AJ, Naber S, Wienert S, Castillo M, Curigliano G, Dieci MV, André F, Swanton C, Reis-Filho J, Sparano J, Balslev E, Chen IC, Stovgaard EIS, Pogue-Geile K, Blenman KRM, Penault-Llorca F, Schnitt S, Lakhani SR, Vincent-Salomon A, Rojo F, Braybrooke JP, Hanna MG, Soler-Monsó MT, Bethmann D, Castaneda CA, Willard-Gallo K, Sharma A, Lien HC, Fineberg S, Thagaard J, Comerma L, Gonzalez-Ericsson P, Brogi E, Loi S, Saltz J, Klaushen F, Cooper L, Amgad M, Moore DA, Salgado R, Working Group IIB. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. NPJ Breast Cancer 6:17, 2020. e-Pub 2020. PMID: 32411819.
169. Haydu LE, Lo S, McQuade JL, Amaria RN, Wargo J, Ross MI, Cormier JN, Lucci A, Lee JE, Ferguson SD, Saw RPM, Spillane AJ, Shannon KF, Stretch JR, Hwu P, Patel SP, Diab A, Wong MKK, Glitza I, Tawbi H, Carlino MS, Menzies AM, Long GV, Lazar AJ, Tetzlaff MT, Scolyer RA, Gershenwald JE, Thompson JF, Davies MA. Cumulative incidence and predictors of central nervous system metastasis for AJCC 8th edition stage III melanoma patients. J Clin Oncol 38(13):1429-1441, 2020. e-Pub 2020. PMID: 31990608.
170. Oak N, Cherniack AD, Mashl RJ, Network TA, Hirsch FR, Ding L, Beroukhim R, Gümüş ZH, Plon SE, Huang KL. Ancestry-specific Predisposing Germline Variants in Cancer. Genome Med 12(1):51, 2020. e-Pub 2020. PMID: 32471518.
171. Mitra A, Andrews MC, Roh W, De Macedo MP, Hudgens CW, Carapeto F, Singh S, Reuben A, Wang F, Mao X, Song X, Wani K, Tippen S, Ng KS, Schalck A, Sakellariou-Thompson DA, Chen E, Reddy SM, Spencer CN, Wiesnoski D, Little LD, Gumbs C, Cooper ZA, Burton EM, Hwu P, Davies MA, Zhang J, Bernatchez C, Navin N, Sharma P, Allison JP, Wargo JA, Yee C, Tetzlaff MT, Hwu WJ, Lazar AJ, Futreal PA. Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma. Nat Commun 11(1):1839, 2020. e-Pub 2020. PMID: 32296058.
172. Bishop AJ, Landry JP, Roland CL, Ratan R, Feig BW, Moon BS, Zarzour MA, Wang WL, Lazar AJ, Lewis VO, Torres KE, Guadagnolo BA. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies. Cancer 126(14):3265-3273, 2020. e-Pub 2020. PMID: 32343846.
173. Chopra S, Lazar AJ, Wang WL. Are ALK Rearrangements Found in Smooth Muscle Tumors of the Gastrointestinal Tract?. Histopathol 76(4):627-628, 2020. e-Pub 2020. PMID: 31596959.
174. Merino DM, McShane LM, Fabrizio D, Funari V, Chen SJ, White JR, Wenz P, Baden J, Barrett JC, Chaudhary R, Chen L, Chen WS, Cheng JH, Cyanam D, Dickey JS, Gupta V, Hellmann M, Helman E, Li Y, Maas J, Papin A, Patidar R, Quinn KJ, Rizvi N, Tae H, Ward C, Xie M, Zehir A, Zhao C, Dietel M, Stenzinger A, Stewart M, Allen J, Consortium TMB. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. J Immunother Cancer 8(1):e000147, 2020. e-Pub 2020. PMID: 32217756.
175. Keung EZ, Burgess M, Salazar R, Parra ER, Rodrigues-Canales J, Bolejack V, Van Tine BA, Schuetze SM, Attia S, Riedel RF, Hu J, Okuno SH, Priebat DA, Movva S, Davis LE, Reed DR, Reuben A, Roland CL, Reinke D, Lazar AJ, Wang WL, Wargo JA, Tawbi HA. Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clin Cancer Res 26(6):1258-1266, 2020. e-Pub 2020. PMID: 31900276.
176. Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic Model for Patient Survival In Primary Anorectal Mucosal Melanoma: Stage At Presentation Determines Relevance Of Histopathologic Features. Mod Pathol 33(3):496-513, 2020. e-Pub 2020. PMID: 31383963.
177. Ali AMR, Tsai JW, Leung CH, Lin H, Ravi V, Conley AP, Lazar AJ, Wang WL, Nathenson MJ. The Immune Microenvironment of Uterine Adenosarcomas. Clin Sarcoma Res 10:5, 2020. e-Pub 2020. PMID: 32231779.
178. Ballester LY, Meis JM, Lazar AJ, Prabhu SS, Hoang KB, Leeds NE, Fuller GN. Intracranial Myxoid Mesenchymal Tumor with EWSR1-ATF1 Fusion. J Neuropathol Exp Neurol 79(3):347-351, 2020. e-Pub 2020. PMID: 32016322.
179. Zhang Y, Chen F, Fonseca NA, He Y, Fujita M, Nakagawa H, Zhang Z, Brazma A, Working Group PT, Working Group PSV, Creighton CJ, Consortium P. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations. Nat Commun 11(1):736, 2020. e-Pub 2020. PMID: 32024823.
180. Rubanova Y, Shi R, Harrigan CF, Li R, Wintersinger J, Sahin N, Deshwar A, Evolution P, Group HW, Morris Q, Consortium P. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nat Commun 11(1):731, 2020. e-Pub 2020. PMID: 32024834.
181. Cmero M, Yuan K, Ong CS, Schröder J, Evolution P, Group HW, Corcoran NM, Papenfuss T, Hovens CM, Markowetz F, Macintyre G, Consortium P. Inferring structural variant cancer cell fraction. Nat Commun 11(1):730, 2020. e-Pub 2020. PMID: 32024845.
182. Paczkowska M, Barenboim J, Sintupisut N, Fox NS, Zhu H, Abd-Rabbo D, Mee MW, Boutros PC, Drivers P, Working Group FI, Reimand J, Consortium P. Integrative pathway enrichment analysis of multivariate omics data. Nat Commun 11(1):735, 2020. e-Pub 2020. PMID: 32024846.
183. Jiao W, Atwal G, Polak P, Karlic R, Cuppen E, Subtypes PT, Working Group CT, Danyi A, de Ridder J, van Herpen C, Lolkema MP, Steeghs N, Getz G, Morris Q, Stein LD, Consortium P. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nat Commun 11(1):728, 2020. e-Pub 2020. PMID: 32024849.
184. Reyna MA, Haan D, Paczkowska M, Verbeke LPC, Vazquez M, Kahraman A, Pulido-Tamayo S, Barenboim J, Wadi L, Dhingra P, Shrestha R, Getz G, Lawrence MS, Pedersen JS, Rubin MA, Wheeler DA, Brunak S, Izarzugaza JMG, Khurana E, Marchal K, von Mering C, Sahinalp SC, Valencia A, Drivers P, Working Group FI, Reimand J, Stuart JM, Raphael BJ, Consortium P. Pathway and network analysis of more than 2500 whole cancer genomes. Nat Commun 11(1):729, 2020. e-Pub 2020. PMID: 32024854.
185. Yakneen S, Waszak SM, Working Group PT, Gertz M, Korbel JO, Consortium P. Butler enables rapid cloud-based analysis of thousands of human genomes. Nat Biotechnol 38(3):288-292, 2020. e-Pub 2020. PMID: 32024987.
186. Carlevaro-Fita J, Lanzós A, Feuerbach L, Hong C, Mas-Ponte D, Pedersen JS, Drivers P, Group FI, Johnson R, Consortium P. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Commun Biol 3(1):56, 2020. e-Pub 2020. PMID: 32024996.
187. Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim HL, Nakagawa H, Park K, Campbell PJ, Liang H, Consortium P. Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat Genet 52(3):342-352, 2020. e-Pub 2020. PMID: 32024997.
188. Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, Santamarina M, Ju YS, Temes J, Garcia-Souto D, Detering H, Li Y, Rodriguez-Castro J, Dueso-Barroso A, Bruzos AL, Dentro SC, Blanco MG, Contino G, Ardeljan D, Tojo M, Roberts ND, Zumalave S, Edwards PAW, Weischenfeldt J, Puiggròs M, Chong Z, Chen K, Lee EA, Wala JA, Raine K, Butler A, Waszak SM, Navarro FCP, Schumacher SE, Monlong J, Maura F, Bolli N, Bourque G, Gerstein M, Park PJ, Wedge DC, Beroukhim R, Torrents D, Korbel JO, Martincorena I, Fitzgerald RC, Van Loo P, Kazazian HH, Burns KH, Working Group PSV, Campbell PJ, Tubio JMC, Consortium P. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet 52(3):306-319, 2020. e-Pub 2020. PMID: 32024998.
189. Akdemir KC, Le VT, Chandran S, Li Y, Verhaak RG, Beroukhim R, Campbell PJ, Chin L, Dixon JR, Futreal PA, Working Group PSV, Consortium P. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer. Nat Genet 52(3):294-305, 2020. e-Pub 2020. PMID: 32024999.
190. Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, Desai N, Sültmann H, Moch H, Pathogens P, Cooper CS, Eils R, Ferretti V, Lichter P, Consortium P. The landscape of viral associations in human cancers. Nat Genet 52(3):320-330, 2020. e-Pub 2020. PMID: 32025001.
191. Shuai S, Drivers P, Working Group FI, Gallinger S, Stein L, Consortium P. Combined burden and functional impact tests for cancer driver discovery using DriverPower. Nat Commun 11(1):734, 2020. e-Pub 2020. PMID: 32024818.
192. Li Y, Roberts ND, Wala JA, Shapira O, Schumacher SE, Kumar K, Khurana E, Waszak S, Korbel JO, Haber JE, Imielinski M, Working Group PSV, Weischenfeldt J, Beroukhim R, Campbell PJ, Consortium P. Patterns of somatic structural variation in human cancer genomes. Nature 578(7793):112-121, 2020. e-Pub 2020. PMID: 32025012.
193. Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD, Evolution P, Group HW, Spellman PT, Wedge DC, Van Loo P, Consortium P. The evolutionary history of 2,658 cancers. Nature 578(7793):122-128, 2020. e-Pub 2020. PMID: 32025013.
194. Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RI, Lin Z, Feuerbach L, Sabarinathan R, Madsen T, Kim J, Mularoni L, Shuai S, Lanzós A, Herrmann C, Maruvka YE, Shen C, Amin SB, Bandopadhayay P, Bertl J, Boroevich KA, Busanovich J, Carlevaro-Fita J, Chakravarty D, Chan CWY, Craft D, Dhingra P, Diamanti K, Fonseca NA, Gonzalez-Perez A, Guo Q, Hamilton MP, Haradhvala NJ, Hong C, Isaev K, Johnson TA, Juul M, Kahles A, Kahraman A, Kim Y, Komorowski J, Kumar K, Kumar S, Lee D, Lehmann KV, Li Y, Liu EM, Lochovsky L, Park K, Pich O, Roberts ND, Saksena G, Schumacher SE, Sidiropoulos N, Sieverling L, Sinnott-Armstrong N, Stewart C, Tamborero D, Tubio JMC, Umer HM, Uusküla-Reimand L, Wadelius C, Wadi L, Yao X, Zhang CZ, Zhang J, Haber JE, Hobolth A, Imielinski M, Kellis M, Lawrence MS, von Mering C, Nakagawa H, Raphael BJ, Rubin MA, Sander C, Stein LD, Stuart JM, Tsunoda T, Wheeler DA, Johnson R, Reimand J, Gerstein M, Khurana E, Campbell PJ, López-Bigas N, Drivers P, Working Group FI, Working Group PSV, Weischenfeldt J, Beroukhim R, Martincorena I, Pedersen JS, Getz G, Consortium P. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578(7793):102-111, 2020. e-Pub 2020. PMID: 32025015.
195. Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN, Islam SMA, Lopez-Bigas N, Klimczak LJ, McPherson JR, Morganella S, Sabarinathan R, Wheeler DA, Mustonen V, Working Group PMS, Getz G, Rozen SG, Stratton MR, Consortium P. The repertoire of mutational signatures in human cancer. Nature 578(7793):94-101, 2020. e-Pub 2020. PMID: 32025018.
196. Core Group PT, Calabrese C, Davidson NR, Demircioğlu D, Fonseca NA, He Y, Kahles A, Lehmann KV, Liu F, Shiraishi Y, Soulette CM, Urban L, Greger L, Li S, Liu D, Perry MD, Xiang Q, Zhang F, Zhang J, Bailey P, Erkek S, Hoadley KA, Hou Y, Huska MR, Kilpinen H, Korbel JO, Marin MG, Markowski J, Nandi T, Pan-Hammarström Q, Pedamallu CS, Siebert R, Stark SG, Su H, Tan P, Waszak SM, Yung C, Zhu S, Awadalla P, Creighton CJ, Meyerson M, Ouellette BFF, Wu K, Yang H, Working Group PT, Brazma A, Brooks AN, Göke J, Rätsch G, Schwarz RF, Stegle O, Zhang Z, Consortium P. Genomic basis for RNA alterations in cancer. Nature 578(7793):129-136, 2020. e-Pub 2020. PMID: 32025019.
197. Wu CC, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang WL, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA. Immuno-genomic landscape of osteosarcoma. Nat Commun 11(1):1008, 2020. e-Pub 2020. PMID: 32081846.
198. Genomes Consortium IPAOW. Pan-cancer analysis of whole genomes. Nature 578(7793):82-93, 2020. e-Pub 2020. PMID: 32025007.
199. Sieverling L, Hong C, Koser SD, Ginsbach P, Kleinheinz K, Hutter B, Braun DM, Cortés-Ciriano I, Xi R, Kabbe R, Park PJ, Eils R, Schlesner M, Working Group PV, Brors B, Rippe K, Jones DTW, Feuerbach L, Consortium P. Genomic footprints of activated telomere maintenance mechanisms in cancer. Nat Commun 11(1):733, 2020. e-Pub 2020. PMID: 32024817.
200. Bhandari V, Li CH, Bristow RG, Boutros PC, Consortium P. Divergent mutational processes distinguish hypoxic and normoxic tumours. Nat Commun 11(1):737, 2020. e-Pub 2020. PMID: 32024819.
201. Petitprez F, de Reyniès A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautès-Fridman C, Tawbi HA, Fridman WH. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577(7791):556-560, 2020. e-Pub 2020. PMID: 31942077.
202. Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautès-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577(7791):549-555, 2020. e-Pub 2020. PMID: 31942075.
203. Molina ER, Chim LK, Salazar MC, Mehta SM, Menegaz BA, Lamhamedi-Cherradi SE, Satish T, Mohiuddin S, McCall D, Zaske AM, Cuglievan B, Lazar AJ, Scott DW, Grande-Allen JK, Ludwig JA, Mikos AG. Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma. Acta Biomater 100:38-51, 2019. e-Pub 2019. PMID: 31542501.
204. Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med 143(10):1203-1211, 2019. e-Pub 2019. PMID: 30969158.
205. Bishop AJ, Bird JE, Conley AP, Roland CL, Moon BS, Satcher RL, Livingston JA, Patel S, Wang WL, Lazar AJ, Lewis VO, Lin PP, Guadagnolo BA. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy with both Radiation and Surgery Improves Local Control. Am J Clin Oncol 42(10):744-748, 2019. e-Pub 2019. PMID: 31436747.
206. Chrisinger JSA, Al-Zaid T, Keung EZ, Cheuk Leung C, Lin HY, Roland CL, Torres KE, Benjamin RS, Ingram DR, Khan S, Somaiah N, Amini B, Feig BW, Lazar AJ, Wei-Lien Wang WL. The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum. J Surg Oncol 120(3):382-388, 2019. e-Pub 2019. PMID: 31206726.
207. Bonvalot S, Rutkowski PL, Thariat J, Carrère S, Ducassou A, Sunyach MP, Agoston P, Hong A, Mervoyer A, Rastrelli M, Moreno V, Li RK, Tiangco B, Herraez AC, Gronchi A, Mangel L, Sy-Ortin T, Hohenberger P, Thierry de Baère T, Le Cesne A, Helfre S, Saada-Bouzid E, Borkowska A, Rodica A, Co A, MD, Gebhart M, Kantor G, Montero A, Loong HH, Vergés R, Lapeire L, Dema S, Kacso G, Austen L, Moureau-Zabotto L, Servois V, Wardelmann E, Terrier P, Lazar AJ, JVMG B, Le Péchoux C, Papai Z. Phase II/III randomized trial of first-in-class radio-enhancer hafnium oxide nanoparticle NBTXR3 plus radiotherapy vs radiotherapy alone in patients with locally advanced soft tissue sarcoma: Act.In.Sarc. Lancet Oncol 20(8):1148-1159, 2019. e-Pub 2019. PMID: 31296491.
208. Members TF, Vidal CI, Sutton A, Armbrect EA, Lee JB, Litzner BR, Hurley MY, Panel R, Alam M, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Robinson JK, Schaffer A. Muir-Torre Syndrome Appropriate Use Criteria: Effect of Patient Age on Appropriate Use Scores. J Cutan Pathol 46(7):484-489, 2019. e-Pub 2019. PMID: 30895633.
209. Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres-Cabala CA, Efstathiou E, Hoang AG, Wong MK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba I, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Clin Cancer Res 25(11):3455-3467, 2019. e-Pub 2019. PMID: 30808776.
210. Fischer GM, Jalali A, Kircher DA, Lee WC, McQuade JL, Haydu LE, Joon AY, Reuben A, de Macedo MP, Carapeto FCL, Yang C, Srivastava A, Ambati CR, Sreekumar A, Hudgens CW, Knighton B, Deng W, Ferguson SD, Tawbi HA, Glitza IC, Gershenwald JE, Vashisht Gopal YN, Hwu P, Huse JT, Wargo JA, Futreal PA, Putluri N, Lazar AJ, DeBerardinis RJ, Marszalek JR, Zhang J, Holmen SL, Tetzlaff MT, Davies MA. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. Cancer Discov 9(5):628-645, 2019. e-Pub 2019. PMID: 30787016.
211. Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J. MAGEA3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers (Basel) 11(5):677, 2019. e-Pub 2019. PMID: 31096717.
212. Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA. Long-term outcomes for patients with desmoid fibromatosis treated with radiation therapy: an effective treatment but with poorer outcomes among young patients. Int J Radiat Oncol Biol Phys 103(5):1167-1174, 2019. e-Pub 2019. PMID: 30552963.
213. Merker JD, Devereaux K, Iafrate AJ, Kamel-Reid S, Kim AS, Moncur JT, Montgomery SB, Nagarajan R, Portier BP, Routbort MJ, Smail C, Surrey LF, Vasalos P, Lazar AJ, Lindeman NI. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays. Arch Pathol Lab Med 143(4):463-471, 2019. e-Pub 2019. PMID: 30376374.
214. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo, BA. Extraskeletal osteosarcomas: a case made for combined modality local therapy with radiation and surgery. Am J Clin Oncol 42(3):238-242, 2019. e-Pub 2019. PMID: 30614820.
215. McKean M, Oba J, Ma J, Roth KG, Wang WL, Macedo MP, Carapeto FCL, Haydu LE, Siroy AE, Vo P, Hong DS, Eterovic AK, Patel KP, Jr BR, Grimm EA, Lazar AJ, Woodman SE. Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma. J Invest Dermatol 139(3):728-731, 2019. e-Pub 2019.
216. Carugo A, Minelli R, Sapio L, Soeung M, Carbone F, Robinson FS, Tepper J, Ziheng C, Lovisa S, Svelto M, Amin S, Srinivasan S, Del Poggetto E, Loponte S, Puca F, Dey P, Malouf GG, Su X, Li L, Lopez-Terrada D, Rakheja D, Lazar AJ, Netto G, Rao P, Sgambato A, Maitra A, Tripathi D, Walker C, Karam J, Heffernan TP, Viale A, Roberts CWM, Msaouel P, Tannir N, Draetta GF, Genovese G. TP53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors. Cancer Cell 35(2):204-220.e9, 2019. e-Pub 2019. PMID: 30753823.
217. Aires DJ, Yoshida M, Richardson SK, Bai M, Liu L, Moreno R, Lazar AJ, Wick JA, Rich BE, Murphy G, Blumberg RS, Fuhlbrigge RC, Kupper TS. T Cell Trafficking Plays an Essential Role in Tumor Immunity. Lab invest 99(1):85-92, 2019. e-Pub 2019. PMID: 30353131.
218. Liu Y, Weber Z, San Lucas FA, Deshpande A, Jakubek YA, Sulaiman R, Fagerness M, Flier N, Sulaiman J, Davis CM, Fowler J, Starks D, Rojas-Espaillat L, Lazar AJ, Davies GE, Ehli EA, Scheet P. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas. Gynecol Oncol 151(2):243-249, 2018. e-Pub 2018. PMID: 30194005.
219. Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med 24(12):1804-1808, 2018. e-Pub 2018. PMID: 30420754.
220. Demicco EG, Wani K, Ingram D, Wagner M, Maki RG, Rizzo A, Meeker A, Lazar AJ, Wang WL. TERT Promoter Mutations in Solitary Fibrous Tumor. Histopathology 73(5):573-851, 2018. e-Pub 2018. PMID: 29985536.
221. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, W-J H, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman SE, Kageyama R, Wells DK, Patrick Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald JE, Simpson L, Burton EM, Posada L, Haydu LE, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto VG, Sharma P, Allison JP, Tetzlaff MT, Wargo JA. Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma. Nat Med 24(11):1649-1654, 2018. e-Pub 2018. PMID: 30297909.
222. Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, Ju Z, Hansel D, de Velasco G, Pennathur A, Andersen JB, O'Rourke CJ, Ohshiro K, Jogunoori W, Nguyen BN, Li S, Osmanbeyoglu HU, Ajani JA, Mani SA, Houseman A, Wiznerowicz M, Chen J, Gu S, Ma W, Zhang J, Tong P, Cherniack AD, Deng C, Resar L, Atlas Network TCG, Weinstein JN, Mishra L, Akbani R. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Cell Syst 7(4):422-437.e7, 2018. e-Pub 2018. PMID: 30268436.
223. Chen H, Luthra R, Patel KP, Routbort M, Rashid A, Roy-Chowdhuri S, Lazar AJ, Broaddus R, Manekia J, Singh RR, Yemelyanova A. Challenges in next generation sequencing analysis of somatic mutations in transplant patients. Cancer Genet 226-227:17-22, 2018. e-Pub 2018. PMID: 30005850.
224. Subbiah V Lamhamedi-Cherradi SE, Cuglievan B, Menegaz BA, Camacho P, Huh W, Ramamoorthy V, Anderson PM, Pollock RE, Lev DC, Qiao W, McAleer MF, Benjamin RS, Patel S, Herzog CE, Daw N, Feig BA, Lazar AJ, Hayes-Jordan A, Ludwig JA. Multimodality Treatment of Desmoplastic Small Round cell tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clin Cancer Res 24(19):4865-4873, 2018. e-Pub 2018. PMID: 29871905.
225. Kim G, Kurnit KC, Djordjevic B, Singh C, Munsell MF, Wang WL, Lazar AJ, Zhang W, Broaddus R. Nuclear β-Catenin Localization and Mutation of the CTNNB1 Gene: A Context-Dependent Association. Mod Pathol 31(10):1553-1559, 2018. e-Pub 2018. PMID: 29795437.
226. Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB, Atlas Network TCG, Camargo F, Liang H. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep 25(5):1304-1317.e5, 2018. e-Pub 2018. PMID: 30380420.
227. Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC. Circulating Tumor DNA Analysis in Patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Arch Pathol Lab Med 142(10):1242-1253, 2018. e-Pub 2018. PMID: 29504834.
228. Nathenson MJ, Conley AP, Lin H, Fleming N, Lazar AJ, Wang WL, Ravi V. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes. Int J Gynecol Cancer 28(7):1297-1310, 2018. e-Pub 2018. PMID: 30044322.
229. Young ED, Ingram D, Metcalf-Doetsch W, Khan D, Al Sannaa G, Le Loarer F, Lazar AJ, Slopis J, Torres KE, Lev D, Pollock RE, McCutcheon IE. Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers. J Neurosurg 129(3):805-814, 2018. e-Pub 2018. PMID: 28885122.
230. Conley AP, Trinh VA, Zobniw CM, Posey K, Martinez JD, Arrieta OG, Wang WL, Lazar AJ, Somaiah N, Roszik J, Patel SR. Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient with Refractory Alveolar Soft Part Sarcoma: A Case Report. J Global Oncol 4:1-6, 2018. e-Pub 2018. PMID: 30241159.
231. Bezrookove V, Nosrati M, Miller III JR, De Semir D, Dar AA, Vosoughi E, Vaquero E, Sucker A, Lazar AJ, Gershenwald JE, Davies MA, Schadendorf D, Kashani-Sabet M. Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma. Clin Cancer Res 24(17):4119-4125, 2018. e-Pub 2018. PMID: 29776954.
232. Roszik J, Ring KL, Wani KM, Lazar AJ, Yemelyanova AV, Soliman PT, Frumovitz M, Jazaeri AA. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol 9(2102), 2018. e-Pub 2018. PMID: 30283446.
233. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 18(1):913, 2018. e-Pub 2018. PMID: 30249211.
234. Kahles A, Lehmann KV, Toussaint NC, Hüser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Research Network TCGA, Rätsch G. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Cancer Cell 34(2):211-224.e6, 2018. e-Pub 2018. PMID: 30078747.
235. Kwong LN, De Macedo MP, Haydu L, Joon AY, Tetzlaff MT, Calderone TL, Wu CJ, Kwong MK, Roszik J, Hess KR, Davies MA, Lazar AJ, Gershenwald JE. Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas. JCO Precis Oncol 2018:PO.17.00259, 2018. e-Pub 2018.
236. Force AUC, Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Yadira Hurley M, Panel R, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology. J Cutan Pathol 45(8):563-580, 2018. e-Pub 2018. PMID: 29566273.
237. McBride MJ, Pulice JL, Nakayama RT, Beird HC, Ingram DR, D’Avino AR, Shern JF, Charville GR, Hornick JL, Garcia-Rivera EM, Araujo D, J-W T, Wang WL, Yeagley M, Wagner AJ, Futreal PA, Khan J, Lazar AJ, Kadoch C. The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell 33(6):1128-1141.e7, 2018. e-Pub 2018. PMID: 29861296.
238. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan BK, Kwaitkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WT, Robertson AG, Research Network TCGA, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23(1):313-326.e5, 2018. e-Pub 2018. PMID: 29925010.
239. Oba J, S-H K, Wang WL, Macedo MP, Carapeto F, McKean MA, Van Arnam J, Eterovic AK, Sen S, Kale CR, Yu X, Haymaker CL, Routbort M, Haydu LE, Bernatchez C, Lazar AJ, Grimm EA, Hong DS, and Woodman SE. Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma. JCO Precision Oncol 2018:PO.18.00055, 2018. e-Pub 2018. PMID: 30094412.
240. Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW. The Clinical Behavior of Well Differentiated Liposarcoma can be Extremely Variable: A Retrospective Cohort Study at a Major Sarcoma Center. J Surg Oncol 117(8):1799-1805, 2018. e-Pub 2018. PMID: 29723411.
241. Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC. Circulating Tumor DNA Analysis in Patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J Clin Oncol 36(16):1631-1641, 2018. e-Pub 2018. PMID: 29504847.
242. Kim A, Bartley A, Bridge J, Kamel-Reid S, Lazar AJ, Lindeman N, Long T, Merker J, Rai A, Rimm D, Rothberg P, Vasalos P, Moncur J. Equivalent Performance of Laboratory Developed Tests and FDA-Approved Assays in BRAF, EGFR, KRAS Testing. JAMA Oncol 4(6):838-841, 2018. e-Pub 2018. PMID: 29242895.
243. Livingston JA, Wang WL, Tsai JW, Lazar AJ, Leung CH, Lin H, Advani S, Daw N, Santiago-O'Farrill J, Hollomon M, Gordon NB, Kleinerman ES. Analysis of HSP27 and the autophagy marker LC3B+ puncta following preoperative chemotherapy identifies high-risk osteosarcoma patients. Mol Cancer Ther 17(6):1315-1323, 2018. e-Pub 2018. PMID: 29592877.
244. Romano G, Chen PL, Song P, McQuade JL, Liang RJ, Liu M, Roh W, Duose DY, Carapeto FCL, Li J, Teh JLF, Aplin AE, Chen M, Zhang J, Lazar AJ, Davies MA, Futreal PA, Amaria RN, Zhang DY, Wargo JA, Kwong LN. A pre-existing rare PIK3CAE545K subpopulation confers clinical resistance to MEK plus CDK4/6 inhibition in NRAS melanoma and is dependent on S6K1 signaling. Cancer Discov 8(5):556-567, 2018. e-Pub 2018. PMID: 29496665.
245. Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology. J Am Acad Dermatol 80(1):189-207, 2018. e-Pub 2018. PMID: 29689323.
246. Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, Schumacher SE, Wang C, Hu H, Liu J, Lazar AJ, Research Network CGA, Cherniack AD, Beroukhim R, Meyerson M. Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell 33(4):676-689.e3, 2018. e-Pub 2018. PMID: 29622463.
247. Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, Research Network CGA, Hu H. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173(2):400-416.e11, 2018. e-Pub 2018. PMID: 29625055.
248. Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kaminska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwinska P, Mazurek S, Mishra L, Heyn H, Krasnitz A, Godwin AK, Lazar AJ, Research Network CGA, Stuart JM, Hoadley KA, Laird PW, Noushmehr H, Wiznerowicz M. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173(2):338-354.e15, 2018. e-Pub 2018. PMID: 29625051.
249. Ding L, Bailey MH, Porta-Pardo E, Thorsson V, Colaprico A, Bertrand D, Gibbs DL, Weerasinghe A, Huang KL, Tokheim C, Cortés-Ciriano I, Jayasinghe R, Chen F, Yu L, Sun S, Olsen C, Kim J, Taylor AM, Cherniack AD, Akbani R, Suphavilai C, Nagarajan N, Stuart JM, Mills GB, Wyczalkowski MA, Vincent BG, Hutter CM, Zenklusen JC, Hoadley KA, Wendl MC, Shmulevich L, Lazar AJ, Wheeler DA, Getz G, Research Network CGA. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell 173(2):305-320.e10, 2018. e-Pub 2018. PMID: 29625049.
250. Saltz J, Gupta R, Hou L, Kurc T, Singh P, Nguyen V, Samaras D, Shroyer KR, Zhao T, Batiste R, Van Arnam J, Research Network CGA, Shmulevich I, Rao AUK, Lazar AJ, Sharma A, Thorsson V. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. Cell Rep 23(1):181-193.e7, 2018. e-Pub 2018. PMID: 29617659.
251. Chen H, Li C, Peng X, Zhou Z, Weinstein JN, Research Network TCGA, Liang H. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Cell 173(2):386-399.e12, 2018. e-Pub 2018. PMID: 29625054.
252. Beird HC, Wu CC, Ingram DR, Wang WL, Alimohamed A, Gumbs C, Little L, Song X, Feig BW, Roland CL, Zhang J, Benjamin RS, Hwu P, Lazar AJ, Futreal PA, Somaiah N. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Cold Spring Harb Mol Case Stud 4(2), 2018. e-Pub 2018. PMID: 29610390.
253. Chiu HS, Somvanshi S, Patel E, Chen TW, Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS, Research Network TCGA, Sood AK, Gunaratne PH, Sumazin P. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context. Cell Rep 23(1):297-312.e12, 2018. e-Pub 2018. PMID: 29617668.
254. Seiler M, Peng S, Agrawal AA, Palacino J, Teng T, Zhu P, Smith PG, Research Network TCGA, Buonamici S, Yu L. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types. Cell Rep 23(1):282-296.e4, 2018. e-Pub 2018. PMID: 29617667.
255. Jayasinghe RG, Cao S, Gao Q, Wendl MC, Vo NS, Reynolds SM, Zhao Y, Climente-González H, Chai S, Wang F, Varghese R, Huang M, Liang WW, Wyczalkowski MA, Sengupta S, Li Z, Payne SH, Fenyö D, Miner JH, Walter MJ, Research Network TCGA, Vincent B, Eyras E, Chen K, Shmulevich I, Chen F, Ding L. Systematic Analysis of Splice-Site-Creating Mutations in Cancer. Cell Rep 23(1):270-281.e3, 2018. e-Pub 2018. PMID: 29617666.
256. Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi PL, Wang Y, Cheng F, Tan L, Mojumdar K, Du D, Ge Z, Li J, Thomas GV, Birsoy K, Liu L, Zhang H, Zhao Z, Marchand C, Weinstein JN, Research Network TCGA, Bathe OF, Liang H. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep 23(1):255-269.e4, 2018. e-Pub 2018. PMID: 29617665.
257. Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Research Network TCGA, Monnat Jr RJ, Xiao Y, Wang C. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23(1):239-254, 2018. e-Pub 2018. PMID: 29617664.
258. Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Hu C, Sun Y, Yao F, Li J, Zhang H, Liu J, Shriver CD, Hu H, Research Network TCGA, Piwnica-Worms H, Li M, Liang H. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell Rep 23(1):213-226.e3, 2018. e-Pub 2018. PMID: 29617661.
259. Way GP, Sanchez-Vega F, La K, Armenia J, Chatila WK, Luna A, Sander C, Cherniack AD, Mina M, Ciriello G, Schultz N, Research Network TCGA, Sanchez Y, Greene CS. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. Cell Rep 23(1):172-180.e3, 2018. e-Pub 2018. PMID: 29617658.
260. Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, Atlas Network TCG, Xie W, Yang D. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell 33(4):706-720.e9, 2018. e-Pub 2018. PMID: 29622465.
261. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Research Network CGA, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173(2):321-337.e10, 2018. e-Pub 2018. PMID: 29625050.
262. Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang LB, Zhou DC, Liu D, Cao S, Kim YW, Koire A, McMichael JF, Hucthagowder V, Kim TB, Hahn A, Wang C, McLellan MD, Al-Mulla F, Johnson KJ, Research Network CGA, Lichtarge O, Boutros PC, Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dipersio JF, Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L. Pathogenic germline variants in 10,389 adult cancers. Cell 173(2):355-370.e14, 2018. e-Pub 2018. PMID: 29625052.
263. Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK, Research Network CGA, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C. Genomic, pathway network, and immunologic features distinguishing squamous carcinomas. Cell Rep 23(1):194-212.e6, 2018. e-Pub 2018. PMID: 29617660.
264. Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE, Research Network CGA, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich L. The Immune Landscape of Cancer. Immunity 48(4):812-830.e14, 2018. e-Pub 2018. PMID: 29628290.
265. Gao Q, Liang WW, Foltz SM, Mutharasu G, Jayasinghe RG, Cao S, Liao WW, Reynolds SM, Wyczalkowski MA, Yao L, Yu L, Sun SQ, Working Group FA, Research Network CGA, Chen K, Lazar AJ, Fields RC, Wendl MC, Van Tine BA, Vij R, Chen F, Nykter M, Shmulevich I, Ding L. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep 23(1):227-238.e3, 2018. e-Pub 2018. PMID: 29617662.
266. Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, Research Network CGA, Weinstein JN, Mills GB, Levine DA, Akbani R. A comprehensive Pan-Cancer molecular study of gynecologic and breast cancers. Cancer Cell 33(4):690-705.e9, 2018. e-Pub 2018. PMID: 29622464.
267. Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Research Network CGA, Thorsson V, Bass AJ, Laird PW. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 33(4):721-735.e8, 2018. e-Pub 2018. PMID: 29622466.
268. Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, Atlas Network CG, Stuart JM, Benz CC, Laird PW. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173(2):291-304.e6, 2018. e-Pub 2018. PMID: 29625048.
269. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, Group MC, Research Network CGA, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173(2):371-385.e18, 2018. e-Pub 2018. PMID: 29625053.
270. Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW. Identification of Preoperative Factors Associated with Outcomes Following Surgical Management Intra-abdominal Recurrent or Metastatic GIST Following Neoadjuvant Tyrosine Kinase Inhibitor Therapy. J Surg Oncol 117(5):879-885, 2018. e-Pub 2018. PMID: 29448300.
271. Somaiah N, Beird H, Shaw K, Song J, Barbo JA, Wang WL, Conley AP, Ravi V, Chen K, Eterovic K, Lazar AJ, Hwu P, Futreal PA, Meric-Bernstam F, Hong DS. Targeted next generation sequencing in well-differentated/dedifferentiated liposarcoma (WD/DD LPS) reveals novel gene alterations. Oncotarget 9(28):19891-19899, 2018. e-Pub 2018. PMID: 29731991.
272. Ellrott K, Bailey MH, Saksena G, Covington KR, Kandoth C, Stewart C, Hess J, Ma S, Chiotti KE, McLellan M, Sofia HJ, Hutter C, Getz G, Wheeler D, Ding L, Group MC, Atlas Network TCG. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. Cell Syst 6(3):271-281.e7, 2018. e-Pub 2018. PMID: 29596782.
273. Schaub FX, Dhankani V, Berger AC, Trivedi M, Richardson AB, Shaw R, Zhao W, Zhang X, Ventura A, Liu Y, Ayer DE, Hurlin PJ, Cherniack AD, Eisenman RN, Bernard B, Grandori C, Atlas Network TCG. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across The Cancer Genome Atlas. Cell Syst 6(3):282-300.e2, 2018. e-Pub 2018. PMID: 29596783.
274. Ali AM, Wang WL, Lazar AJ. Primary Chondro-osseous melanoma (Chondrosarcomatous & Osteosarcomatous Melanoma). J Cutan Pathol 45(2):146-150, 2018. e-Pub 2018. PMID: 29068062.
275. Amaria RN, Prieto PA, Tetzlaff MT, Reuben A, Andrews MC, Ross MI, Glitza IC, Cormier J, Hwu WJ, Tawbi HA, Patel SP, Lee JE, Gershenwald JE, Spencer CN, Gopalakrishnan V, Bassett R, Simpson L, Mouton R, Hudgens CW, Zhao L, Zhu H, Cooper ZA, Wani K, Lazar AJ, Hwu P, Diab A, Wong MK, McQuade JL, Royal R, Lucci A, Burton EM, Reddy S, Sharma P, Allison J, Futreal PA, Woodman SE, Davies MA, Wargo J. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol 19(2):181-193, 2018. e-Pub 2018. PMID: 29361468.
276. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97-103, 2018. e-Pub 2018. PMID: 29097493.
277. Panse G, Chrisinger JSA, Leung CH, Ingram DR, Khan S, Wani K, Lin H, Lazar AJ, Wang WL. Clinicopathological analysis of ATRX, DAXX and NOTCH Receptor Expression in Angiosarcomas. Histopathology 72(2):239-247, 2018. e-Pub 2018. PMID: 28796347.
278. Nagarajan R, Bartley AN, Bridge JA, Jennings LJ, Kamel-Reid S, Kim A, Lazar AJ, Lindeman NI, Moncur J, Rai AJ, Routbort MJ, Vasalos P, Merker JD. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices. Arch Pathol Lab Med 141(12):1679-1685, 2017. e-Pub 2017. PMID: 29028368.
279. Research Network TCGA, Demicco EG, Ding L, Ladanyi M, Lazar AJ, Singer S. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell 171(4):950-965.e28, 2017. e-Pub 2017. PMID: 29100075.
280. Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF, Expert Panel FMOTAJCOCM, Melanoma Database TI, Platform D. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472-492, 2017. e-Pub 2017. PMID: 29028110.
281. Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol 18(11):1493-1501, 2017. e-Pub 2017. PMID: 28988646.
282. Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, Oliveira AM, Billings SD, JVMG B, Roy A, Lazar AJ, Lopez-Terrada DH, Wang WL. USP6 Activation in Nodular Fasciitis by Promoter-Swapping Gene Fusions. Mod Pathol 30(11):1577-1588, 2017. e-Pub 2017. PMID: 28752842.
283. Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL. Risk Assessment in Solitary Fibrous Tumors: Validation and Refinement of a Risk Stratification Model. Mod Pathol 30(10):1433-1442, 2017. e-Pub 2017. PMID: 28731041.
284. Kasper B, Baumgarten C, Garcia J, Bonvalot S, Haas R, Haller F, Hohenberger P, Penel N, Messiou C, van der Graaf WT, Gronchi A, Group DW. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol 28(10):2399-2408, 2017. e-Pub 2017. PMID: 28961825.
285. Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CL. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology 7(2):e1385689, 2017. e-Pub 2017. PMID: 29308306.
286. May CD, Bolshakov S, Landers SM, Ingram DR, Ma XY, Kivlin CM, Watson KL, Al Sannaa GA, Bhalla A, Wang WL, Lazar AJ, Torres KE. Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma. Cancer Biol Ther 18(10):816-826, 2017. e-Pub 2017. PMID: 29099264.
287. Wagner MJ, Vinod R, Patel S, Lazar AJ, Ludwig JA, Conley AP, Ratan R, Zarzour MA, Somaiah N, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin (Vid) for Initial Treatment of Ewing Sarcoma in Adults. Oncologist 22(10):1271-1277, 2017. e-Pub 2017. PMID: 28710342.
288. Livingston JA, Bugano D, Barbo A, Lin H, Madewell JE, Wang WL, Lazar AJ, Tseng WW, Roland CL, Feig BW, Pollock R, Conley AP, Benjamin RS, Patel S, Somaiah N. Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Sci Rep 7(1):11836, 2017. e-Pub 2017. PMID: 28928422.
289. Semenova G, Stepanova DS, Dubyk C, Deyev SM, Lazar AJ, and Chernoff J. Targeting Group I p21-Activated Kinases in Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Oncogene 36(38):5421-5431, 2017. e-Pub 2017. PMID: 28534510.
290. Charville GW, Wang WL, Ingram DR, Roy A, Thomas D, Patel RM, Hornick JL, van de Rijn M, Lazar AJ. EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma. Mod Pathol 30(9):1312-1320, 2017. e-Pub 2017. PMID: 28643791.
291. Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D, Widemann B, Perry A. Histopathologic Evaluation of Atypical Neurofibromatous Tumors and Their Transformation into Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis 1 Patients - A Consensus Overview. Hum Pathol 67:1-10, 2017. e-Pub 2017. PMID: 28551330.
292. de Graaff MA, Malu S, Guardiola I, Kruisselbrink AB, de Jong Y, Corver WE, Gelderblom H, Hwu P, Nielsen TO, Lazar AJ, Somaiah N, JVMG B. High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth. Transl Oncol 10(4):546-554, 2017. e-Pub 2017. PMID: 28654818.
293. Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O, Akbani R, Bristow CA, Hoadley KA, Iype L, Chang MT, Network TR, Cherniack AD, Benz C, Mills GB, Verhaak RGW, Griewank KG, Felau I, Zenklusen JC, Gershenwald JE, Schoenfield L, Lazar AJ, Abdel-Rahman MH, Roman-Roman S, Stern MH, Cebulla CM, Williams MD, Jager MJ, Coupland SE, Esmaeli B, Kandoth C, Woodman SE. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell 32(2):204-220.e15, 2017. e-Pub 2017. PMID: 28810145.
294. Al-Zaid T, Wang WL, Somaiah N, Lazar AJ. Molecular profiling of sarcomas: new vistas for precision medicine. Virchows Arch 471(2):243-255, 2017. e-Pub 2017. PMID: 28664413.
295. Reuben A, de Macedo MP, McQuade J, Joon A, Ren Z, Calderone T, Conner B, Wani K, Cooper ZA, Tawbi H, Tetzlaff MT, Padera RF, J-B D, Lazar AJ, Wargo JA, Davies MA. Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab. Oncoimmunology 6(12):e1361097, 2017. e-Pub 2017. PMID: 29209563.
296. Dodd RD, Lee CL, Overton T, Huang W, Eward WC, Luo L, Ma Y, Ingram DR, Torres KE, Cardona DM, Lazar AJ, Kirsch DG. NF1(+/-) Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response. Cancer Res 77(16):4486-4497, 2017. e-Pub 2017. PMID: 28646022.
297. Gopalakrishnan V, Amini B, Wagner MJ, Nowell EN, Lazar AJ, Lin PP, Benjamin RS, Araujo DM. Synovial Sarcoma of the Head and Neck: A Single Institution Review. Sarcoma 2017:2016752, 2017. e-Pub 2017. PMID: 28655993.
298. Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal PA, Lazar AJ, Patel SR, Conley AP. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes. Clin Sarcoma Res 7(11), 2017. e-Pub 2017. PMID: 28630682.
299. Sarkar S, Bristow CA, Dey P, Rai K, Perets R, Ramirez-Cardenas A, Malasi S, Huang-Hobbs E, Haemmerle M, Wu SY, McGuire M, Protopopov A, Jiang S, Liu JF, Hirsch MS, Chang Q, Lazar AJ, Sood AK, Drapkin R, DePinho R, Draetta G, Chin L. PRKCI promotes immune suppression in ovarian cancer. Genes Dev 31(11):1109-1121, 2017. e-Pub 2017. PMID: 28698296.
300. Panse G, Leung CH, Ingram DR, Wani K, Torres KE, Lin H, Lazar AJ, Wang WL. The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumours. Histopathol 70(6):946-953, 2017. e-Pub 2017. PMID: 27992966.
301. Qin Y, Petaccia de Macedo M, Reuben A, Forget MA, Haymaker C, Bernatchez C, Spencer CN, Gopalakrishnan V, Reddy S, Cooper ZA, Fulbright OJ, Ramachandran R, Wahl A, Flores E, Thorsen ST, Tavera RJ, Conrad C, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Amaria RN, Hwu P, Wargo JA, Lazar AJ, Patel SP. Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study. Oncoimmunology 6(6):e1321187, 2017. e-Pub 2017. PMID: 28680759.
302. Leon-Castillo A, Chrisinger JSA, Panse G, Samdani RT, Ingram DR, Ravi V, Prieto VG, Wang WL, Lazar AJ. Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series. J Cutan Pathol 44(8):692-697, 2017. e-Pub 2017. PMID: 28556023.
303. Reuben A, Spencer CN, Prieto PA, P-L C, Mao X, Jiang H, Gopalakrishnan V, Miller JP, De Macedo MP, Chen J, Cheung H, Roh W, Garber HR, Austin-Breneman J, W-S C, Haymaker C, A-M F, Little LD, Gumbs C, Thornton RL, Hudgens CW, Sangeetha M Reddy SM, Jason Roszik J, Patrick Hwu P, Scott E Woodman SE, Lynda Chin L, Michael A Davies MA, Gershenwald JE, Amaria RN, Glitza IC, Diab A, Patel SP, Hu J, Lee JE, Grimm EA, Sharma P, Allison JP, Tetzlaff MT, Lazar AJ, Wistuba II, Dwyer KC, Zhang J, Futreal PA, Cooper ZA, Wargo JA. Genomic and immune heterogeneity in synchronous melanoma metastases contribute to differential tumor growth and response to therapy. NPJ Genomic Med 2:10, 2017. e-Pub 2017. PMID: 28819565.
304. Reuben A, Spencer CN, Prieto PA, Gopalakrishnan V, Reddy SM, Miller JP, Mao X, De Macedo MP, Chen J, Song X, Jiang H, Chen PL, Beird HC, Garber HR, Roh W, Wani K, Chen E, Haymaker C, Forget MA, Little LD, Gumbs C, Thornton RL, Hudgens CW, Chen WS, Austin-Breneman J, Sloane RS, Nezi L, Cogdill AP, Bernatchez C, Roszik J, Hwu P, Woodman SE, Chin L, Tawbi H, Davies MA, Gershenwald JE, Amaria RN, Glitza IC, Diab A, Patel SP, Hu J, Lee JE, Grimm EA, Tetzlaff MT, Lazar AJ, Wistuba II, Clise-Dwyer K, Carter BW, Zhang J, Futreal PA, Sharma P, Allison JP, Cooper ZA, Wargo JA. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genom Med 2(10), 2017. e-Pub 2017. PMID: 28819565.
305. Oba J, Esmaeli B, Ellerhorst JA, Lyons GR, Milton DR, Wang WL, Macedo MP, Lazar AJ, Grimm EA, Chattopadhyay C. Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progression. Melanoma Res 27(2):126-133, 2017. e-Pub 2017. PMID: 28118269.
306. Kim DW, Haydu LE, Joon AY, Bassett RL, Siroy AE, Tetzlaff MT, Routbort MJ, Amaria RN, Wargo JA, McQuade JL, Kemnade J, Hwu P, Woodman SE, Roszik J, Kim KB, Gershenwald JE, Lazar AJ, Davies MA. Clinicopathological features and clinical outcomes associated with TP53 and BRAF non-V600 mutations in cutaneous melanoma patients. Cancer 123(8):1372-1381, 2017. e-Pub 2017. PMID: 27911979.
307. El Beaino M, Araujo DM, Lazar AJ, Lin PP. Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy. Ann Surg Oncol 24(6):2145-2154, 2017. e-Pub 2017. PMID: 28397189.
308. Roh W, Chen PL, Reuben A, Spencer CN, Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy SM, Gumbs C, Little L, Chang Q, Chen WS, Wani K, De Macedo MP, Chen E, Austin-Breneman JL, Jiang H, Roszik J, Tetzlaff MT, Davies MA, Gershenwald JE, Tawbi H, Lazar AJ, Hwu P, Hwu WJ, Diab A, Glitza IC, Patel SP, Woodman SE, Amaria RN, Prieto VG, Hu J, Sharma P, Allison JP, Chin L, Zhang J, Wargo JA, Futreal PA. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med 9(379), 2017. e-Pub 2017. PMID: 28251903.
309. Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg 126(1):319-329, 2017. e-Pub 2017. PMID: 27035165.
310. Kumar E, Patel NR, Demicco EG, Bovée JV, Olivera AM, Lopez-Terrada DH, Billings SD, Lazar AJ, Wang WL. Cutaneous Nodular Fasciitis with Genetic Analysis: A Case Series. J Cutan Pathol 43(12):1143-1149, 2016. e-Pub 2016. PMID: 27686647.
311. Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med 213(13):2989-3005, 2016. e-Pub 2016. PMID: 27956588.
312. Al Sannaa G, Watson KL, Olar A, Wang WL, Fuller GN, McCutcheon I, Torres KE, Lazar AJ. Sarcoma Brain Metastases: 28 Years of Experience at a Single Institution. Ann Surg Oncol 23(Suppl 5):s962-s967, 2016. e-Pub 2016. PMID: 27646022.
313. Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JA. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. J Natl Cancer Inst 108(12), 2016. e-Pub 2016. PMID: 27576731.
314. Charville GW, Varma S, Forgó E, Dumont SN, Zambrano E, Trent JC, Lazar AJ, van de Rijn M. PAX7 expression in rhabdomyosarcoma, related soft-tissue tumors, and small round blue-cell neoplasms. Am J Surg Pathol 40(10), 2016. e-Pub 2016. PMID: 27526298.
315. Roszik J, Haydu LE, Hess KR, Oba J, Joon AY, Siroy AE, Karpinets TV, Stingo FC, Baladandayuthapani V, Tetzlaff MT, Wargo JA, Chen K, Forget MA, Haymaker CL, Chen JQ, Meric-Bernstam F, Eterovic AK, Shaw KR, Mills GB, Gershenwald JE, Radvanyi LG, Hwu P, Futreal PA, Gibbons DL, Lazar AJ, Bernatchez C, Davies MA, Woodman SE. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC Med 14(1):168, 2016. e-Pub 2016. PMID: 27776519.
316. Kattan MW, Hess KR, Amin M, Lu Y, Moons KG, Gershenwald JE, Gimotty PA, Guinney J, Halabi S, Lazar AJ, Mahar A, Patel T, Sargent DJ, Weiser MR, Compton C, Medicine Core MOTAP. American Joint Committee on Cancer Acceptance Criteria for Inclusion of Risk Models for Individualized Prognosis in the Practice of Precision Medicine. CA Cancer J Clin 66(5):370-4, 2016. e-Pub 2016. PMID: 26784705.
317. Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, Van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovée JV. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29(9), 2016. e-Pub 2016. PMID: 27573709.
318. Bird JE, Morse LJ, Feng L, Wang WL, Lin PP, Moon BS, Lazar AJ, Satcher RL, Madewell JE, Lewis VO. Non-radiographic Risk Factors Differentiating Atypical Lipomatous Tumors from Lipomas. Front Oncol 6(6):197, 2016. e-Pub 2016. PMID: 27713864.
319. El Beaino ka M Araujo DM, Gopalakrishnan V, Lazar AJ, Lin PP. Prognosis of T1 Synovial Sarcoma Depends Upon Surgery by Oncologic Surgeons. J Surg Oncol 114(4):490-4, 2016. e-Pub 2016. PMID: 27220538.
320. Chen PL, Roh W, Reuben A, Cooper ZA, Spencer CN, Prieto PA, Miller JP, Bassett RL, Gopalakrishnan V, Wani K, De Macedo MP, Austin-Breneman JL, Jiang H, Chang Q, Reddy SM, Chen WS, Tetzlaff MT, Broaddus RJ, Davies MA, Gershenwald JE, Haydu L, Lazar AJ, Patel SP, Hwu P, Hwu WJ, Diab A, Glitza IC, Woodman SE, Vence LM, Wistuba II, Amaria RN, Kwong LN, Prieto V, Davis RE, Ma W, Overwijk WW, Sharpe AH, Hu J, Futreal PA, Blando J, Sharma P, Allison JP, Chin L, Wargo JA. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov 6(8):827-37, 2016. e-Pub 2016. PMID: 27301722.
321. Chen G, McQuade JL, Panka DJ, Hudgens CW, Amin-Mansour A, Mu XJ, Bahl S, Jané-Valbuena J, Wani KM, Reuben A, Creasy CA, Jiang H, Cooper ZA, Roszik J, Bassett RL, Joon AY, Simpson LM, Mouton RD, Glitza IC, Patel SP, Hwu WJ, Amaria RN, Diab A, Hwu P, Lazar AJ, Wargo JA, Garraway LA, Tetzlaff MT, Sullivan RJ, Kim KB, Davies MA. Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial. JAMA Oncol 2(8):1056-64, 2016. e-Pub 2016. PMID: 27124486.
322. de Graaff MA, Yu JS, Beird HC, Ingram DR, Nguyen T, Juehui Liu J, Bolshakov S, Szuhai K, Åman P, Torres KE, Lev D, Nielsen TO, Bovée JV, Lazar AJ, Somaiah N. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation. Lab Invest 96(8):885-94, 2016. e-Pub 2016. PMID: 27270875.
323. Roland CL, May CD, Watson KL, Al Sannaa GA, Dineen SP, Feig R, Landers S, Ingram DR, Wang WL, Guadagnolo BA, Feig B, Hunt KK, Cormier JN, Lazar AJ, Torres KE. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol 23(7):2220-8, 2016. e-Pub 2016. PMID: 26847678.
324. Sholl LM, Andea A, Bridge JA, Cheng L, Davies MA, Ehteshami M, Gangadhar TC, Kamel-Reid S, Lazar AJ, Raparia K, Siroy A, Watson KL, Reporting Committee MOCB, American Pathologists CO. Template for Reporting Results of Biomarker Testing of Specimens from Patients With Melanoma. Arch Pathol Lab Med 140(4):355-7, 2016. e-Pub 2016. PMID: 26340412.
325. Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KE. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg 151(4):1-8, 2016. e-Pub 2016. PMID: 26629783.
326. Bill KL, Garnett J, Meaux I, Ma X, Creighton CJ, Bolshakov S, Barriere C, Debussche L, Lazar AJ, Prudner BC, Casadei L, Braggio D, Lopez G, Zewdu A, Bid H, Lev D, Pollock RE. SAR405838: A novel and potent inhibitor of the MDM2:p53 axis for the treatment of dedifferentiated liposarcoma. Clin Cancer Res 22(5):1150-60, 2016. e-Pub 2016. PMID: 26475335.
327. Maher OM, Khatua S, Mukherjee D, Olar A, Lazar AJ, Luthra R, Liu D, Wu J, Ketonen L, Zaky W. Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature. J Neurooncol 127(1):155-63, 2016. e-Pub 2016. PMID: 26718692.
328. Kivlin CM, Watson KL, Al Sannaa GA, Belousov R, Ingram DR, Huang KL, May CD, Bolshakov S, Landers SM, Kalam AA, Slopis JM, McCutcheon IE, Pollock RE, Lev D, Lazar AJ, Torres KE. Poly (ADP) Ribose Polymerase Inhibition: A Potential Treatment of Malignant Peripheral Nerve Sheath Tumor. Cancer Biol Ther 17(2):129-38, 2016. e-Pub 2016. PMID: 26650448.
329. Kamali F, Wang WL, Guadagnolo BA, Fox PS, Lewis VO, Lazar AJ, Conley AP, Ravi V, Toliyat M, Ladha HS, Hobbs BP, Amini B. MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumors. Br J Radiol 89(1058):20150308, 2016. e-Pub 2016. PMID: 26577289.
330. Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres-Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li HS, Kwong LN, Heffernan TP, Hu J, Bassett RL, Bosenberg MW, Woodman SE, Overwijk WW, Lizée G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi L, Davies MA, Hwu P. Loss of PTEN Promotes Resistence to T-Cell Mediated Immunotherapy. Cancer Discov 6(2):202-16, 2016. e-Pub 2016. PMID: 26645196.
331. Jamshidi F, Bashashati A, Shumansky K, Dickson B, Gogkoz N, Wunder JS, Andrulis I, Lazar AJ, Shah S, Huntsman DG, Nielsen TO. The genomic landscape of epithelioid sarcoma cell lines and tumor specimens. J Pathol 238(1):63-73, 2016. e-Pub 2016. PMID: 26365879.
332. Wardelmann E, Haas RL, JVMG B, Terrier P, Lazar AJ, Messiou C, LePechoux C, Hartmann W, Collin F, Fisher C, Mechtersheimer G, DeiTos AP, Gronchi A, Bonvalot S. Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. Eur J Cancer 53:84-95, 2016. e-Pub 2016. PMID: 26700077.
333. Messiou C, Bonvalot S, Gronchi A, Vanel D, Meyer M, Robinson P, Morosi C, Bloem JL, Terrier PH, Lazar AJ, Le Péchoux C, Wardelman E, Winfield JM, Boulet B, Bovée J, Haas RL. Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC - STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging. Eur J Cancer 56:37-44, 2016. e-Pub 2016. PMID: 26802529.
334. Roszik J, Wu CJ, Siroy AE, Lazar AJ, Davies MA, Woodman SE, Kwong LN. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression. Sci Rep 6:19649, 2016. e-Pub 2016. PMID: 26787600.
335. Rai K, Akdemir KC, Kwong LN, Fiziev P, Wu CJ, Keung EZ, Sharma S, Samant NS, Williams M, Axelrad JB, Shah A, Yang D, Grimm EA, Barton MC, Milton DR, Heffernan TP, Horner JW, Ekmekcioglu S, Lazar AJ, Ernst J, Chin L. Dual Roles of RNF2 in Melanoma Progression. Cancer Discov 5(12):1314-27, 2015. e-Pub 2015. PMID: 26450788.
336. Verschoor AJ, A-M C, Wijers-Koster P, Coffin CM, Lazar AJ, Nout RA, Rubin BP, Gelderblom H, JVMG B. Radiation induced sarcomas occurring in desmoid-type fibromatosis are not always derived from the primary tumor. Am J Surg Pathol 39(12):1701-7, 2015. e-Pub 2015. PMID: 26414222.
337. Zhang P, Yang X, Ma X, Ingram DR, Lazar AJ, Torres KE, Pollock RE. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway. Mol Cancer 14(1):325, 2015. e-Pub 2015. PMID: 25777567.
338. Shang H, Braggio D, Lee YJ, Al Sannaa GA, Creighton CJ, Bolshakov S, Lazar AJ, Lev D, Pollock RE. Targeting the notch pathway: a potential therapeutic approach for desmoid tumors. Cancer 121(22):4088-96, 2015. e-Pub 2015. PMID: 26349011.
339. May CD, Garnett J, Ma X, Landers SM, Ingram DR, Demicco EG, Al Sannaa GA, Vu T, Han L, Zhang Y, Kivlin CM, Bolshakov S, Kalam AA, Liu J, Zhou F, Broccoli D, Wang WL, Lazar AJ, Pollock RE, Lev D, Torres KE. AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. BMC Cancer 15(1):901, 2015. e-Pub 2015. PMID: 26573603.
340. Chinyengetere F, Sekula DJ, Lu Y, Giustini AJ, Sanglikar A, Kawakami M, Ma T, Burkett SS, Burton L Eisenberg BL, Wells WA, Hoopes PJ, Demicco EG, Lazar AJ, Torres KE, Memoli V, Freemantle SJ, Dmitrovsky E. Mice Null for the Deubiquitinase USP18 Spontaneously Develop Leiomyosarcoma. BMC Cancer 15:866, 2015. e-Pub 2015. PMID: 26555296.
341. Patel NR, Salim AA, Sayeed H, Sarabia SF, Hollingsworth F, Warren M, Jakacky J, Tanas M, Oliveira AM, Rubin BP, Lazar AJ, López-Terrada D, Wang WL. Molecular Characterization of Epithelioid Haemangioendotheliomas Identifies Novel WWTR1-CAMTA1 Fusion Variants. Histopathology 67(5):699-708, 2015. e-Pub 2015. PMID: 25817592.
342. Roy-Chowdhuri S, de Melo Gagliato D, Routbort MJ, Patel KP, Singh RR, Broaddus RR, Lazar AJ, Sahin A, Alvarez RH, Moulder S, Wheler JJ, Janku F, Gonzalez-Angulo AM, Chavez-MacGregor M, Valero V, Ueno NT, Mills G, Mendelsohn J, Yao H, Aldape KD, MD, Luthra R, Meric-Bernstam F. Multigene Clinical Mutational Profiling of Breast Carcinoma using Next Generation Sequencing (NGS). Am J Clin Pathol 144(5):713-21, 2015. e-Pub 2015. PMID: 26486734.
343. Tseng WW, Zhou S, To CA, Thall PF, Lazar AJ, Pollock RE, Lin PP, Cormier JN, Lewis VO, Feig BW, Hunt KK, Ballo MT, Patel S, Pisters PW. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer 121(20):3659-67, 2015. e-Pub 2015. PMID: 26177983.
344. Hameed M, Corless C, George S, Hornick JL, Kakar S, Lazar AJ, Tang L, American Pathologists FTMOTCBRCCO. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Gastrointestinal Stromal Tumors. Arch Pathol Lab Med 139(10):1271-1275, 2015. e-Pub 2015. PMID: 25729899.
345. Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton CJ, Rao P, Hicks J, Man TK, Lau C, Brown AM, Jones SN, Lazar AJ, Ingram D, Lev D, Donehower LA, Yustein JT. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene 34(39):5069-79, 2015. e-Pub 2015. PMID: 25579177.
346. Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E immunohistochemistry expression pattern as a surrogate of BRAF mutation status in 154 patients with advanced melanoma. Hum Pathol 46(8):1101-1110, 2015. e-Pub 2015. PMID: 26058727.
347. Bill KL, Garnett J, Ma X, May CD, Bolshakov S, Lazar AJ, Lev DC, Pollock RE. The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma. Lab Invest 95(8):951-61, 2015. e-Pub 2015. PMID: 26006023.
348. Zutter MM, Bloom KJ, Cheng L, Hagemann IS, Kaufman JH, Krasinskas AM, Lazar AJ, Leonard DG, Lindeman NI, Moyer AM, Nikiforova MN, Nowak JA, Pfeifer JD, Sepulveda AR, Willis JE, Yohe SL. The Cancer Genomics Resource List 2014. Arch Pathol Lab Med 139(8):989-1008, 2015. e-Pub 2015. PMID: 25436904.
349. Demicco EG, Wani K, Fox PS, Bassett RL, Young ED, Lev D, Aldape KD, Lazar AJ, Wang WL. Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations. Hum Pathol 46(7):1015-26, 2015. e-Pub 2015. PMID: 25976141.
350. Keung EZ, Akdemir KC, Al Sannaa GA, Garnett J, Lev D, Torres KE, Lazar AJ, Rai K, Chin L. Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma. J Clin Invest 125(8):2965-78, 2015. e-Pub 2015. PMID: 26193637.
351. Atlas Network TCG. Genomic Classification of Cutaneous Melanoma. Cell 161(7):1681-96, 2015. e-Pub 2015. PMID: 26091043.
352. Wang WL, Torres-Cabala C, Curry JL, Ivan D, McLemore M, Tetzlaff M, Zembowicz A, Prieto VG, Lazar AJ. Metastatic Atypical Fibroxanthoma: A series of 11 cases including with minimal and no subcutaneous involvement. Am J Dermatopathol 37(6):455-61, 2015. e-Pub 2015. PMID: 25590287.
353. Goswami RS, Patel KP, Singh RR, Meric-Bernstam F, Kopetz ES, Subbiah V, Alvarez RH, Davies MA, Jabbar KJ, Roy-Chowdhuri S, Lazar AJ, Medeiros LJ, Broaddus RR, Luthra R, Routbort MJ. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors. Clin Cancer Res 21(11):2644-51, 2015. e-Pub 2015. PMID: 25695693.
354. Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT. Use of Clinical Next-Generation Sequencing to Identify Melanomas Harboring SMARCB1 Mutations. J Cutan Pathol 42(5):308-17, 2015. e-Pub 2015. PMID: 25754356.
355. Gong L, Govan JM, Evans EB, Dai H, Wang E, Lee SW, Lin HK, Lazar AJ, Mills GB, Lin SY. Nuclear PTEN Tumor-Suppressor Functions Through Maintaining Heterochromatin Structure. Cell Cycle 14(14):2323-32, 2015. e-Pub 2015. PMID: 25946202.
356. Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol 143(5):672-82, 2015. e-Pub 2015. PMID: 25873501.
357. Endo M, de Graaff MA, Ingram DR, Lim S, Lev DC, Briaire-de Bruijn IH, Somaiah N, Bovée JV, Lazar AJ, Nielsen TO. NY-ESO-1 (CTAG1B) expression in mesenchymal tumors. Mod Pathol 28(4):587-95, 2015. e-Pub 2015. PMID: 25412843.
358. Peters TL, Kumar V, Polikepahad S, Lin FY, Sarabia SF, Liang Y, Wang WL, Lazar AJ, Doddapaneni H, Chao H, Muzny DM, Wheeler DA, Okcu MF, Plon SE, Hicks MJ, López-Terrada D, Parsons DW, Roy A. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol 28(4):575-86, 2015. e-Pub 2015. PMID: 25360585.
359. Demicco EG, Boland GM, Brewer Savannah KJ, Lusby K, Young ED, Ingram D, Watson KL, Bailey M, Guo X, Hornick JL, van de Rijn M, Wang WL, Torres KE, Lev D, Lazar AJ. Progressive Loss of Myogenic Differentiation in Leiomyosarcoma has Prognostic Value. Histopathology 66(5):627-38, 2015. e-Pub 2015. PMID: 24889065.
360. Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF V600: clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2015. PMID: 25148578.
361. Kasper C, Baumgarten C, Bonvalot S, Haas R, Haller F, PHohenberger P, Moreau G, van der Graaf WT, Gronchi A, Group DW. Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients’ and professionals’ expertise – A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. Eur J Cancer 51(2):127-136, 2015. e-Pub 2015. PMID: 25434922.
362. Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar AJ, Feig B, Torres KE. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Ann Surg Oncol 22(12):3913-3920, 2015. e-Pub 2015. PMID: 25743327.
363. Romeo S, Rossi S, Acosta Marín M, Canal F, Sbaraglia M, Laurino L, Mazzoleni G, Montesco MC, Valori L, Campo Dell'Orto M, Gianatti A, Lazar AJ, Dei Tos AP. Primary Synovial Sarcoma of the Digestive System: A Molecular and Clinicopathological study of 15 cases. Clin Sarcoma Res 5:7, 2015. e-Pub 2015. PMID: 25699170.
364. Chen G, Chakravarti N, Aardalen K, Lazar AJ, Tetzlaff MT, Wubbenhorst B, Kim SB, Kopetz S, Ledoux AA, Gopal YN, Pereira CG, Deng W, Lee JS, Nathanson KL, Aldape KD, Prieto VG, Stuart D, Davies MA. Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target. Clin Cancer Res 20(21):5537-46, 2014. e-Pub 2014. PMID: 24803579.
365. Bucheit AD, Chen G, Siroy A, Tetzlaff M, Broaddus R, Milton D, Fox P, Bassett R, Hwu P, Gershenwald JE, Lazar AJ, Davies MA. Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations. Clin Cancer Res 20(21):5527-36, 2014. e-Pub 2014. PMID: 25165098.
366. Hwang JA, Yang HM, Hong DP, Joo SY, Choi YL, Park JH, Lazar AJ, Pollock RE, Lev D, Kim SJ. Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma. Oncotarget 5(19):9065-78, 2014. e-Pub 2014. PMID: 25238053.
367. Ingram DR, Dillon LM, Lev DC, Lazar AJ, Demicco EG, Eisenberg BL, Miller TW. Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma. BMC Clin Pathol 14:42, 2014. e-Pub 2014. PMID: 25349530.
368. Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar AJ, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KK. Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors. Ann Surg Oncol 21(8):2499-505, 2014. e-Pub 2014. PMID: 24639192.
369. Sudheendran N, Qi J, Young ED, Lazar AJ, Lev DC, Pollock RE, Larin KV, Shih WC. Line-scan Raman microscopy complements optical coherence tomography for tumor boundary detection. Laser Phys Lett 11(10):1-6, 2014. e-Pub 2014.
370. Stockman DL, Hornick JL, Deavers MT, Lev DC, Lazar AJ, Wang WL. ERG and FLI1 Protein Expression in Epithelioid Sarcoma. Mod Pathol 27(4):496-501, 2014. e-Pub 2014. PMID: 24072183.
371. Behjati S, Tarpey PS, Sheldon H, Martincorena I, Van Loo P, Gundem G, Wedge DC, Ramakrishna M, Cooke SL, Pillay N, Vollan HK, Papaemmanuil E, Koss H, Bunney TD, Hardy C, Joseph OR, Martin S, Mudie L, Butler A, Teague JW, Patil M, Steers G, Cao Y, Gumbs C, Ingram D, Lazar AJ, Little L, Mahadeshwar H, Protopopov A, Al Sannaa GA, Seth S, Song X, Tang J, Zhang J, Ravi V, Torres KE, Khatri B, Halai D, Roxanis I, Baumhoer D, Tirabosco R, Amary MF, Boshoff C, McDermott U, Katan M, Stratton MR, Futreal PA, Flanagan AM, Harris A, Campbell PJ. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet 46(4):376-9, 2014. e-Pub 2014. PMID: 24633157.
372. Abadin SS, Ayala-Ramirez M, Jimenez C, Dickson PV, Liang Y, Lazar AJ, Hornick JL, Cotton M, Sui D, Rich T, Lee JE, Grubbs E, Perrier ND. Impact of Surgical Resection for Subdiaphragmatic Paragangliomas. World J Surg 38(3):733-41, 2014. e-Pub 2014. PMID: 24390286.
373. Al-Zaid T, Somaiah N, Lazar AJ. Targeted Therapies for Sarcomas: New Roles for the Pathologist. Histopathology 64(1):119-33, 2014. e-Pub 2014. PMID: 24117526.
374. Shaker M, Pascarelli KM, Plantinga MJ, Love MA, Lazar AJ, Ingram DR, von Mehren M, Lev D, Kipling D, Broccoli D. Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas. Biomark Cancer 6(6):1-10, 2014. e-Pub 2014. PMID: 24741338.
375. Wang S, Liu CH, Zakharov VP, Lazar AJ, Pollock RE, Larin KV. Three-dimensional computational analysis of optical coherence tomography images for the detection of soft tissue sarcomas. J Biomed Opt 19(2):21102, 2014. e-Pub 2014. PMID: 23807552.
376. Tseng WW, Madewell JE, Wei W, Somaiah N, Lazar AJ, Ghadimi MP, Hoffman A, Pisters PW, Lev DC, Pollock RE. Locoregional Disease Patterns in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection?. Ann Surg Oncol 21(7):2136-2143, 2014. e-Pub 2014. PMID: 24705628.
377. Zhang P, Garnett J, Creighton CJ, Al Sannaa G, Ingram DR, Lazar AJ, Liu X, Liu C, Pollock RE. EZH2–miR-30d–KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis. J Pathol 232(3):308-18, 2014. e-Pub 2014. PMID: 24132643.
378. Bucheit AD, Syklawer E, Jakob JA, Bassett RL, Curry JL, Gershenwald JE, Kim KB, Hwu P, Lazar AJ, Davies MA. Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma. Cancer 119(21):3821-9, 2013. e-Pub 2013. PMID: 23922205.
379. Colombo C, Miceli R, Lazar AJ, Perrone F, Pollock RE, Le Cesne A, Hartgrink HH, Cleton-Jansen AM, Domont J, Bovée JV, Bonvalot S, Lev D, Gronchi A. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent multicenter validation study. Cancer 119(20):3696-702, 2013. e-Pub 2013. PMID: 23913621.
380. Kim KB, Cabanillas ME, Lazar AJ, Williams MD, Sanders DL, Ilagan JL, Nolop K, Lee RJ, Sherman SI. Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring V600EBRAF Mutation. Thyroid 23(10):1277-83, 2013. e-Pub 2013. PMID: 23489023.
381. Ramakrishnan R, Chaudhry IH, Ramdial P, Lazar AJ, McMenamin ME, Kazakov D, Brenn T, Calonje E. Primary Cutaneous Adenoid Cystic Carcinoma: A clinicopathologic And Immunohistochemical Study of 27 Cases. Am J Surg Pathol 37(10):1603-1611, 2013. e-Pub 2013. PMID: 24025525.
382. Zhang Y, Young ED, Bill K, Belousov R, Peng T, Lazar AJ, Pollock RE, Simmons PJ, Lev D, Kolonin MG. Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas. Stem Cell Res 11(2):772-81, 2013. e-Pub 2013. PMID: 23770802.
383. Bowles DW, Ma WW, Senzer N, Brahmer JR, Adjei AA, Davies M, Lazar AJ, Vo A, Peterson S, Walker L, Hausman D, Rudin CM, Jimeno A. A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours. Br J Cancer 109(5):1085-92, 2013. e-Pub 2013. PMID: 23942080.
384. Lee N, Luthra R, Lopez-Terrada D, Wang WL, Lazar AJ. Retroperitoneal undifferentiated pleomorphic sarcoma having microsatellite instability associated with Muir-Torre syndrome: case report and review of literature. J Cutan Pathol 40(8):730-3, 2013. e-Pub 2013. PMID: 23672746.
385. Lusby K, Savannah KB, Demicco EG, Zhang Y, Ghadimi MP, Young ED, Colombo C, Lam R, Dogan TE, Hornick JL, Lazar AJ, Hunt KK, Anderson ML, Creighton CJ, Lev D, Pollock RE. Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution's Experience. Ann Surg Oncol 20(7):2364-72, 2013. e-Pub 2013. PMID: 23334251.
386. Rao P, Lahat G, Arnold C, Gavino AC, Lahat S, Hornick JL, Lev D, Lazar AJ. Angiosarcoma: A Tissue Microarray Study with Diagnostic Implications. Am J Dermatopathol 35(4):432-437, 2013. e-Pub 2013. PMID: 23689692.
387. Kurek KC, Pansuriya TC, van Ruler MA, van den Akker B, Luks VL, Verbeke SL, Kozakewich HP, Sciot R, Lev D, Lazar AJ, Fletcher CD, Bovée JV. R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations. Am J Pathol 182(5):1494-500, 2013. e-Pub 2013. PMID: 23485734.
388. Hoffman A, Ghadimi MP, Demicco EG, Creighton CJ, Torres K, Colombo C, Peng T, Lusby K, Ingram D, Hornick JL, Wang WL, Ravi V, Lazar AJ, Lev D, Pollock RE. Localized and metastatic myxoid/round cell liposarcoma: Clinical and molecular observations. Cancer 119(10):1868-77, 2013. e-Pub 2013. PMID: 23401071.
389. Torres KE, Ravi V, Kin K, Yi M, Guadagnolo BA, May CD, Arun BK, Hunt KK, Lam R, Lahat G, Hoffman A, Cormier JN, Feig BW, Lazar AJ, Lev D, Pollock RE. Long-Term Outcomes in Patients with Radiation-Associated Angiosarcomas of the Breast Following Surgery and Radiotherapy for Breast Cancer. Ann Surg Oncol 20(4):1267-74, 2013. e-Pub 2013. PMID: 23224828.
390. Al-Zaid T, Wang WL, Lopez-Terrada D, Lev D, Hornick JL, Hafeez Diwan A, Fletcher CD, Lazar AJ. Pleomorphic fibroma and dermal atypical lipomatous tumor: are they related?. J Cutan Pathol 40(4):379-84, 2013. e-Pub 2013. PMID: 23506010.
391. Greaves WO, Verma S, Patel KP, Davies MA, Barkoh BA, Galbincea JM, Yao H, Lazar AJ, Aldape KD, Medeiros LJ, Luthra R. Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1,112 Cases of Melanoma. J Mol Diagn 15(2):220-6, 2013. e-Pub 2013. PMID: 23273605.
392. Mo W, Chen J, Patel A, Zhang L, Chau V, Li Y, Cho W, Lim K, Xu J, Lazar AJ, Creighton CJ, Bolshakov S, McKay RM, Lev D, Le LQ, Parada LF. CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell 152(5):1077-90, 2013. e-Pub 2013. PMID: 23434321.
393. Patel SP, Lazar AJ, Papadopoulos NE, Liu P, Infante JR, Glass MR, Vaughn CS, LoRusso PM, Cohen RB, Davies MA, Kim KB. Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma. Cancer 119(4):799-805, 2013. e-Pub 2013. PMID: 22972589.
394. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res 3(1):7, 2013. e-Pub 2013. PMID: 23663788.
395. Tseng WW, Somaiah N, Lazar AJ, Lev DC, Pollock RE. Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results. Cancers (Basel) 5(2):529-49, 2013. e-Pub 2013. PMID: 24216990.
396. Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, Deangelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One 8(6):e67306, 2013. e-Pub 2013. PMID: 23825651.
397. Fong ELS, S-E L, Burdett E, Ramamoorthy V, Lazar AJ, Kasper FK, Farach-Carson MC, Vishwamitra D, Demicco EG, Menegaz BA, Amin HM, Mikos A, Ludwig JA. Modeling Ewing's sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci USA 110(16):6500-5, 2013. e-Pub 2013. PMID: 23576741.
398. Plantinga MJ, Pascarelli KM, Merkel AS, Lazar AJ, von Mehren M, Lev D, Broccoli D. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles. Molec Cell Biol 11(6):557-67, 2013. e-Pub 2013. PMID: 23505069.
399. Suchak R, Wang WL, Prieto VG, Ivan D, Lazar AJ, Brenn T, Calonje E. Cutaneous Digital Papillary Adenocarcinoma: A Clinicopathologic Study of 31 Cases of a Rare Neoplasm with New Observations. Am J Surg Pathol 36(12):1883-91, 2012. e-Pub 2012. PMID: 23026931.
400. Wang S, Li J, Manapuram RK, Menodiado FM, Ingram DR, Twa MD, Lazar AJ, Lev DC, Pollock RE, Larin KV. Noncontact measurement of elasticity for the detection of soft-tissue tumors using phase-sensitive optical coherence tomography combined with a focused air-puff system. Opt Lett 37(24):5184-6, 2012. e-Pub 2012. PMID: 23258046.
401. McKay KM, Doyle LA, Lazar AJ, Hornick JL. Expression of ERG, an Ets family transcription factor, distinguishes cutaneous angiosarcoma from histological mimics. Histopathology 61(5):989-91, 2012. e-Pub 2012. PMID: 22716285.
402. Wang WL, Patel NR, Caragea M, Hogendoorn PC, López-Terrada D, Hornick JL, Lazar AJ. Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma. Mod Pathol 25(10):1378-83, 2012. e-Pub 2012. PMID: 22766791.
403. Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD, Hornick JL. MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma: Association with FUS Gene Rearrangement. Am J Surg Pathol 36(10):1444-1451, 2012. e-Pub 2012. PMID: 22982887.
404. Brewer Savannah KJ, Demicco EG, Lusby K, Ghadimi MP, Belousov R, Young E, Zhang Y, Huang KL, Lazar AJ, Hunt KK, Pollock RE, Creighton CJ, Anderson ML, Lev D. Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma. Clin Cancer Res 18(17):4633-45, 2012. e-Pub 2012. PMID: 22821997.
405. Yang J, Kantrow S, Sai J, Hawkins OE, Boothby M, Ayers GD, Young ED, Demicco EG, Lazar AJ, Lev D, Richmond A. INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma. Cancer Res 72(18):4682-95, 2012. e-Pub 2012. PMID: 22836752.
406. Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25(9):1298-306, 2012. e-Pub 2012. PMID: 22575866.
407. Wang WL, Nero C, Pappo A, Lev D, Lazar AJ, López-Terrada D. CTNNB1 Genotyping and APC Screening in Pediatric Desmoid Tumors: A Proposed Alogrithm. Pediatr Dev Pathol 15(5):361-7, 2012. e-Pub 2012. PMID: 22372443.
408. Zimmerman MA, Rahman NT, Yang D, Lahat G, Lazar AJ, Pollock RE, Lev D, Liu K. Unphosphorylated STAT1 promotes sarcoma development by repressing expression of Fas and Bad and conferring apoptotic resistance. Cancer Res 72(18):4724-32, 2012. e-Pub 2012. PMID: 22805310.
409. Kim J, Lazar AJ, Davies MA, Homsi J, Papadopoulos NE, Hwu WJ, Bedikian AY, Woodman SE, Patel SP, Hwu P, Kim KB. BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma. J Cutan Pathol 39(9):821-5, 2012. e-Pub 2012. PMID: 22809251.
410. Jakob JA, Bassett RL, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA. NRAS Mutation Status is an Independent Prognostic Factor in Metastatic Melanoma. Cancer 118(16):4014-23, 2012. e-Pub 2012. PMID: 22180178.
411. Ghadimi MP, Lopez G, Torres KE, Belousov R, Young ED, Liu J, Brewer KJ, Hoffman A, Lusby K, Lazar AJ, Pollock RE, Lev D. Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors. Mol Cancer Ther 11(8):1758-69, 2012. e-Pub 2012. PMID: 22848094.
412. Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Randall RL, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS. Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother 61(7):1113-24, 2012. e-Pub 2012. PMID: 22198309.
413. Wang WL, Bones-Valentin RA, Prieto VG, Pollock RE, Lev DC, Lazar AJ. Sarcoma metastases to the skin: a clinicopathologic study of 65 patients. Cancer 118(11):2900-4, 2012. e-Pub 2012. PMID: 21989966.
414. Wang WL, Evans HL, Meis JM, Liegl-Atzwanger B, Bovée JV, Goldblum JR, Billings SD, Rubin BP, López-Terrada D, Lazar AJ. FUS rearrangements are rare in 'pure' sclerosing epithelioid fibrosarcoma. Mod Pathol 25(6):846-53, 2012. e-Pub 2012. PMID: 22388756.
415. Edris B, Espinosa I, Mühlenberg T, Mikels A, Lee CH, Steigen SE, Zhu S, Montgomery KD, Lazar AJ, Lev D, Fletcher JA, Beck AH, West RB, Nusse R, van de Rijn M. ROR2 is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour. J Pathol 227(2):223-33, 2012. e-Pub 2012. PMID: 22294416.
416. Tseng WW, Demicco EG, Lazar AJ, Lev DC, Pollock RE. Lymphocyte Composition and Distribution in Inflammatory, Well-Differentiated Retroperitoneal Liposarcoma: Clues to a Potential Adaptive Immune Response and Therapeutic Implications. Am J Surg Pathol 36(6):941-4, 2012. e-Pub 2012. PMID: 22446945.
417. Colombo C, Foo WC, Whiting D, Young ED, Lusby K, Pollock RE, Lazar AJ, Lev D. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center. Histol Histopathol 27(5):641-9, 2012. e-Pub 2012. PMID: 22419028.
418. Ghadimi MP, Young ED, Belousov R, Zhang Y, Lopez G, Lusby K, Kivlin C, Demicco EG, Creighton CJ, Lazar AJ, Pollock RE, Lev D. Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors. Clin Cancer Res 18(9):2545-57, 2012. e-Pub 2012. PMID: 22407831.
419. Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilemmomas Show Loss of PTEN in Cowden Syndrome But Only Rarely in Sporadic Tumors. J Cutan Pathol 39(5):493-9, 2012. e-Pub 2012. PMID: 22486434.
420. Dumont AG, Rink L, Godwin AK, Miettinen M, Joensuu H, Strosberg JR, Gronchi A, Corless CL, Goldstein D, Rubin BP, Maki RG, Lazar AJ, Lev D, Trent JC, von Mehren M. A non-random association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): Case series of 28 patients. Ann Oncol 23(5):1335-40, 2012. e-Pub 2012. PMID: 21994214.
421. Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D. MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer Res 72(7):1751-62, 2012. e-Pub 2012. PMID: 22350414.
422. Trufant J, Kurz W, Frankel A, Muthusamy V, McKinnon W, Greenblatt M, Lazar AJ, Cook D, Bosenberg M. Familial Multiple Pilomatrixomas as a Presentation of Attenuated Adenomatosis Polyposis Coli. J Cutan Pathol 39(4):440-3, 2012. e-Pub 2012. PMID: 22150579.
423. Shalin SC, Sakharpe A, Lyle S, Lev D, Calonje E, Lazar AJ. P53 Staining Correlates with Tumor Type and Location in Sebaceous Neoplasms. Am J Dermatopathol 34(2):129-35; quiz 136-8, 2012. e-Pub 2012. PMID: 22441365.
424. Shvartsbeyn M, Lazar AJ, Lopez-Terrada D, Meehan SA. Pseudocystic Dermatofibrosarcoma Protuberans: Report of Two Cases and Demonstration of COL1A1-PDGFB Rearrangement. J Cutan Pathol 39(3):356-60, 2012. e-Pub 2012. PMID: 22335595.
425. Demicco EG, Torres KE, Ghadimi MP, Colombo C, Bolshakov S, Hoffman A, Peng T, Bovée JV, Wang WL, Lev D, Lazar AJ. Involvement of the PI3K/Akt Pathway in Myxoid/Round Cell Liposarcoma. Mod Pathol 25(2):212-21, 2012. e-Pub 2012. PMID: 22020193.
426. Davies MA, Fox PS, Papadopoulos NE, Bedikian AY, Hwu WJ, Lazar AJ, Prieto VG, Culotta KS, Madden TL, Xu Q, Huang S, Deng W, Ng CS, Gupta S, Liu W, Dancey JE, Wright JJ, Bassett RL, Hwu P, Kim KB. Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma. Clin Cancer Res 18(4):1120-8, 2012. e-Pub 2012. PMID: 22223528.
427. Dumont SN, Lazar AJ, Bridge JA, Benjamin RS, Trent JC. PAX3/7-FOXO1 Fusion Status in Older Rhabdomyosarcoma Patient Population by Fluorescent In Situ Hybridization. J Cancer Res Clin Oncol 138(2):213-20, 2012. e-Pub 2012. PMID: 22089931.
428. Li Q, Li M, Wang YL, Fauzee NJ, Yang Y, Pan J, Yang L, Lazar AJ. RNA Interference of PARG Could Inhibit the Metastatic Potency of Colon Carcinoma Cells via PI3-Kinase/Akt Pathway. Cell Physiol Biochem 29(3-4):361-372, 2012. e-Pub 2012. PMID: 22508044.
429. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res 2(1):2, 2012. e-Pub 2012. PMID: 22587772.
430. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive Adipocytic Maturation Can Be Seen in Myxoid Liposarcomas Treated with Neoadjuvant Doxorubicin and Ifosfamide and Pre-operative Radiation Therapy. Clin Sarcoma Res 2(1):25, 2012. e-Pub 2012. PMID: 23272660.
431. Ghadimi MP, Liu P, Peng T, Bolshakov S, Young ED, Torres KE, Colombo C, Hoffman A, Broccoli D, Hornick JL, Lazar AJ, Pisters P, Pollock RE, Lev D. Pleomorphic liposarcoma: Clinical observations and molecular variables. Cancer 117(23):5359-69, 2011. e-Pub 2011. PMID: 21598240.
432. Ghadimi MP, Al-Zaid T, Madewell J, Peng T, Colombo C, Hoffman A, Creighton CJ, Zhang Y, Zhang A, Lazar AJ, Pollock RE, Lev D. Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis. Ann Surg Oncol 18(13):3762-70, 2011. e-Pub 2011. PMID: 21614627.
433. Colombo C, Creighton CJ, Ghadimi MP, Bolshakov S, Warneke CL, Zhang Y, Lusby K, Zhu S, Lazar AJ, West RB, van de Rijn M, Lev D. Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target. J Pathol 225(4):574-82, 2011. e-Pub 2011. PMID: 21826666.
434. Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, Wang WL, Barahmani N, Okcu MF, Hicks J, Debelenko L, Spunt SL. Liposarcoma in Children and Young Adults: A Multi-Institutional Experience. Pediatr Blood Cancer 57(7):1142-6, 2011. e-Pub 2011. PMID: 21394894.
435. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of Temozolomide and Bevacizumab in the Treatment of Locally Advanced, Recurrent, and Metastatic Hemangiopericytoma and Malignant Solitary Fibrous Tumor. Cancer 117(21):4939-47, 2011. e-Pub 2011. PMID: 21480200.
436. Wang X, Asmann YW, Erickson-Johnson MR, Oliveira JL, Zhang H, Moura RD, Lazar AJ, Lev D, Bill K, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma. Genes Chromosomes Cancer 50(11):849-58, 2011. e-Pub 2011. PMID: 21793095.
437. Xie X, Ghadimi MP, Young ED, Belousov R, Zhu QS, Liu J, Lopez G, Colombo C, Peng T, Reynoso D, Hornick JL, Lazar AJ, Lev D. Combining EGFR and mTOR blockade for the treatment of epithelioid sarcoma. Clin Cancer Res 17(18):5901-12, 2011. e-Pub 2011. PMID: 21821699.
438. Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, Mitsopoulos C, Zvelebil M, Hoch BL, Weiss SW, Debiec-Rychter M, Sciot R, West RB, Lazar AJ, Ashworth A, Reis-Filho JS, Lord CJ, Gerstein MB, Rubin MA, Rubin BP. Identification of a novel WWTR1/CAMTA1 gene fusion in epithelioid hemangioendothelioma by a unique integrative genomic approach. Sci Transl Med 3(98):98ra82, 2011. e-Pub 2011. PMID: 21885404.
439. Colombo C, Bolshakov S, Hajibashi S, Lopez-Terrada L, Wang WL, Rao P, Benjamin RS, Lazar AJ, Lev D. 'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis. Histopathology 59(2):336-40, 2011. e-Pub 2011. PMID: 21884214.
440. Torres KE, Liu J, Young E, Huang KL, Ghadimi M, Lusby K, Lazar AJ, Lev D. Expression of 'drugable' tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancer. Histopathology 59(1):156-9, 2011. e-Pub 2011. PMID: 21771036.
441. Hsu A, Esmaeli B, Hayek B, Hossain MG, Shinder R, Lazar AJ, McCarty JH. Analysis of αv Integrin Protein Expression in Squamous Cell Carcinomas of the Human Eyelid Skin. J Cutan Pathol 38(7):570-5, 2011. e-Pub 2011. PMID: 21375561.
442. Swaby MG, Evans HL, Fletcher CD, Prieto VG, Patel KU, Lev DC, Lòpez-Terrada D, Lazar AJ, Wang WL. Dermatofibrosarcoma protuberans (DFSP) with unusual sarcomatous transformation: a series of four cases with molecular confirmation. Am J Dermatopathol 33(4):354-60, 2011. e-Pub 2011. PMID: 21478726.
443. Torres KE, Zhu QS, Bill K, Lopez G, Ghadimi MP, Xie X, Young ED, Liu J, Nguyen T, Bolshakov S, Belousov R, Wang S, Lahat G, Liu J, Hernandez B, Lazar AJ, Lev D. Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors. Clin Cancer Res 17(12):3943-55, 2011. e-Pub 2011. PMID: 21540237.
444. Dayrit JF, Wang WL, Goh SG, Ramdial PK, Lazar AJ, Calonje E. T-cell Rich Angiomatoid Polypoid Pseudolymphoma of the Skin: A Clinicopathological Study of 17 Cases and a Proposed Nomenclature. J Cutan Pathol 38(6):475-82, 2011. e-Pub 2011. PMID: 21352259.
445. Peng T, Zhang P, Liu J, Nguyen T, Bolshakov S, Belousov R, Young ED, Wang X, Brewer K, López-Terrada DH, Oliveira AM, Lazar AJ, Lev D. An experimental model for the study of well differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors. Lab Invest 91(3):392-403, 2011. e-Pub 2011. PMID: 21060307.
446. Carbajal EF, Baranov SA, Manne VG, Young ED, Lazar AJ, Lev DC, Pollock RE, Larin KV. Revealing retroperitoneal liposarcoma morphology using Optical Coherence Tomography. J Biomed Opt 16(2):020502, 2011. e-Pub 2011. PMID: 21361658.
447. Ylipää A, Hunt KK, Yang J, Lazar AJ, Torres KE, Lev DC, Nykter M, Pollock RE, Trent J, Zhang W. Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumor. Cancer 117(2):380-9, 2011. e-Pub 2011. PMID: 20818650.
448. Hu Q, Gao F, Tian W, Ruteshouser EC, Wang Y, Lazar AJ, Stewart J, Strong LC, Behringer RR, Huff V. Wt1 ablation and Igf2-up-regulation in mice result in Wilms tumors with activated pERK1/2. J Clin Invest 121(1):174-83, 2011. e-Pub 2011. PMID: 21123950.
449. Lopez G, Torres K, Liu J, Hernandez B, Young E, Belousov R, Bolshakov S, Lazar AJ, Slopis JM, McCutcheon IE, McConkey D, Lev D. Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res 71(1):185-96, 2011. e-Pub 2011. PMID: 21084276.
450. Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL. Epithelioid Inflammatory Myofibroblastic Sarcoma: An Aggressive Intra-Abdominal Variant of Inflammatory Myofibroblastic Tumor with Nuclear Membrane or Perinuclear Alk. Am J Surg Pathol 35(1):135-44, 2011. e-Pub 2011. PMID: 21164297.
451. Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar AJ, Dicker A, Mills GB, Hung MC, Lev D. Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene 30(4):457-70, 2011. e-Pub 2011. PMID: 20856200.
452. Sakharpe A, Lahat G, Gulamhusein T, Liu P, Bolshakov S, Nguyen T, Zhang P, Belousov R, Young E, Xie X, Rao P, Hornick JL, Lazar AJ, Pollock RE, Lev D. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model. Oncologist 16(4):512-22, 2011. e-Pub 2011. PMID: 21357725.
453. Lahat G, Pingyu Zhang P, Q-S Z, Torres K, Ghadimi M, Smith KD, W-L W, Lazar AJ, Lev D. Molecular subclassification of unclassified pleomorphic sarcoma (UPS/MFH). Histopathol 59(3):556-61, 2011. e-Pub 2011. PMID: 22034893.
454. Wang X, Asmann YW, Erickson-Johnson M, Oliveira JL, Zhang H, de Deus Moura R, Lazar AJ, Lev D, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM. High Resolution Genomic Mapping Reveals Consistent Amplification of the Fibroblast Growth Factor Receptor Substrate 2 (FRS2) Gene in Well Differentiated and Dedifferentiated Liposarcoma. Clin Cancer Research 50(11):849-58, 2011. e-Pub 2011. PMID: 21793095.
455. Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ, Hunt KK, Trent JC, Zhang W. Integrated Proteomic and Genomic Analysis Reveals a Novel Mesenchymal to Epithelial Reverting Transition in Leiomyosarcoma through Regulation of Slug. Mol Cell Proteomics 9(11):2405-13, 2010. e-Pub 2010. PMID: 20651304.
456. Weaver J, Rao P, Goldblum JR, Joyce MJ, Turner SL, Lazar AJ, López-Terada D, Tubbs RR, Rubin BP. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?. Mod Pathol 23(10):1301-6, 2010. e-Pub 2010. PMID: 20495536.
457. Powers MP, Wang WL, Hernandez VS, Patel KS, Lev DC, Lazar AJ, López-Terrada DH. Detection of Myxoid Liposarcoma Associated FUS/DDIT3 Rearrangement Variants Including a Newly Identified Breakpoint using an Optimized RT-PCR Assay. Mod Pathol 23(10):1307-15, 2010. e-Pub 2010. PMID: 20581806.
458. Gupta A, Roy S, Lazar AJ, Wang WL, McAuliffe JC, Reynoso D, McMahon J, Taguchi T, Floris G, Debiec-Rychter M, Schoffski P, Trent JA, Debnath J, Rubin BP. Autophagy inhibition and anti-malarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci U S A 107(32):14333-8, 2010. e-Pub 2010. PMID: 20660757.
459. Brown JG, Folpe AL, Rao P, Lazar AJ, Paner GP, Gupta R, Parakh R, Cheville JC, Amin MB. Primary Vascular Tumors and Tumor-like Lesions of the Kidney: A Clinicopathologic Analysis of 25 Cases. Am J Surg Pathol 34(7):942-9, 2010. e-Pub 2010. PMID: 20534992.
460. Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, Lazar AJ, Lev D. Angiosarcoma: Clinical and Molecular Insights. Ann Surg 251(6):1098-1106, 2010. e-Pub 2010. PMID: 20485141.
461. Wang S, Ren W, Liu J, Lahat G, Torres K, Lopez G, Lazar AJ, Hayes-Jordan A, Liu K, Bankson J, Hazle JD, Lev D. TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In vivo. Clin Cancer Res 16(9):2591-604, 2010. e-Pub 2010. PMID: 20406839.
462. Lahat G, Tuvin D, Wei C, Wang WL, Pollock RE, Anaya DA, Bekele BN, Corely L, Lazar AJ, Pisters PW, Lev D. Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study. Ann Oncol 21(5):1112-20, 2010. e-Pub 2010. PMID: 19875755.
463. Rubin BP, Cooper K, Fletcher CD, Folpe AL, Gannon FH, Hunt JL, Lazar AJ, Montag AG, Peabody TD, Pollock RE, Reith JD, Qualman SJ, Rosenberg AE, Weiss SW, Krausz T, Cancer Committee MOT, American Pathologists CO. Protocol for the Examination of Specimens from Patients with Tumors of Soft Tissue. Arch Pathol Lab Med 134(4):e31-39, 2010. e-Pub 2010. PMID: 20367297.
464. Ostler DA, Prieto VG, Reed JA, Deavers MT, Lazar AJ, Ivan D. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology - an immunohistochemical study of 117 cases. Mod Pathol 23(4):567-73, 2010. e-Pub 2010. PMID: 20118912.
465. Wang WL, Patel KU, Coleman NM, Smith-Zagone MJ, Ivan D, Reed JA, López-Terrada D, Lazar AJ, Prieto VG. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin. Am J Dermatopathol 32(2):149-53, 2010. e-Pub 2010. PMID: 19940748.
466. Rutkowski P, van Glabbeke M, Rankin C, Ruka W, Rubin BP, Debiec-Rychter M, Lazar AJ, Gerderblom H, Sciot R, Lopez-Terrada D, Hohenberger P, van Oosterom A, Schuetze S. Imatinib mesylate in advanced dermatofibrosarcoma protuberans (DFSP)-pooled analysis of two phase II clinical trials. J Clin Oncol 28(10):1772-9, 2010. e-Pub 2010. PMID: 20194851.
467. Hantschke M, Mentzel T, Rütten A, Palmedo G, Calonje E, Lazar AJ, Kutzner H. Cutaneous Clear Cell Sarcoma: a clinicopathologic, immunohistochemical and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol 34(2):216-222, 2010. e-Pub 2010. PMID: 20087159.
468. Ivan D, Prieto VG, Esmaeli B, Wistuba II, Tang X, Lazar AJ. Epidermal Growth Factor Receptor (EGFR) Expression in Periocular and Extraocular Sebaceous Carcinoma. J Cutan Pathol 37(2):231-236, 2010. e-Pub 2010. PMID: 19614729.
469. Rubin BP, Blanke CD, Demetri GD, Dematteo RP, Fletcher CD, Goldblum JR, Lasota J, Lazar AJ, Maki RG, Miettinen M, Noffsinger A, Washington MK, Krausz T, Committee C, American Pathologists CO. Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Arch Pathol Lab Med 134(2):165-70, 2010. e-Pub 2010. PMID: 20121601.
470. Lahat G, Zhu QS, Huang KL, Wang S, Bolshakov S, Liu J, Torres K, Langley RR, Lazar AJ, Hung MC, Lev D. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One 5(4):e10105, 2010. e-Pub 2010. PMID: 20419128.
471. Lazar AJ, Lahat G, Myers SE, Smith KD, Zou C, Wang WL, Lopez-Terrada D, Lev D. Validation of potential therapeutic targets in Alveolar Soft Part Sarcoma: an immunohistochemical study utilizing tissue microarray. Histopathology 55(6):750-5, 2009. e-Pub 2009. PMID: 20002771.
472. Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, Prieto VG, Aldape K, Mills GB, Gershenwald JE. Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res 15(24):7538-7546, 2009. e-Pub 2009. PMID: 19996208.
473. Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 22(11):1446-56, 2009. e-Pub 2009. PMID: 19718013.
474. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Outcome of Locally Recurrent and Metastatic Angiosarcoma. Ann Surg Oncol 115(13):2971-9, 2009. e-Pub 2009. PMID: 19551444.
475. Wang WL, Mayordomo E, Zhang W, Hernandez VS, Tuvin D, Garcia L, Lev DC, Lazar AJ, López-Terrada D. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod Pathol 22(9):1201-1209, 2009. e-Pub 2009. PMID: 19561568.
476. Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Lev D. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol 16(9):2579-86, 2009. e-Pub 2009. PMID: 19557478.
477. Woodman SE, Trent JC, Stemke-Hale K, Lazar AJ, Pricl S, Pavan GM, Fermeglia M, Gopal YN, Yang D, Podoloff DA, Ivan D, Kim KB, Papadopoulos N, Hwu P, Mills GB, Davies MA. Activity of Dasatinib Against L576P Kit Mutant Melanoma: Molecular. Cellular, and Clinical Correlates. Mol Cancer Ther 8(8):2079-85, 2009. e-Pub 2009. PMID: 19671763.
478. Blazer DG, Lazar AJ, Xing Y, Askew RL, Feig BW, Pisters PW, Pollock RE, Lev D, Hunt KK, Cormier JN. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. Cancer 115(13):2971-9, 2009. e-Pub 2009. PMID: 19402173.
479. Pomahac B, Garcia JA, Lazar AJ, Tilney N, Orgill DP. The skin allograft revisited: a potentially permanent wound coverage option in the critically ill patient. Plast Reconstr Surg 123(6):1755-8, 2009. e-Pub 2009. PMID: 19483575.
480. Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 249(6):1014-22, 2009. e-Pub 2009. PMID: 19474676.
481. Zou CY, Smith KD, Zhu QS, Liu J, McCutcheon IE, Slopis JM, Meric-Bernstam F, Peng Z, Bornmann WG, Mills GB, Lazar AJ, Pollock RE, Lev D. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther 8(5):1157-68, 2009. e-Pub 2009. PMID: 19417153.
482. Wang WL, Hornick JL, Mallipeddi R, Zelger BG, Rother JD, Yang D, Lev DC, Trent JC, Prieto VG, Brenn T, Robson A, Calonje E, Lazar AJ. Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: a series of 5 cases with molecular analysis. Am J Dermatopathol 31(3):297-300, 2009. e-Pub 2009. PMID: 19384074.
483. McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 16(4):910-9, 2009. e-Pub 2009. PMID: 18953611.
484. Lahat G, Lazar AJ, Wang X, Wang WL, Zhu QS, Hunt KK, Pollock RE, Lev D. Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas. Clin Cancer Res 15(8):2637, 2009. e-Pub 2009. PMID: 19351758.
485. Yang D, Wang S, Brooks C, Dong Z, Schoenlein PV, Kumar V, Ouyang X, Xiong H, Lahat G, Hayes-Jordan A, Lazar AJ, Pollock R, Lev D, Liu K. IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor-initiated Apoptosis via Repression of FLICE-like Protein Expression. Cancer Res 69(3):1080-8, 2009. e-Pub 2009. PMID: 19155307.
486. Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ, Rubin BP. Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. Mod Pathol 22(1):66-70, 2009. e-Pub 2009. PMID: 18836421.
487. Mito JK, Riedel RF, Dodd L, Lahat G, Lazar AJ, Dodd RD, Stangenberg L, Eward WC, Hornicek FJ, Yoon SS, Brigman BE, Jacks T, Lev D, Mukherjee S, Kirsch DG. Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One 4(11):e8075, 2009. e-Pub 2009. PMID: 19956606.
488. Quintás-Cardama A, Lazar AJ, Woodman SE, Kim K, Ross M, Hwu P. Complete Response of Stage IV Anal Mucosal Melanoma Expressing KIT V560D to the multikinase inhibitor sorafenib. Nat Clin Pract Oncol 5(12):737-40, 2008. e-Pub 2008. PMID: 18936790.
489. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Dal Cin P, Araujo DM, Lev DC, López-Terrada D, Lazar AJ. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol 21(11):1303-10, 2008. e-Pub 2008. PMID: 18587326.
490. Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173(5):1518-27, 2008. e-Pub 2008. PMID: 18832571.
491. Lahat G, Tuvin D, Wei C, Anaya DA, Bekele BN, Lazar AJ, Pisters PW, Lev D, Pollock RE. New perspectives for Staging and Prognosis in Soft Tissue Sarcoma. Ann Surg Oncol 15(10):2739-48, 2008. e-Pub 2008. PMID: 18521685.
492. Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG, Lazar AJ, Gershenwald JE, Mills GB. A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99(8):1265-8, 2008. e-Pub 2008. PMID: 18813315.
493. Rothberg BE, Moeder CB, Kluger H, Halaban R, Elder DE, Murphy GF, Lazar AJ, Prieto V, Duncan LM, Rimm DL. Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. Mod Pathol 21(9):1121-9, 2008. e-Pub 2008. PMID: 18552823.
494. Jin Z, Lahat G, Korchin B, Nguyen T, Zhu QS, Wang X, Lazar AJ, Trent J, Pollock RE, Lev D. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin Cancer Res 14(16):5033-42, 2008. e-Pub 2008. PMID: 18698021.
495. McAuliffe JC, Wang WL, Pavan GM, Pricl S, Yang D, Chen SS, Lazar AJ, Pollock RE, Trent JC. Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors. Mol Oncol 2(2):161-3, 2008. e-Pub 2008. PMID: 19383335.
496. Diwan AH, Skelton HG, Horenstein MG, Kelly DR, Barrett TL, Bussian AH, Sanders DY, Lazar AJ, Prieto VG, Smith KJ. Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity. J Cutan Pathol 35(7):647-50, 2008. e-Pub 2008. PMID: 18201229.
497. Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, Lev D, Lyle S, Calonje E, Lazar AJ. Site and Tumor Type Predicts DNA Mismatch Repair Status in Cutaneous Sebaceous Neoplasia. Am J Surg Pathol 32(6):936-42, 2008. e-Pub 2008. PMID: 18551751.
498. Ren W, Korchin B, Zhu QS, Wei C, Dicker A, Heymach J, Lazar AJ, Pollock RE, Lev D. Epidermal growth factor receptor (EGFR) blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma (STS) cell growth in vitro and in vivo. Clin Cancer Res 14(9):2785-2795, 2008. e-Pub 2008. PMID: 18451246.
499. Robson A, Lazar AJ, Ben Nagi J, Hanby A, Grayson W, Feinmesser M, Granter SR, Seed P, Warneke CL, McKee PH, Calonje E. Primary Cutaneous Apocrine Carcinoma: A Clinico-pathological Analysis of 24 Cases. Am J Surg Pathol 32(5):682-690, 2008. e-Pub 2008. PMID: 18347508.
500. Uzquiano MC, Prieto VG, Nash JW, Ivan DS, Gong Y, Lazar AJ, Diwan AH. Metastatic Basal Cell Carcinoma Exhibits Reduced Actin Expression. Mod Pathol 21(5):540-3, 2008. e-Pub 2008. PMID: 18223552.
501. Euscher ED, Deavers MT, Lopez-Terrada D, Lazar AJ, Silva EG, Malpica A. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol 32(2):219-228, 2008. e-Pub 2008. PMID: 18223324.
502. Wang Q, Prieto VG, Esmaeli B, Kolda T, Lazar AJ, Ivan D, Diwan AH. Cellular blue nevi of the eyelid: A possible diagnostic pitfall. J Am Acad Dermatol 58(2):257-60, 2008. e-Pub 2008. PMID: 18222322.
503. Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, Strong L, Chen LL, Choi H, Benjamin RS, Zhang W, Trent JC. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer 122(3):711-8, 2008. e-Pub 2008. PMID: 17943734.
504. Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, López-Terrada D. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all DFSP Cases when investigated by newly developed multiplex RT-PCR and FISH Assays. Hum Pathol 39(2):184-193, 2008. e-Pub 2008. PMID: 17950782.
505. Ren W, Korchin B, Lahat G, Wei C, Bolshakov S, Nguyen T, Merritt W, Dicker A, Lazar AJ, Sood A, Pollock RE, Lev D. Combined vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft tissue sarcoma. Clin Cancer Res 14(17):5466-75, 2008. e-Pub 2008. PMID: 18765538.
506. Rebhun RB, Lazar AJ, Fidler IJ, Gershenwald JE. Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin Exp Metastasis 25(3):191-9, 2008. e-Pub 2008. PMID: 18264782.
507. Lazar AJ, Das P, Tuvin D, Korchin B, Zhu Q, Jin Z, Warneke CL, Zhang PS, Hernandez V, Lopez-Terrada D, Pisters PW, Pollock RE, Lev D. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma (ASPS): a highly metastatic tumor with prolonged survival. Clin Cancer Res 13(24):7314-7321, 2007. e-Pub 2007. PMID: 18094412.
508. McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC. Association of Intra-Tumoral Vascular Endothelial Growth Factor Expression and Clinical Outcome for Patients with Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate. Clin Cancer Res 13(22):6727-6734, 2007. e-Pub 2007. PMID: 18006774.
509. Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S. Epidermodysplasia Verruciformis in the Setting of Graft-Versus-Host Disease. J Am Acad Dermatol 57(5):S78-80, 2007. e-Pub 2007. PMID: 17938030.
510. Kantrow SM, Ivan D, Williams MD, Prieto VG, Lazar AJ. Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus. Am J Dermatopathol 29(5):462-466, 2007. e-Pub 2007. PMID: 17890915.
511. Lazar AJ, Lyle S, Calonje E. Sebaceous neoplasia and Torre-Muir syndrome. Curr Diagn Pathol 13(4):301-319, 2007. e-Pub 2007. PMID: 18670585.
512. Khalifeh I, Taraif S, Reed JA, Lazar AJ, Diwan AH, Prieto VG. A Subgroup of Melanocytic Nevi on the Distal Lower Extremity (Ankle) Shares Features of Acral Nevi, Dysplastic Nevi and Melanoma In-Situ: A Potential Misdiagnosis of Melanoma in-Situ. Am J Surg Pathol 29(5):462-466, 2007. e-Pub 2007. PMID: 17592281.
513. Fan YS, Carr RA, Sanders DS, Smith AP, Lazar AJ, Calonje E. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology 51(1):80-86, 2007. e-Pub 2007. PMID: 17593083.
514. Ivan D, Nash JW, Prieto VG, Calonje E, Lyle S, Diwan AH, Lazar AJ. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol 34(6):474-480, 2007. e-Pub 2007. PMID: 17518775.
515. Das P, Kotilingam D, Korchin B, Liu J, Yu D, Lazar AJ, Pollock RE, Lev D. High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Cancer 109(11):2323-2333, 2007. e-Pub 2007. PMID: 17429838.
516. Hannay JA, Liu J, Zhu QS, Bolshakov SV, Li L, Pisters PW, Lazar AJ, Yu D, Pollock RE, Lev D. Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther 6(5):1650-60, 2007. e-Pub 2007. PMID: 17513613.
517. Goddard DS, Magee CC, Lazar AJ, Miller DM. Nephrogenic fibrosing dermopathy with recurrence after allograft failure. J Am Acad Dermatol 56(5 Suppl):S109-11, 2007. e-Pub 2007. PMID: 17434031.
518. Perna AG, Ostler DA, Ivan D, Lazar AJ, Diwan AH, Prieto VG, Reed JA. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma. J Cutan Pathol 34(5):381-385, 2007. e-Pub 2007. PMID: 17448192.
519. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AJ, Patel SR, Benjamin RS, Pollock RE. Optimizing treatment of desmoid tumors. J Clin Oncol 25(13):1785-91, 2007. e-Pub 2007. PMID: 17470870.
520. Doherty SD, Giancola A, Nash J, Lazar AJ, Duvic M. Papulo-vesicular eruption. Dermatol Online J 13(2):24, 2007. e-Pub 2007. PMID: 17498443.
521. Cosme-Blanco W, Shen MF, Lazar AJ, Pathak S, Lozano G, Multani AS, Chang S. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep 8(5):497-503, 2007. e-Pub 2007. PMID: 17396137.
522. Ivan D, Bengana C, Lazar AJ, Diwan AH, Prieto VG. Merkel Cell Tumor in a Trichilemmal Cyst: Collision or Association?. Am J Dermatopathol 29(2):180-183, 2007. e-Pub 2007. PMID: 17414443.
523. Bieniek R, Lazar AJ, Photopoulos C, Lyle S. Sebaceous tumours contain a subpopulation of cells expressing the keratin 15 stem cell marker. Br J Dermatol 156(2):378-80, 2007. e-Pub 2007. PMID: 17223883.
524. May SA, Jones D, Medeiros LJ, Duvic M, Prieto VG, Lazar AJ. Oral-cutaneous CD4-positive T-cell lymphoma: a study of two patients. Am J Dermatopathol 29(1):62-7, 2007. e-Pub 2007. PMID: 17284964.
525. Wyatt AJ, Herzog CE, Lazar AJ. An Erythematous Plaque on the Face. Clin Exp Dermatol 32(1):123-4, 2007. e-Pub 2007. PMID: 17059446.
526. Nash JW, Barrett TL, Kies M, Ross MI, Sneige N, Diwan AH, Lazar AJ. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications. J Cutan Pathol 34(1):49-54, 2007. e-Pub 2007. PMID: 17214855.
527. Liu J, Zhan M, Hannay JA, Das P, Bolshakov SV, Kotilingam D, Yu D, Lazar AJ, Pollock RE, Lev D. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res 4(11):803-10, 2006. e-Pub 2006. PMID: 17077165.
528. Prieto VG, Mourad-Zeidan AA, Melnikova V, Johnson MM, Lopez A, Diwan AH, Lazar AJ, Shen SS, Zhang PS, Reed JA, Gershenwald JE, Raz A, Bar-Eli M. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res 12(22):6709-15, 2006. e-Pub 2006. PMID: 17121890.
529. Natarajan E, Omobono JD, Guo Z, Hopkinson S, Lazar AJ, Brenn T, Jones JC, Rheinwald JG. A keratinocyte hypermotility/growth arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence. Am J Pathol 168(6):1821-37, 2006. e-Pub 2006. PMID: 16723698.
530. Takeda H, Lyle S, Lazar AJ, Zouboulis CC, Smyth I, Watt FM. Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 12(4):395-7, 2006. e-Pub 2006. PMID: 16565724.
531. Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG. Examination of mutations in BRAF, NRAS and PTEN in Primary Cutaneous Melanoma. J Invest Dermatol 126(1):154-160, 2006. e-Pub 2006. PMID: 16417231.
532. Lazar AJ, Fletcher CD. Primitive nonneural granular cell tumors of skin: clinicopathologic analysis of 13 cases. Am J Surg Pathol 29(7):927-34, 2005. e-Pub 2005. PMID: 15958858.
533. Haskell HD, Haynes HA, McKee PH, Redston M, Granter SR, Lazar AJ. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin. J Cutan Pathol 32(3):245-50, 2005. e-Pub 2005. PMID: 15701088.
534. Lazar AJ, Calonje E, Grayson W, Dei Tos AP, Mihm MC, Redston M, McKee PH. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol 32(2):148-57, 2005. e-Pub 2005. PMID: 15606674.
535. Lepourcelet M, Tou L, Cai L, Sawada J, Lazar AJ, Glickman JN, Williamson JA, Everett AD, Redston M, Fox EA, Nakatani Y, Shivdasani RA. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development 132(2):415-27, 2005. e-Pub 2005. PMID: 15604097.
536. Lazar AJ, Chen X, Rush J, Horazdovsky B, Waechter CJ, Carman GM, Sternweis PC. The LPP1 and DPP1 gene products account for most of the isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiae. J Biol Chem 274(21):14831-14837, 1999. e-Pub 1999. PMID: 10329682.
537. Xie Z, Fang M, Rivas MP, Lazar AJ, Sternweis PC, Engebrecht JA, Bankaitis VA. Phospholipase D activity is required for suppression of yeast phosphatidylinositol transfer protein defects. Proc Natl Acad Sci U S A 95(21):12346-51, 1998. e-Pub 1998. PMID: 9770489.
538. Cherry LM, Lazar AJ, Grossberg LA, Balczon R. Kinetochore size variation in mammalian chromosomes: an image analysis study with evolutionary implications. J Cell Sci 92(2):281-9, 1989. e-Pub 1989. PMID: 2674167.
539. Zhang D, Jiang J, Cho KS, Liu Y, Chen J, Lazcano RS, Yan X, Pei G, Solis Soto LM, Chu Y, Sinjab A, Yee C, Kopetz S, Maitra A, Futreal PA, Lazar AJ, Jazaeri AA, Kadara H, Gao JJ, Li M, Wang L. iStarTLS: Advanced Detection and Phenotyping of Tertiary Lymphoid Structures. Cancer Cell.
540. Nery CVC, Werneck I, Lopez RPG, DVM, CRGR O, Silva ANE, Tolentino JM, Canedo PH, Favoretto SM, Lazar AJ, Soares F, da Cruz JB, Couto SS. Undifferentiated pleomorphic sarcoma with widespread metastasis in a 53-year-old, captive hippopotamus (Hippopotamus amphibius). J Zoo Wildlife Med.
541. Patel RR, Bishop AJ, Lazar AJ, Lin PR, Benjamin RS, Patel SR, Ludwig J, Ravi V, Vaporciyan AA, Araujo DM. Metastasis is the primary cause of failure in apparently localized intrathoracic synovial sarcoma. Cancers.

Invited Articles

1. Hirbe AC, Dehner CA, Dombi E, Eulo V, Gross AM, Sundby T, Lazar AJ, Widemann BC. Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. Am Soc Clin Oncol Educ Book 44(3):e432242, 2024. e-Pub 2024. PMID: 38710002.
2. Beird HC, Lin D, Lazar AJ, Futreal PA. Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary. J Pathol, 2024. e-Pub 2024. PMID: 38482738.
3. Lazar AJ, Demicco EG. Human and machine: Better at pathology together?. Cancer Cell 40(8):806-808, 2022. e-Pub 2022. PMID: 35944500.
4. Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA, Board WHO. Diagnosis of Digestive System Tumours: The WHO Classification. Histopathol 77(3):340-250, 2020. e-Pub 2020. PMID: 32320495.
5. El Beaino M, Roszik J, Livingston JA, Wang WL, Lazar AJ, Amini B, Subbiah V, Lewis V, Conley AP. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology. Curr Oncol Rep 20(5):37, 2018. e-Pub 2018.
6. Archiv V. Molecular profiling in sarcoma: new vistas for precision medicine. Al-Zaid T, Wang WL, Somaiah N, Lazar AJ 471(2):243-255, 2017. e-Pub 2017. PMID: 28664413.
7. Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. Surg Oncol Clin N Am 25(4):775-88, 2016. e-Pub 2016. PMID: 27591498.
8. Loghavi S, Routbort MJ, Patel KP, Luthra R, Wang WL, Broaddus RR, Davies MA, Lazar AJ. How Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?. J Natl Compr Canc Netw 14(6):787-92, 2016. e-Pub 2016. PMID: 27283170.
9. Yang J, Du X, Wang G, Sun Y, Chen K, Zhu X, Lazar AJ, Hunt KK, Pollock RE, Zhang W. Mesenchymal to epithelial transition in sarcomas. Eur J Cancer 50(3):593-601, 2014. e-Pub 2014. PMID: 24291235.
10. Foo WC, Liegl-Atzwanger B, Lazar AJ. Pathology of Gastrointestinal Stromal Tumors. Clin Med Insights Pathol 5:23-33, 2012. e-Pub 2012. PMID: 22855636.
11. Torres K, Lazar AJ, Pollock RE, Lev D. Angiosarcoma: A Frequently Recurrent and Highly Metastatic Malignancy. Eur J Clin Med Oncol 4(2):73-81, 2012. e-Pub 2012.
12. Demicco EG, Maki RG, Lev DC, Lazar AJ. New Therapeutic Targets in Soft Tissue Sarcoma. Adv Anat Pathol 19(3):170-80, 2012. e-Pub 2012. PMID: 22498582.
13. Woodman SE, Lazar AJ, Aldape KD, Davies MA. New Strategies in Melanoma: Molecular Testing in Advanced Disease. Clin Cancer Res 18(5):1195-200, 2012. e-Pub 2012. PMID: 22275506.
14. Demicco EG, Lazar AJ. The Current State of Molecular Pathology in Diagnosing Sarcomas. ESUN Website, 2012. e-Pub 2012.
15. Berri RN, Baumann DP, Madewell JE, Lazar AJ, Pollock RE. Desmoid tumor: Current multidisciplinary approaches. Ann Plast Surg 67(5):551-564, 2011. e-Pub 2011. PMID: 21587055.
16. Demicco EG, Lazar AJ. Clinicopathologic Considerations: How Can We Fine Tune Our Approach to Sarcoma?. Semin Oncol 38(Suppl 3):S3-S18, 2011. e-Pub 2011. PMID: 22055969.
17. Fritchie K, Fisher C, J-M C, Lazar AJ, Rubin BP. A Brief History and Contemporary Re-assessment of Malignant Fibrous Histiocytoma: “Fact or Fancy”. Diagn Histopathol 17(8):340-347, 2011. e-Pub 2011.
18. Hoffman A, Lazar AJ, Pollock RE, Lev D. New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort. Drug Resist Updat 14(1):52-66, 2011. e-Pub 2011. PMID: 21169051.
19. Wang WL, Conley A, Reynoso D, Nolden L, Lazar AJ, George S, Trent JC. Mechanisms of Resistance To Imatinib and Sunitinib in Gastrointestinal Stromal Tumor. Cancer Chemother Pharmacol 67(Suppl 1):S15-24, 2011. e-Pub 2011. PMID: 21181476.
20. Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, Pollock RE, Ludwig JA. Neoadjuvant treatment of soft-tissue sarcoma: A multimodality approach. J Surg Oncol 101(4):327-333, 2010. e-Pub 2010. PMID: 20187067.
21. Shalin SC, Lyle S, Calonje E, Lazar AJ. Sebaceous Neoplasia and the Muir-Torre syndrome: Important Connections with Clinical Implications. Histopathology 56(1):133-147, 2010. e-Pub 2010. PMID: 20055911.
22. Katz D, Lazar AJ, Lev D. Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signaling pathways. Expert Rev Mol Med 11:e30, 2009. e-Pub 2009. PMID: 19835664.
23. Lazar AJ, Hajibashi S, Lev D. Desmoid Tumor: From Surgical Extirpation to Molecular Dissection. Curr Opin Oncol 21(4):352-9, 2009. e-Pub 2009. PMID: 19436199.
24. Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Ewing's sarcoma: standard and experimental treatment options. Curr Treat Options Oncol 10(1-2):126-40, 2009. e-Pub 2009. PMID: 19533369.
25. Yang J, Du X, Chen K, Ylipää A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang W. Genetic Aberrations in Soft Tissue Leiomyosarcoma. Cancer Lett 275(1):1-8, 2009. e-Pub 2009. PMID: 18649996.
26. Liegl B, Hornick JL, Lazar AJ. Contemporary Pathology of Gastrointestinal Stromal Tumor. Hematol Oncol Clin North Am 23(1):49-68, 2009. e-Pub 2009. PMID: 19248970.
27. Lahat G, Lazar AJ, Lev D. Sarcoma epidemiology and etiology; potential environmental and genetic factors. Surg Clin North Am 88(3):451-81, 2008. e-Pub 2008. PMID: 18514694.
28. Kotiligam D, Lazar AJ, Pollock RE, Lev D. Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol 23(1):117-26, 2008. e-Pub 2008. PMID: 17952864.
29. Trent JC, Lazar AJ, Zhang W. Molecular Approaches to Resolve Diagnostic Dilemmas: The Case of Gastrointestinal Stromal Tumor and Leiomyosarcoma. Future Oncol 3(6):629-527, 2007. e-Pub 2007. PMID: 18041915.
30. Lazar AJ, Trent JC, Lev D. Sarcoma Molecular Testing: Diagnosis and Prognosis. Curr Oncol Rep 9(4):309-315, 2007. e-Pub 2007. PMID: 17588356.
31. Perna AG, Prieto VG, Lazar AJ, Ivan D. Primary cutaneous adnexal neoplasms and their metastatic look-alikes. Pathol Case Rev 12(2):61-69, 2007. e-Pub 2007.
32. Lazar AJ, Calonje E, Lyle S. Sebaceous Neoplasia and the Torre-Muir Syndrome. Curr Diagn Pathol 13(4):301-319, 2007. e-Pub 2007.
33. Kotilingam D, Lev DC, Lazar AJ, Pollock RE. Staging Soft Tissue Sarcoma: Evolution and Change. CA Cancer J Clin 56(5):282-291; quiz 314-315, 2006. e-Pub 2006. PMID: 17005597.
34. Haluska FG, Tsao H, Wu H, Haluska FS, Lazar AJ, Goel V. Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 12(2):2103s-2307s, 2006. e-Pub 2006. PMID: 16609049.
35. Lazar AJ, Abruzzo LV, Lee S, Pollock RE, Czerniak BA. Molecular Diagnosis Sarcomas: Chromosomal Translocations in Sarcomas. Arch Pathol Lab Med 130(8):1199-1207, 2006. e-Pub 2006. PMID: 16879024.
36. Lazar AJ. AfCS-Nature Molecule Pages. LPP1, 2005. e-Pub 2005.
37. Lazar AJ. AfCS-Nature Molecule Pages. LPP3, 2005. e-Pub 2005.

Review Articles

1. Goldman-Levy G, Barnhill R, Bastian BC, Kempf W, Elder D, Gerami P, Grayson W, Kazakov D, Massi D, Messina J, de la Fouchardiere A, Lazar AJ, Brenn T, Rous B, Field A, Gill A, Hodge JC, Khoury JD, Leite K, Sayed S, Tan PH, Elenitsas R, Calonje E, Duncan LM, Zhiyong L, Moch H, Singh R, Wijesinghe H, Cree I, Lokuhetty D. WHO classification of skin tumours: key updates in the fifth edition. Histopathology, 2025. e-Pub 2025. PMID: 41263762.
2. Kelsey, A, Alaggio, R, Webster, F, Bailey, K, Bisogno, G, Davis, JL, Dry, S, Konovalov, DM, Lazar, A, O'Sullivan, MJ, Rudzinski, ER, Venkatramani, R, Vokuhl, C, Zambrano, E, Cohen, M, Reyes-Mugica, M. Data set for reporting of paediatric rhabdomyosarcoma. Histopathology 87(4):503-513, 2025. e-Pub 2025. PMID: 40007148.
3. Torrado, C, Nassif, EF, Somaiah, N, Msaouel, P, Lazar, AJ, Piha-Paul, SA. Advancing Understanding and Therapeutic Strategies for NUT Sarcomas. Journal of Immunotherapy and Precision Oncology 8(2):113-120, 2025. e-Pub 2025. PMID: 40070529.
4. Duncan LM, Elder DE, Piepkorn MW, Knezevich SR, Blokx WAM, Bosenberg M, Busam KJ, Carr R, Cook MG, Gerami P, Ko J, Landman G, Lazar AJ, Lowe L, Mihic-Probst D, Schmidt B, Shea CR, Scolyer RA, Xu X, Elmore JG, Barnhill RL. Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5. J Cutan Pathol, 2025. e-Pub 2025. PMID: 40181698.
5. Lucas, CG, Gross, A, Romo, CG, Dehner, CA, Lazar, AJ, Miettinen, M, Pekmezci, M, Quezado, M, Rodriguez, FJ, Stemmer-Rachamimov, AO, Viskochil, DH, Perry, A, Ahlawat, S, Akshintala, S, Amrami, K, Bakker, AC, Belzberg, AJ, Blakeley, JO, Bredella, MA, Chittiboina, P, Clapp, DW, Daldrup-Link, HE, De Raedt, T, Dehner, C, Dombi, E, Draper, G, Fayad, LM, Ferner, R, Fisher, MJ, Gutmann, DH, Hawk, K, Hirbe, AC, Johnston, FM, Kim, A, Korf, B, Largaespada, DA, Lazar, A, Le, L, Legius, E, Levin, AS, Ly, KI, Miller, DT, Morris, CD, Murphey, MD, Parada, LF, Pratilas, CA, Ratley, M, Ratner, N, Rhodes, SD, Ristow, I. Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Neuro-oncology 27(3):616-624, 2025. e-Pub 2025. PMID: 39500722.
6. Dehner CA, Lazar AJ, Chrisinger JSA. Updates on WHO classification for small round cell tumors: Ewing Sarcoma vs. Everything Else. Hum Pathol 147:101-113, 2024. e-Pub 2024. PMID: 38280658.
7. Cope BM, Traweek RS, Lazcano R, Keung EZ, Lazar AJ, Roland CL, Nassif EF. Targeting the Molecular and Immunologic Features of Leiomyosarcoma. Cancers (Basel) 15(7), 2023. e-Pub 2023. PMID: 37046760.
8. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis V, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL. ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas-A Systematic Review of the Literature. Ann Surg Oncol 30(2):970-971, 2023. e-Pub 2023. PMID: 36323987.
9. Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG, Noguchi M, Nonaka D, Papotti MG, Porubsky S, Sholl LM, Tateyama H, Thomas de Montpréville V, Travis WD, Rajan A, Roden AC, Ströbel P. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?. J Thorac Oncol 17(2):200-213, 2022. e-Pub 2022. PMID: 34695605.
10. Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA, Board WHO. Diagnosis of digestive system tumours. Int J Cancer 148(5):1040-1050, 2021. e-Pub 2021. PMID: 32674220.
11. Amgad M, Stovgaard ES, Balslev E, Thagaard J, Chen W, Dudgeon S, Sharma A, Kerner JK, Denkert C, Yuan Y, AbdulJabbar K, Wienert S, Savas P, Voorwerk L, Beck AH, Madabhushi A, Hartman J, Sebastian MM, Horlings HM, Hudecek J, Ciompi F, Moore DA, Singh R, Roblin E, Balancin ML, Mathieu MC, Lennerz JK, Kirtani P, Chen IC, Braybrooke JP, Pruneri G, Demaria S, Adams S, Schnitt SJ, Lakhani SR, Rojo F, Comerma L, Badve SS, Khojasteh M, Symmans WF, Sotiriou C, Gonzalez-Ericsson P, Pogue-Geile KL, Kim RS, Rimm DL, Viale G, Hewitt SM, Bartlett JMS, Penault-Llorca F, Goel S, Lien HC, Loibl S, Kos Z, Loi S, Hanna MG, Michiels S, Kok M, Nielsen TO, Lazar AJ, Bago-Horvath Z, Kooreman LFS, Laak JAWM VD, Saltz J, Gallas BD, Kurkure U, Barnes M, Salgado R, Cooper LAD, Working Group IIB. Report on computational assessment of Tumor Infiltrating Lymphocytes in solid tumors from the International Immuno-Oncology Biomarker Working group. NPJ Breast Cancer 6:16, 2020. e-Pub 2020. PMID: 32411818.
12. Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, Kos Z, Carter JM, Michiels S, Le Quesne J, Nielsen TO, Laenkholm AV, Fox SB, Adam J, Bartlett JM, Rimm DL, Quinn C, Peeters D, Dieci MV, Vincent-Salomon A, Cree I, Hida AI, Balko JM, Haynes HR, Frahm I, Acosta-Haab G, Balancin M, Bellolio E, Yang W, Kirtani P, Sugie T, Ehinger A, Castaneda CA, Kok M, McArthur H, Siziopikou K, Badve S, Fineberg S, Gown A, Viale G, Schnitt SJ, Pruneri G, Penault-Llorca F, Hewitt S, Thompson EA, Allison KH, Symmans WF, Bellizzi AM, Brogi E, Moore DA, Larsimont D, Dillon DA, Lazar A, Lien H, Goetz MP, Broeckx G, El Bairi K, Harbeck N, Cimino-Mathews A, Sotiriou C, Adams S, Liu SW, Loibl S, Chen IC, Lakhani SR, Juco JW, Denkert C, Blackley EF, Demaria S, Leon-Ferre R, Gluz O, Zardavas D, Emancipator K, Ely S, Loi S, Salgado R, Sanders M, Working Group IIB. The Path to a Better Biomarker: Application of a Risk Management Framework for the Implementation of PD-L1 and TILs as Immuno-Oncology Biomarkers into Breast Cancer Clinical Trials and Daily Practice. J Pathol 250(5):667-684, 2020. e-Pub 2020. PMID: 32129476.
13. The Desmoid Tumor Working Group: Alman B, Attia S, Baumgarten C, Benson C, J-Y B, Bonvalot S, Breuing J, Cardona K, Casali PG, Van Coevorden F, Colombo C, Dei Tos AP, Dileo P, Ferrari A, Flore M, Frezza AM, Garcia J, Galddy R, Gounder M Gronchi A, Haas R, Hackett S, Haller F, Hohenberger P, Husson O, Jones RL, Judson I, Kasper B, Kawai A, Kogosov V, Lazar AJ, Maki R, Mathes T, Messiou C, Navid F, Nishida Y, Palassini E, Penel N, Pollock RE, Pieper D, Portnoy M, Raut CP, Roets E, Sandrucci S, Sbaraglia M, Stacchiotti S, Thornton KA, Van Der Graaf W, Van Der Zande K, Van Houdt WJ, Villalobos V, Wagner AJ, Wardelmann E, Wartenberg M, Watson S, Weiss A, Zafiropoulos N. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 127:96-107, 2020. e-Pub 2020. PMID: 32004793.
14. El Beaino M, Jupiter DC, Assi T, Rassy E, Lazar AJ, Araujo DM, Lin PP. Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis. Sarcoma 2020:7192347, 2020. e-Pub 2020. PMID: 32322158.
15. Cooper LA, Demicco EG, Saltz JH, Powell RT, Rao A, Lazar AJ. Pan-Cancer Insights from The Cancer Genome Atlas: The Pathologist’s Perspective. J Pathol 244(5):512-524, 2018. e-Pub 2018. PMID: 29288495.
16. Yang J, Du X, Lazar AJ, Pollock R, Hunt K, Chen K, Hao X, Trent J, Zhang W. Genetic aberrations of gastrointestinal stromal tumors. Cancer 113(7):1532-43, 2008. e-Pub 2008. PMID: 18671247.

Professional Educational Materials

1. Working Group TDT. The management of desmoid tumors: a joint global evidence-based consensus guideline approach for adult and pediatric patients. ERN EURCAN (European Reference Network: European Reference Network on Rare Adult Solid Cancers), 2019.
2. Sullivan R, Lazar AJ. Melanoma (October 2015): Molecular Oncology Tumor Boards - See more at: https://connection.asco.org/discussion/melanoma-october-2015-molecular-oncology-tumor-boards#sthash.LcCecT0L.dpuf. ASCO University, 2015.
3. Hornick JL, Lazar AJ. Understanding Your Pathology Report for Gastrointestinal Stromal Tumor (GIST) - online. GIST Support International, 2010.
4. Hornick JL, Lazar AJ. Understanding Your Pathology Report for Gastrointestinal Stromal Tumor (GIST) - booklet/pamplet for patients. Gist Support International, 2010.
5. authors M. Surgical Pathology Grossing Manual, Soft Tissue (re-write) and Dermatopathology (edit) sections, 2009.
6. authors M. Brigham and Women's Hospital, Surgical Pathology Manual. Churchill-Livingston, 2006.

Other Articles

1. Vega DM, Yee LM, McShane LM, Williams PM, Chen L, Vilimas T, Fabrizio D, Funari V, Newberg J, Bruce LK, Chen SJ, Baden J, Carl Barrett J, Beer P, Butler M, Cheng JH, Conroy J, Cyanam D, Eyring K, Garcia E, Green G, Gregersen VR, Hellmann MD, Keefer LA, Lasiter L, Lazar AJ, Li MC, MacConaill LE, Meier K, Mellert H, Pabla S, Pallavajjalla A, Pestano G, Salgado R, Samara R, Sokol ES, Stafford P, Budczies J, Stenzinger A, Tom W, Valkenburg KC, Wang XZ, Weigman V, Xie M, Xie Q, Zehir A, Zhao C, Zhao Y, Stewart MD, Allen J Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636]. Ann Oncol 35(1):145, 2024. PMID: 37558578.
2. Pozner A, Verma SP, Li L, Wang S, Barrott JJ, Nelson ML, Yu JSE, Negri GL, Colborne S, Hughes CS, Zhu JF, Lambert SL, Carroll LS, Smith-Fry K, Stewart MG, Kannan S, Jensen B, Mortenson KL, John C, Sikdar S, Liu H, Dang NH, Bourdage J, Li J, Vahrenkamp JM, Groundland JS, Wustrack R, Senger DL, Zemp FJ, Mahoney DJ, Gertz J, Zhang X, Lazar AJ, Hirst M, Morin GB, Nielsen TO, Shen PS, Jones KB ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p9. bioRxiv [Preprint]. PMID: 37873234.
3. Anderson N, Barrett JC, A-L B, Baxi V, Beaubier N, Cohen DN, Couto S, Dasgupta T, Doyle M, French D, Gallas BD, Gulturk E, Gustavson M, Hersey S, Kulig K, Lazar AJ, Lennerz JK, Montalto M, Mrowiec T, Mukhopadhyay S, Richardson ET, Salgado R, Silk A, Sireci N, Stumpe M, Wang J Supporting the Application of Computational Pathology in Oncology. Friend of Cancer Research White Paper.
4. Roberts K, Demner-Fushman D, Voorhees EM, Hersh WR, Bedrick S, Lazar AJ Overview of the TREC 2018 Precision Medicine Track. NIST Special Publication: SP 500-331: The Twenty-Seventh Text REtrieval Conference (TREC 2018) Proceedings, 2018.
5. Roberts K, Demner-Fushman D, Voorhees EM, Hersh WR, Bedrick S, Lazar AJ, Pant S Overview of the TREC 2017 Precision Medicine Track. NIST Special Publication: SP 500-324 The Twenty-Sixth Text REtrieval Conference (TREC 2017) Proceedings, 2017.

Editorials

1. Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, Sapino A, Sasano H, Schnitt S, Sotiriou C, van Diest P, White VA, Lokuhetty D, Cree IA, Board WHO. The 2019 WHO classification of tumours of the breast. Histopathology 77(2):181-185, 2020. PMID: 32056259.
2. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA, Board WHO. The 2019 WHO classification of tumours of the digestive system. Histopathology 76(2):182-188, 2020. PMID: 31433515.
3. Erstine EM, Lazar AJ. Toward an effective use of β-catenin immunohistochemistry in the evaluation of challenging melanocytic lesions. Virchows Arch 474(5):1-3, 2019. PMID: 30868296.
4. Charville GW, Lazar AJ. Prognostic Gene Expression Signatures in Sarcoma: Finding Clarity in Complexity. Ann Oncol 29(8):1632-1633, 2018. PMID: 29982358.
5. Wang WL, Lazar AJ. Undifferentiated "round" cell ("Ewing-like") sarcoma: not always so-round nor Ewing-like. Virchows Arch 470(4):371-372, 2017. PMID: 28191614.
6. Hughes DP, Kummar S, Lazar AJ. New, Tolerable gamma-Secretase Inhibitor Takes Desmoid Down a Notch. Clin Cancer Res 21(1):7-9, 2015. PMID: 25336699.
7. Fitzgibbons PL, Lazar AJ, Spencer S. Introducing New College of American Pathologists Reporting Templates for Cancer Biomarkers. Arch Pathol Lab Med 138(2):157-8, 2014. PMID: 23808404.
8. Al Saanna G, JVMG JB, Hornick JL, Lazar AJ. A Review of the WHO Classification of Tumours of Soft Tissue and Bone. ESUN website, 2013.
9. Lazar AJ. Book Review: Pathology of Melanocytic Disorders, 2nd Edition. Am J Surg Pathol 32(11):1749-50, 2008.

Abstracts

1. Alqaidy D, Ingram I, Cloutier J, Wani K, Lazar AJ, Livingston J, Wang WL. ATM Loss in High-Grade Sarcomas. Modern Pathology-2022 USCAP Annual Meeting, 2022. e-Pub 2022.
2. Cloutier J, Beird H, Maloney N, Ingram D, Wani K, Lazar, AJ, Wang WL, Demicco E. Genome-Wide DNA Methylation Profiling Reveals Differentially Methylated Genes in Clinically Distinct Subsets of Solitary Fibrous Tumors. Modern Pathology-2022 USCAP Annual Meeting, 2022. e-Pub 2022.
3. Garcia, A, Reuther J, Voicu H, Mohila C, Adesina A, Schady D, Wang WL, Lazar AJ, Lopez-Terrada D, Lin F, Venkatramani R, Plon S, Parsons W, Fisher K, Angshumoy R. Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel. Modern Pathology-2022 USCAP Annual Meeting, 2022. e-Pub 2022.
4. Lopez G, Ren W, Zhu QS, Lazar AJ, Hunt K, Pollock RE, Lev D. c-Met: a prognostic factor and potential therapeutic target for complex karyotype soft tissue sarcoma. AACR, 2009. e-Pub 2009.
5. Dumont AG, Lev D, Lazar A, Joensuu H, Trent J. Simultaneous gastrointestinal stromal tumor (GIST) and desmoid fibromatosis (DF). ASCO, 2009. e-Pub 2009.
6. Zhu QS, Zou CY, Smith KD, Liu J, McCutcheon IE, Slopis JM, Meric-Bernstam F, Peng Z, Bornmann WG, Mills GB, Lazar AJ, Pollock RE, Lev D. Dual targeting of AKT and mTOR: a potential therapeutic approach for malignant peripheral nerve sheath tumor. AACR, 2009. e-Pub 2009.
7. Schuetze S, Rutkowski P, Van Glabbeke MM, Rankin C, Rubin BP, Lazar AJ, Debiec-Rychter M, Gelderblom H, Hohenberger P, van Oosterom AT. Combined analysis of two phase II trials of imatinib in advanced dermatofibrosarcoma protuberans (DFSP). ASCO 27(Suppl 15):10520, 2009. e-Pub 2009. PMID: 27963939.
8. Rao P, Lahat G, Dukah A, Halevi H, Xiao L, Changye Z, Smith KD, Pollock RE, Lev D, Lazar AJF. Angiosarcoma: Clinical, Pathological, and Molecular Predictors of Disease-Specific Survival in 222 Patients. USCAP, Mod Pathol 22(Suppl 1):20A (#81), 2009. e-Pub 2009.
9. Powers MP, W-L W, Hernandez VS, Patel KU, Lazar AJF, Lopez-Terrada DH. An RT-PCR Assay for FFPE Tissue Identifies a New FUS-DDIT3 Gene Fusion in Myxoid Liposarcoma. USCAP, Mod Pathol 22(Suppl 1):20A (#80), 2009. e-Pub 2009.
10. Brown JG, Amin MB, Rao P, Lazar AJ, Paner GP, Gupta R, Cheville JC. Primary Vascular Tumors of the Kidney: A Clinicopathologic analysis of 26 Cases. USCAP, Mod Pathol 22(Suppl 1):160A (#721), 2009. e-Pub 2009.
11. Balzar B, Gupta R, Rao P, Paner GP, Amin M, Mckenney JK, Lazar AJ, Amin MB. Dedifferentiated Liposarcoma (De-Diff LPS) Presenting as a Primary Renal Mass Resulting in a Nephrectomy: A Report of 8 Cases with Discussion of Differential Diagnostic Implications. USCAP, Mod Pathol 22(Suppl 1):150A (#712), 2009. e-Pub 2009.
12. Balzer B, Gupta R, Lazar AJ, Rao P, Amin MB. Pseudoliposarcomatous Changes in the Perinephric Adipose Tissue of Nephrectomy Specimens Mimicking Well Differentiated Retroperitoneal Liposarcoma: Evaluation of 200 Nephrectomies. USCAP, Mod Pathol 22(Suppl 1):158A (#711), 2009. e-Pub 2009.
13. Lazar AJF, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D. Specific Mutations in the B-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors. USCAP, Mod Pathol 22(Suppl 1):17A (#64), 2009. e-Pub 2009.
14. Hantschke M, Mentzel T, Calonje E, Lazar AJ, Kutzner H. Cutaneous Clear Cell Sarcoma: Clinicopathologic, Immunohistochemical and Molecular Analysis of 12 Cases Emphasizing Distinction from Dermal Melanoma. USCAP, Mod Pathol 22(Suppl 1):104A (#457), 2009. e-Pub 2009.
15. Deyrup AT, Thway K, Fisher C, W-L W, Lazar AJ, Jones RL, Tighiouart M, Weiss SW. Clinicopathologic Analysis of Adult Alveolar and Embryonal Rhabdomyosarcoma: A Study of 62 Cases. USCAP, Mod Pathol 22(Suppl 1):13A (#44), 2009. e-Pub 2009.
16. W-L W, Mayordomo E, Czerniak B, Abruzzo LV, Lev D, Lopez-Terrada, Lazar AJF. Fluorescence In-situ Hybridization (FISH) is a Useful Ancillary Diagnostic Tool for Extraskeletal Myxoid Chondrosarcoma. USCAP, Mod Pathol 21(11):1303-1310, 2008. e-Pub 2008. PMID: 18587326.
17. Lahat G, Wei-lien W, Tuvin D, Anaya DA, Wei C, Bekele N, Smith KD, Lazar AJ, Pisters PW, Pollock RE, Lev D. Clinical Variables, Pathological Factors, and Molecular Markers for Enhanced Soft tissue Sarcoma Prognostication. CTOS, 2008. e-Pub 2008.
18. Hajibashi S, Wang W, Lazar AJF, Tuvin D, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D. Identifying Molecular Markers using a Clinically Annotated Tissue Microarray. CTOS, 2008. e-Pub 2008.
19. Myers SE, Nguyen T, Zhu QS, Lazar AJ, Pollock R, Lev D. The C-Met Receptor Contributes to Motility and Invasion in a Broad Range of STS Histologies; A Potential Anti-STS Therapeutic Target. CTOS, 2008. e-Pub 2008.
20. Blazer DG, Lazar AJ, Xing Y, Askew RL, Lev DC, Feig BW, Pisters PW, Pollock RE, Hunt KK, Cormier JN. Improved outcomes in patients with lymph node-only stage IV disease in clear cell sarcoma: Results from a large single-institution experience and SEER database analysis. ASCO, J Clin Ocol 26(15S):10571, 2008. e-Pub 2008.
21. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad AJ, Lazar AJF, Choi H, Benjamin RS, Aurajo DM. Combination therapy with temozolomide and bevacizumab in the treatment of hemangiopericytoma/malignant solitary fibrous tumor. ASCO, J Clin Oncol 26(16S):10512, 2008. e-Pub 2008.
22. Smith KD, Zou CY, Liu J, Lahat G, Lazar AJF, Pollock RE, Lev, D. Malignant Peripheral Nerve Sheath Tumors (MPNST): Clinical, Pathologic and Molecular Predictors of Survival. CTOS 249(6):1014-1022, 2008. e-Pub 2008. PMID: 19474676.
23. Luzar B, W-L W, Asher R, Lazar AJ, Bracko M, Calonje E. Spindle cell carcinoma of the skin: a clinicopathologic analysis of 30 cases. USCAP, Mod Pathol 21(s.1):97A-98A (#439), 2008. e-Pub 2008.
24. Mayordomo E, Zhang W, Hernandez V, Tuvin D, Garcia L, Lev D, Lazar AJF, Lopez-Terrada D. Diagnostic utility of a newly designed fusion-type-specific RT-PCR and FISH in clear cell sarcoma. USCAP, Mod Pathol 21(s.1):15A (#54), 2008. e-Pub 2008.
25. Ostler DA, Malpica A, Sun CC, Perna AG, Diwan AH, Lazar AJF, Deavers MT, Prieto VG. Comparative study of methods to determine depth of invasion in vulvar squamous cell carcinoma. USCAP, Mod Pathol 31(s.1):216A-217A (#990), 2008. e-Pub 2008.
26. Hayes-Jordan A, Maldonado Y, Xiao LC, Cormier J, Lazar AJF, Harting M, Herzog C, Huh W, Pisters P. Outcome of Non Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) in Children and Adolescents: Does Age Matter?. 61st Annual Cancer Symposium, Ann Surg Oncol 15(s.2):27, 2008. e-Pub 2008.
27. Wang DM, Lazar AJF, Lev DC, Tuvin D, Feig BW, Cormier JN, Hunt KK, Patel S, Benjamin RS, Pollock RE, Pisters P. Intraabdominal visceral angiosarcoma (IAVA): Experience from a major referral center. 61st Annual Cancer Symposium, Ann Surg Oncol 15(s.2):66, 2008. e-Pub 2008.
28. Hannay JAF, Liu J, Bolshakov S, Yu D, Lazar AJ, Pollock RE, Lev D. Rad51 Over-expression contributes to chemoresistance in human soft tissue sarcoma (STS); A role for p53/AP-2 transcriptional regulation. CTOS 6(5):1650-60, 2007. e-Pub 2007. PMID: 17513613.
29. Lazar AJ, Das P, Tuving D, Korchin B, Pollock RE, Lev D. Alveolar Soft Part Sarcoma (ASPS) has unique angiogenic profile and relatively favorable clinical outcome. CTOS 13(24), 2007. e-Pub 2007.
30. Jin Z, Korchin B, Lazar A, Pollock RE, Lev D. The Heparin-binding Growth factor Midkine; a possible novel target for STS therapy. CTOS, 2007. e-Pub 2007.
31. Lazar AJ, Parimal D, Tuvin D, Korchin B, Lopez-Terrada D, Pollock RE, Lev D. Alveolar Soft Part Sarcoma (ASPS) Has a Unique Angiogenic Profile and Relatively Favorable Clinical Outcome. CTOS 13(24), 2007. e-Pub 2007.
32. Rimm DL, Moeder CB, GouldRothberg BE, Kluger H, Halaban R, Elder DE, Murphy GF, Lazar AJ, Prieto VG, Duncan LM. Quantitative Analysis of the SPORE Melanoma Progression Array with Ki67 and HMB-45. 15th Annual SPORE Investigator's Workshop, 2007. e-Pub 2007.
33. McAuliffe J, Lazar AJ, Steinert D, Patel S, Benjamin R, Trent J. Kit-Stem Cell Factor (Kit Ligand) Axis in GIST Patients Treated With Imatinib. ASCO 25(18S):10046, 2007. e-Pub 2007.
34. Guo Z, Bieniek R, Barbagallo B, Lazar AJ, Lyle S. A subset of sebaceous tumor cells express stem cell markers. Keystone Symposium: Stem Cells and Cancer. Keystone Symposium: Stem Cells and Cancer, 2007. e-Pub 2007.
35. McAuliffe JC, Lazar AJ, Steinert D, Trent JC. Imatinib (GleevecTM) failure in gastrointestinal stromal tumor (GIST) correlates with VEGF expression: A role for front-line sunitinib therapy?. 9th International Symposium on Anti-Angiogenic Agents, 2007. e-Pub 2007.
36. Habeebu S, Lopez-Terrada D, Lazar AJ, Tuvin D, Lev D. Beta-catenin codon 41 and 45 mutations are frequent in aggressive fibromatosis (desmoid tumor) and are useful markers in their differential diagnosis. AMP, J Mol Diagn 9(5):693-694, 2007. e-Pub 2007.
37. Patel K, Habeebu S, Szabo S, Lazar AJ, Lopez-Terrada D. Dermatofibrosarcoma Protuberans PDGFB/COLA1A newly developed RT-PCR detection assay identifies novel COL1A1 breakpoints. AMP, J Mol Diagn 9(5):699, 2007. e-Pub 2007.
38. Wang Q, Lazar AJ, Prieto VG, Esmaeli B, Ivan D, Diwan AH. Cellular Blue Nevi of the Eyelid: A Possible Diagnostic Pitfall. ASDP, J Cutan Pathol 34(1):121, 2007. e-Pub 2007.
39. Wang Q, Diwan AH, Lazar AJ, Hymes S, Ivan D, Prieto VG. Graft Versus Host Disease Mimicking Erythema Dyschromicum Perstans (Ashy Dermatosis). ASDP, J Cutan Pathol 34(1):121, 2007. e-Pub 2007.
40. Ostler D, Lazar AJ, Prieto VG, MacFarlane D, Khalifeh I, Diwan AH. Cutaneous Syringoid Eccrine Carcinoma (Basal Cell Carcinoma with Eccrine Differentiation) Metastatic to Axillary Lymph Nodes Mimicking Synovial Sarcoma. ASDP, J Cutan Pathol 34(1):106, 2007. e-Pub 2007.
41. Kantrow S, Ivan D, Prieto VG, Williams M, Lazar AJ. Adenocarcinoma with multiple differentiation lines arising in a nevus sebaceous. ASDP, J Cutan Pathol 34(1):128, 2007. e-Pub 2007.
42. Perna AG, Ivan D, Gershenwald JE, Ross MI, Lazar AJF. Lymph node metastasis of an atypical hidradenoma identified by sentinel lymph node biopsy. ASDP, J Cutan Pathol 34(1):105, 2007. e-Pub 2007.
43. Diwan AH, Gershenwald JE, Lazar AJ, Prieto VG. Does Ethanol Fixation of Cutaneous Melanoma Specimens Impair Histologic Evaluation. ASDP, J Cutan Pathol 34(1):84, 2007. e-Pub 2007.
44. Sajid MA, Prieto VG, Abruzzo LV, Lopez-Terrada D, Lazar AJ. Angiomatoid Fibrous Histiocytoma with Clonal Rearrangement of the EWSR1 locus (22q12). ASDP, J Cutan Pathol 34(1):84, 2007. e-Pub 2007.
45. Nash JW, Prieto VG, Papadopoulos N, Diwan AH, Lazar AJ. Detection of a KIT-Activating Point Mutation in a c-Kit Immunoreactive Metastatic Melanoma Subsequently Treated with Adjuvant Imatinib Therapy. ASDP, J Cutan Pathol 34(1):82, 2007. e-Pub 2007.
46. Perna AG, Ostler DA, Ivan D, Lazar AJ, Diwan AH, Prieto VG, Reed JA. Renal Cell Carcinoma Marker (RCC-Ma) is a specific marker for cutaneous metastasis of renal cell carcinoma. ASDP, J Cutan Pathol 34(5):381-385, 2007. e-Pub 2007.
47. Taibjee S, Bedlow A, Lazar AJF, Carr R. Absence of widespread nuclear beta-catenin supports a diagnosis of basal cell carcinoma with matrical differentiation. British Dermatology Society, Br J Dermatol 157(s.1):96, 2007. e-Pub 2007.
48. Patel KU, Szabo SS, Prieto VG, Lazar AJ, Lopez-Terrada. Dermatofibrosarcoma Protuberans COL1A1-PDGFB Fusion is Identified in Virtually All DFSP Cases When Investigated by Newly Developer Multiplex RT-PCR and FISH Assays. USCAP, Lab Invest 87(s.1):20A (#70), 2007. e-Pub 2007.
49. Lazar AJ, Kotlingham D, Lopez-Terrada, Warneke C, Lev D. Alveolar Soft Part Sarcoma: Review of 71 Cases Treated at a Single Institution. USCAP, Lab Invest 87(s.1):17A (#58), 2007. e-Pub 2007.
50. Bienek R, Lazar AJ, Photopoulos C, Lyle S. Cutaneous sebaceous tumors contain a subpopulation of cells expressing the keratin 15 stem cell marker. 55th Annual Montagna Symposium on the Biology of the Skin 156(2):378-380, 2006. e-Pub 2006.
51. Liu J, Hannay JA, Bolshakov S, Yu D, Lazar AJ, Pollock RE, Lev D. Wild type p53 transcriptionally represses matrix metalloproteinase-9 (MMP-9) expression: Implications for soft tissue sarcoma growth and metastasis. CTOS 4(11), 2006. e-Pub 2006.
52. May SA, Diwan AH, Prieto VG, Lazar AJ. Osteocartilaginous/sarcomatous differentiation in a sinonasal mucosal melanoma. ASDP, J Cutan Pathol 33(1):99, 2006. e-Pub 2006.
53. Nash JN, Barrett TL, Lazar AJ. Metastatic Hidradenocarcinoma with Her-2/neu Gene Amplification. ASDP, J Cutan Pathol, 33(1):102, 2006. e-Pub 2006.
54. Bengana C, Wyatt AJ, Ivan D, Hymes SR, Diwan AH, Prieto VG, Lazar AJ. Epidermodysplsia verruciformis-like lesions and graft-versus-host disease in a stem cell transplant patient. ASDP, J Cutan Pathol 33(1):74, 2006. e-Pub 2006.
55. Lazar AJ, Prieto VG, Goel V, Niveiro M, Gershenwald JE, Haluska FG. PTEN Expression, BRAF and NRAS Mutational Status in Primary Cutaneous Melanoma. Keystone Symposium: Advances in the Understanding and Treatment of Melanoma. Keystone Symposium: Advances in the Understanding and Treatment of Melanoma, 2006. e-Pub 2006.
56. Chen SS, Pulliam JF, Hernandez V, Lazar AJ, Lopez-Terrada D. Variant SYT-SSX Fusion Transcripts and Beta-Catenin Mutations detected in Synovial Sarcoma FFPE Tissues by RT-PCR and Direct Sequencing. AMP, 2006. e-Pub 2006.
57. Rother J, Bailey J, Alvarado G, Prieto VG, Lazar AJ, Jones D, W-J H. Molecular dissection of the RAS/RAF/MAPK pathway in primary and metastatic melanoma. ASCO, J Clin Oncol, 24(18S):8050, 2006. e-Pub 2006.
58. Kleinbaum EP, Chen LL, Lazar AJ, Strong L, Zhang W, Choi H, Benjamin R, Patel S, Trent JC. Familial gastrointestinal stromal tumor with homo-/hemizygous kit exon 11 deletion: Genotypic, histopathologic, radiographic, and therapeutic findings. ASCO, J Clin Oncol 24(18S):9527, 2006. e-Pub 2006.
59. Lazar AJ, Lyle S, Calonje E. Body site and type of sebaceous tumor are indicative of DNA mismatch repair status. 55th Annual Montagna Symposium on the Biology of the Skin, 2006. e-Pub 2006.
60. Prieto VG, Diwan AH, Lazar AJ, Johnson MM, Shacherer C, Gershenwald JE. Histo-logic Quantification of Tumor Size in Sentinel Lymph Node Metastases Correlates with Prognosis with Cutaneous Malignant Melanoma. USCAP, Lab Invest 86(Suppl 1):87A (#391), 2006. e-Pub 2006.
61. Prieto VG, Mourad-Zeidan AA, Johnson MM, Diwan AH, Lazar AJ, Shen SS, Reed JA Raz A, Bar-Eli M. Analysis of Galectin-3 Expression in Melanocytic Lesions by Tissue Array. Possible Involvement in Tumor Progression. USCAP, Lab Invest 86(Suppl 1):87A (#390), 2006. e-Pub 2006.
62. Nash JW, Ivan D, Prieto VG, Diwan AH, Calonje E, Barrett T, Sneige N, Lyle S, Lazar AJ. Her-2/neu Expression and Gene Amplification in Malignant and Metastasizing Skin Adnexal Tumors. USCAP, Lab Invest 86(Suppl 1):85A (#382), 2006. e-Pub 2006.
63. Ivan D, Nash JW, Prieto VG, Diwan AH, Calonje E, Lyle S, Lazar AJ. Use of p63 Expression in Distinguishing Primary and Metastatic Cutaneous Adnexal Neoplasms From Metastatic Adenocarcinomas to Skin. USCAP, Lab Invest 86(Suppl 1):82A (#366), 2006. e-Pub 2006.
64. Uzquiano MC, Prieto VG, Lazar AJ, Diwan AH. Metastatic Basal Cell Carcinoma Exhibits Reduced Actin and Calponin Expression. USCAP, Lab Invest 86(Suppl 1):89A (#398), 2006. e-Pub 2006.
65. Ostler DA, Perna AG, Ivan D, Reed JA, Lazar AJ, Diwan AH, Ghorbani R, Prieto VG. Cytokeratin 7 and 20 Expression in Clear Cell Lesions of the Skin. USCAP, Lab Invest 86(Suppl 1):86A (#385), 2006. e-Pub 2006.
66. Khalifeh I, Reed J, Lazar AJ, Diwan AH, Prieto VG. Melanocytic Lesions on the Distal Lower Extremity Share Features of Dysplastic Nevi and Melanoma In-Situ. USCAP, Lab Invest 86(Suppl 1):82A (#367), 2006. e-Pub 2006.
67. Bieniek R, Lazar AJ, Lyle S. Keratin 15 Stem Cell Marker and Other Immunohisto- chemical Characteristics of Sebaceous Neoplasms. USCAP, Lab Invest 86(Suppl 1):77A (#341), 2006. e-Pub 2006.
68. McAuliffe JC, Lazar AJ, Steinert DM, Raymond AK, Benjamin RS, and Trent JC. Vascular Endothelial Growth Factor Expression Correlates With Poor Prognosis in Patients with Gastrointestinal Stromal Tumor Treated with Imatinib Mesylate: Clinical Implications. AACR, 2005. e-Pub 2005.
69. Lazar AJ, Fletcher CD. Distinctive dermal clear cell mesenchymal neoplasm: clinicopathologic analysis of five cases. Am J Dermatopathol 26(4):273-9, 2004. e-Pub 2004. PMID: 15249856.
70. Natarajan E, Lazar AJ, Omobono J, Browne S, and Rheinwald J. Co-expression of p16INK4A and laminin 5 gamma 2 in keratinocytes: a normal wound healing response that goes awry during neoplastic progression to carcinoma. Society for Investigative Dermatology 163(2):477-491, 2004. e-Pub 2004. PMID: 12875969.
71. Lazar AJ, Redston M, Grayson W, Calonje E. Analysis of sebaceous hyperplasia, adenoma and carcinoma by immunohistochemistry for deficiency of DNA mismatch repair proteins MLH1, MSH2 and MSH6. USCAP, Mod Pathol 17(Suppl 1):94A (#389), 2004. e-Pub 2004.
72. Lazar AJ, Fletcher CDM. Cutaneous non-neural granular cell tumors: Analysis of ten cases. USCAP, Mod Pathol 17(Suppl 1):94A (#388), 2004. e-Pub 2004.
73. Lazar AJ, Calonje E, Jr MM, Redston M, McKee PH. Malignant pilomatrixomas are associated with mutations in exon 3 of CTNNB1, the gene encoding beta-catenin. USCAP, Mod Pathol 17(Suppl 1):94A (#390), 2004. e-Pub 2004.
74. Lazar AJ, Fletcher CDM. Distinctive Dermal Clear Cell Mesenchymal Neoplasm: Clinicopathologic Analysis of 5 Cases. Mod Pathol 26(4):273-279, 2003. e-Pub 2003. PMID: 15249856.
75. Lazar AJ McKee PH. Malignant pilomatrixoma with regional lymph node metastasis: analysis of beta-catenin. Mod Pathol 31(1):85, 2003. e-Pub 2003.
76. Kurz W, McKinnon W, Lazar AJ, Cook D, Bosenberg M. Familial multiple pilomatrixomas as a presentation of Gardner's Syndrome. J Cutan Pathol 39(4):440–443, 2003. e-Pub 2003. PMID: 22150579.

Book Chapters

1. Research Programs ACOSC. In: Operative Standards for Cancer Surgery: Volume III Sarcoma, Adrenal, Neuroendocrine, Peritoneal Malignancies, Urothelial, Hepatobiliary. 1. Wolters Kluwer, 2022.
2. Al-Refaie W, Callegaro D, Crago A, Fabbri N, Fairweather M, Gladdy R, Houdek M, Kane III, JM, Keung EZ, Krause KJ, Lazar AJ, Lewis V, Maxwell JE, Miller B, Morris C, Raut CP, Roland CL, Silberfein EJ, Wong SL. Section 1: Sarcoma (5 chapters). In: Operative Standards for Cancer Surgery: Sarcoma, Adrenal, Neuroendocrine, Peritoneal Malignancies, Urothelial, Hepatobiliary. 1st. American College of Surgeons, 2022.
3. Al Sannaa G, Lazar AJ. Cutaneous Metastases (Chapter 35). In: Barnhill's Dermatopathology. 4th. McGraw-Hill, 1240-1266, 2020.
4. Wang WL, Lazar AJ. Soft Tissue. In: Oncologic Surgical Pathology. Springer, 229-283, 2020.
5. Wick MR, Cree IA, Kazakov DV, Lazar AJ, Michal M, Wood BA, Zembowicz A, Sangueza OP. Chapter 3-5: Tumours with sebaceous differentiation: Sebaceous Adenoma. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 213, 2018.
6. Lazar AJ, Forpe A, Kutzner H. Chapter 5-1: Adipocytic tumours: Pleomorphic liposarcoma. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 295, 2018.
7. Lazar AJ, Mahar A. Chapter 5-2: Fibroblastic, myofibroblastic, and fibrohistiocytic tumours: Dermatofibrosarcoma protuberans and variants. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 304-306, 2018.
8. Kutzner H, Lazar AJ, Patel RM, Wang W. Chapter 5-2: Fibroblastic, myofibroblastic, and fibrohistiocytic tumours: Fibromas. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 314-317, 2018.
9. Lazar AJ, Karim R. Chapter 5-2: Fibroblastic, myofibroblastic, and fibrohistiocytic tumours: Nodular fasciitis. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 326-327, 2018.
10. Lazar AJ, Argenyl ZB. Chapter 5-6: Neural tumours: Granular cell tumour. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 364, 2018.
11. Billings SD, Lazar AJ. Chapter 5-7: Tumours of uncertain differentiation: Myxofibrosarcoma. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 371-372, 2018.
12. LeBoit PE, Lazar AJ. Chapter 5-7: Tumours of uncertain differentiation: Primitive non-neural granular cell tumour. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 376, 2018.
13. Scolyer RA, Cree IA, Elder DE, Lazar AJ, Massi D. Chapter 6: Inherited tumour syndromes associated with skin malignancies. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 380-382, 2018.
14. Lazar AJ, Calonje E, Wood BA. Chapter 6-6: Muir-Torre syndrome. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 395-396, 2018.
15. Alkatan H, Loeffler KU, Grossniklaus HE, Lazar AJ. Chapter 1-4: Soft tissue tumours: Fibrous histiocytoma of the conjunctiva and caruncle. In: WHO Classification of Tumours of the Eye. 4th. International Agency of Research on Cancer, 47-48, 2018.
16. Prieto-Granada CN, Van Arnam J, Shah KK, Andea AA, Lazar AJ. Genomic Applications in Melanoma. In: Genomic Applications in Pathology. 2nd. Springer, 509-540, 2018.
17. Elder DE, Barnhill RL, Bastian BC, Cook MG, de la Fouchardiere A, Gerami P, Lazar AJ, Massi D, Mihm MC, Nagore E, Scolyer RA, Yun SJ. Chapter 2: Melanocytic tumours: Introduction. In: Who Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 66-71, 2018.
18. Bastian BC, de la Fouchardiere A, Elder DE, Gerami P, Lazar AJ, Massi D, Nagore E, Scolyer RA, Yun SJ. Chapter 2: Introduction: Genomic landscape of melanoma. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 72-75, 2018.
19. Wick MR, Cree IA, Kazakov DV, Lazar AJ, Michal M, Sangueza OP, Singh R, Wood BA, Zembowicz A. Chapter 3-5: Tumours with sebaceous differentiation: Sebaceoma. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 214-215, 2018.
20. Lazar AJ, Billings, SD, Calonje E, Elder DE, Hornick, JL, Massi D, Requena L, Scolyer RA. Chapter 5: Soft tissue tumours: Introduction. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 292-293, 2018.
21. Folpe A, Kutzner H, Lazar AJ. Chapter 5-1: Adipocytic tumours: Atypical lipomatos tumours. In: WHO Classification of Skin Tumours. 4th. International Agency of Research on Cancer, 294, 2018.
22. DeMatteo RP, Maki RG, Agulnik M, Brookland RK, Hornick JL, Keedy VL, Lazar AJ, O'Sullivan B, Raut, CP, Tedder PS, Pollock RE. Chapter 43: Gastrointestinal Stromal Tumor. In: AJCC Cancer Staging Manual. 8th. Springer, 523-529, 2016.
23. Raut CP, Maki RG, Baldini EH, Hornick JL, Lazar AJ, Riedel RF, Tedder PS, Pollock RE. Chapter 42: Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs. In: AJCC Cancer Staging Manual. 8th. Springer, 517-521, 2016.
24. Yoon SS, Maki RG, Asare EA, Cooper K, Hornick JL, Lazar AJ, Keedy VL, Kirsch DG, Madewell JE, Panicek DM, Randall RL, Tedder PS, Pollock RE. Chapter 41: Soft Tissue Sarcoma of the Trunk and Extremities. In: AJCC Cancer Staging Manual. 8th. Springer, 507-515, 2016.
25. O'Sullivan B, Maki RG, Agulnik M, Patel SG, Lazar AJ, Jones RL, Sturgis EM, Pollock RE. Chapter 40: Soft Tissue Sarcoma of the Head and Neck. In: AJCC Cancer Staging Manual. 8th. Springer, 499-505, 2016.
26. Compton CC, Hess KR, Halabi S, Balis UGJ, Gershenwald JE, Gimotty PA, Guinney J, Lazar AJ, Lu Y, Mahar AL, Mariotto, Moons KGM, Patel SG, Sargent DJ, Weiser MR, Kattan MW. Chapter 4: Risk Models for Individualized Prognosis in the Practice of Precision Oncology. In: AJCC Cancer Staging Manual. 8th. Springer, 47-52, 2016.
27. Gershenwald JE, Scolyer RA, Hess KR, Thompson JF, Long GV, Ross MI, Lazar AJ, Atkins MB, Balch CM, Barnhill RL, Billmoria KY, Brierly JD, Buzaid AC, Byrd DR, Chapman PB, Cochran AJ, Coit DG, Eggermont AM, Elder DE, Faries MB, Flaherty KT, Garbe C, Gardner JM, Gimotty PA, Halpern AC, Haydu LE, Johnson T, Kirkwood JM, Lee AWM, McArthur GA, Mihm MC, Prieto VG, Sober AJ, Wahl RL, Wong SL, Sondak VK. Chapter 47: Melanoma of the Skin. In: AJCC Cancer Staging Manual. 8th. Springer, 563-585, 2016.
28. Pollock RE, Maki FG, Baldini EH, Hornick JL, Keedy VL, Lazar AJ, Madewell JE, Raut CP, Tedder PS, Yoon SS. Chapter 44: Soft Tissue Sarcoma of the Retroperitoneum. In: AJCC Cancer Staging Manual. 8th. Springer, 531-537, 2016.
29. Maki RG, Folpe AL, Guadagnolo BA, Keep VL, Lazar AJ, Randall RL, Raut CP, Yoon SS, Pollock RE. Chapter 45: Soft Tissue Sarcoma -- Unusual Histologies and Sites. In: AJCC Cancer Staging Manual. 8th. Springer, 539-545, 2016.
30. Shalin SC, Lazar AJ. Sebaceous Carcinoma (id: 00469). In: Encyclopedia of Pathology. Springer-Verlag GmbH, 2016.
31. Siroy AE, Davies MA, Lazar AJ. The PI3K-AKT Pathway in Melanoma: An Overview. In: Genetics of Melanoma. Springer, 165-180, 2016.
32. Wang WL, Lazar AJ. Molecular Testing in Cutaneous Mesenchymal Tumors. In: Precision Molecular Pathology of Dermatologic Diseases. Springer, 37-54, 2015.
33. Curry JL, Tetzlaff MT, Lazar AJ, Prieto VG. Application of Molecular Pathology to Cutaneous Melanocytic Lesions. In: Precision Molecular Pathology of Dermatologic Diseases. Springer, 2015.
34. Kunishige JH, Lazar AJ. Cutaneous Tumors. In: McGraw-Hill Specialty Board Review Dermatology A Pictorial Review 3/E. 3rd. McGraw-Hill, 2015.
35. Lazar AJ. Chapter 25: The Skin. In: Robbins Basic Pathology, 9th edition. 9th. Saunders (Elsevier), 2015.
36. Reimann JDR, Lazar AJ, Granter SR. Chapter 13: Neoplastic and Non-neoplastic Vascular Tumors. In: Vascular Disease in Atlas of Heart Diseases. 3rd. Mosby (Elsevier), 2014.
37. Mentzel T, Pedeutour F, Lazar AJ. Chapter 3-23: Dermatofibrosarcoma protuberans. In: World Health Organization (WHO) Classification of Tumours: Pathology & Genetics, Tumours of Soft Tissue and Bone. 4th. IARC Press, 2013.
38. Lazar AJ, Mertens F. Chapter 16-8: Parosteal osteosarcoma. In: World Health Organization (WHO) Classification of Tumours: Pathology & Genetics, Tumours of Soft Tissue and Bone. 4th. IARC Press, 2013.
39. Lazar AJ, Knuutila S, Vigorita V. Chapter 17-2: Fibrosarcoma of Bone. In: World Health Organization (WHO) Classification of Tumours: Pathology & Genetics, Tumours of Soft Tissue and Bone. 4th. IARC Press, 2013.
40. Lazar AJ. Chapter 11-4: Granular cell tumour. In: World Health Organization (WHO) Classification of Tumours: Pathology & Genetics, Tumours of Soft Tissue and Bone. 4th. IARC Press, 2013.
41. Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. In: Practical Soft Tissue Pathology. Elsevier, 2013.
42. Lazar AJ, Oliveira AM, Evans HL. Chapter 3-1: Nodular fasciitis (including cranial and intravascular). In: World Health Organization (WHO) Classification of Tumours: Pathology & Genetics, Tumours of Soft Tissue and Bone. 4th. IARC Press, 2013.
43. Lazar AJ, Bridge JA, Evans HL. Chapter 3-2: Proliferative fasciitis and proliferative myositis. In: World Health Organization (WHO) Classification of Tumours: Pathology & Genetics, Tumours of Soft Tissue and Bone. 4th. IARC Press, 2013.
44. Lazar AJ, Shipley J, Evans HL. Chapter 5-3: Leiomyosarcoma. In: World Health Organization (WHO) Classification of Tumours: Pathology & Genetics, Tumours of Soft Tissue and Bone. 4th. IARC Press, 2013.
45. Raymond AK, Lazar AJ. Pathologic and Molecular Analysis of Bone Sarcomas. In: MD Anderson Cancer Series: Bone Sarcomas. Springer, 2012.
46. Foo WC, Lazar AJ. Chapter 4: Pathology of Desmoid Tumors. In: Desmoid Fibromatosis. Springer-Verlag GmbH, 2011.
47. Diwan AH, Lazar AJ. Nevoid Melanoma. In: Clin Lab Med. 3rd, 2011.
48. Bowles TL, Ross MI, Lazar AJ. Sarcomas of the Skin. In: Chapter 15: Cancer of the Skin. 2nd. Saunders (Elsevier), 2011.
49. Lazar AJ, Murphy GF. Chapter 25, The Skin. In: Pocket Companion to Robbins and Cotran Pathologic Basis of Disease, 8th edition. 8th. Elsevier, 2011.
50. Powers M, Zhang W, Czerniak BA, Lopez-Terrada D, Lazar AJ. Chapter 22: The Molecular Pathology of Sarcomas. In: Translational Pathology of Early Cancer. IOS Press BV, 475-491, 2011.
51. Shalin SC, Lazar AJ. Muir-Torre Syndrome (id: 00450). In: Encyclopedia of Pathology. Springer-Verlag GmbH, 2010.
52. Laga AC, Lazar AJ, Granter SR, Crum CP, Haefner HK. Chapter 5: Benign cysts, rests and adnexal tumors and Cysts of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. 2nd. Saunders (Elsevier), 2010.
53. Laga AC, Lazar AJ, Granter SR, Haefner HK. Chapter 4: Infectious disorders of the lower genital tract. In: Diagnostic Gynecologic and Obstetric Pathology. 2nd. Saunders (Elsevier), 2010.
54. Cangelosi J, Ivan D, Lazar AJ. Chapter 33: Cutaneous Tumors. In: Dermatology: A Pictorial Review. 2nd. McGraw-Hill, 2010.
55. Soft Tissue Sarcoma Committee (Pollock RE, chair, Lazar AJ. Part 5: American Joint Cancer Committee Cancer Staging Manual. In: Musculoskeletal Sites, Soft Tissue Sarcoma. 7th. Greene FL, 2010.
56. Laga AC, Lazar AJ, Haefner H, Granter SR. Chapter 2: Non-infectious inflammatory disorders of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. 2nd. Saunders (Elsevier), 2010.
57. Expert Panel STS. Chapter 26: Soft Tissue Sarcoma. In: AJCC Cancer Staging Manual. 7th. Springer, 291-298, 2009.
58. Lazar AJ, Nash JW, Diwan AH. Chapter 6: Molecular Dermatopathology, Section III of Foundations. In: Diagnostic Pathology: Cell and Tissue Based Molecular Diagnostic Pathology. Churchill Livingston (Elsevier), 2009.
59. Lazar AJ, Murphy GF. Chapter 25: Skin. In: Robbins and Cotran’s Pathologic Basis of Disease. 8th. Saunders (Elsevier), 2009.
60. Oliveira AM, Lazar AJ, Rubin BP. Chapter 10: Molecular Pathology of Sarcomas, Section III of Foundations. In: Diagnostic Pathology: Cell and Tissue Based Molecular Diagnostic Pathology. Churchill Livingston (Elsevier), 2009.
61. Lazar AJ. Chapter 22: The Skin. In: Robbins Basic Pathology, 8th Edition. 8th. Saunders (Elsevier), 2007.
62. Lazar AJ, McKee PH, Haefner H, Granter SR. Chapter 2: Non-infectious inflammatory disorders of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. Saunders (Elsevier), 2005.
63. Lazar AJ, Granter SR, McKee PH, Haefner HK. Chapter 4: Infectious disorders of the lower genital tract. In: Diagnostic Gynecologic and Obstetric Pathology. 1. Saunders (Elsevier), 2005.
64. Lazar AJ, Granter SR, Haefner, HK. Chapter 5: Benign cysts, rests and adnexal tumors and Cysts of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. Saunders (Elsevier), 2005.
65. Granter SR, Lazar AJ, Haefner HK, McKee PH. Chapter 8: Melanocytic tumors of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. Saunders (Elsevier), 2005.
66. Lazar AJ. Chapter 32: Tumors of the Sebaceous Glands. In: Pathology of the Skin with Clinical Correlations. 3rd. Mosby (Elsevier), 2005.
67. Lazar AJ, Granter SR. Chapter 13: Neoplastic and Non-neoplastic Vascular Tumors. In: Atlas of Heart Diseases, Vascular Diseases. 2nd. Mosby (Elsevier), 2003.
68. Kunishige JH, Panse G, Lazar AJ. Cutaneous Tumors. In: McGraw-Hill Specialty Board Review Dermatology A Pictorial Review, 4/E. 4th. McGraw-Hill Education.

Books (edited and written)

1. WHO Classification of Tumours Editorial Board. Endocrine and Neuroendocrine Tumours. Ed(s) 5th. IARC Press, 2025.
2. WHO Classification of Tumours Editorial Board. Head and Neck Tumours. Ed(s) 5th. IARC Press, 2024.
3. WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours. Ed(s) 5th. IARC Press, 2024.
4. The Covid Crisis Group. Lessons from the Covid War: An Investigative Report. Ed(s) 1st. Public Affairs / Perseus Books Group, 2023.
5. WHO Classification of Tumours Editorial Board. Paediatric Tumours. Ed(s) 5th. IARC Press, 2023.
6. WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours. Ed(s) 5th. IARC Press, 2022.
7. WHO Classification of Tumours Editorial Board. Thoracic Tumours. Ed(s) 5th. IARC Press, 2021.
8. WHO Classification of Tumours Editorial Board. Central Nervous System Tumours. Ed(s) 5th. IARC Press, 2021.
9. WHO Classification of Tumours Editorial Board. Female Genital Tumours. Ed(s) 5th. IARC Press, 2020.
10. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. Ed(s) 5th. IARC Press, 2020.
11. WHO Classification of Tumours Editorial Board. Breast Tumours. Ed(s) 5th. IARC Press, 2019.
12. WHO Classification of Tumours Editorial Board. Digestive System Tumours. Ed(s) 5th. IARC Press, 2019.
13. Calonje E, Lazar AJ, Luzar B. Diagnostic Atlas of Cutaneous Mesenchymal Neoplasia. Ed(s) 1st. Elsevier, 2019.
14. authors WHO. WHO Classification of Skin Tumors (Editor, Soft tissue and Genetic Syndromes chapters). Ed(s) 4th. IARC Press, 2018.
15. Multi-authored. McKee's Pathology of the Skin with Clinical Correlations, 5th ed. Ed(s) 5th. Elsevier, 2018.
16. Multi-authored. Pathology of the Skin with Clinical Correlations 4th ed. Ed(s) 4th. Saunders/Elsevier, 2012.

Letters to the Editor

1. Charville GW, Wang WL, Ingram DR, Roy A, Thomas D, Patel RM, Hornick JL, van de Rijn M, Lazar AJ. PAX7 expression in sarcomas bearing the EWSR1-NFATC2 translocation. Mod Pathol 32: 154-156, 2019.
2. Ivan D, Diwan AH, Lazar AJ, Prieto VG. The usefulness of p63 detection for differentiating primary from metastatic skin adenocarcinomas. J Cutan Pathol 35: 880-881, 2008.